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ABSTRACT
ABSTRACT
The aim of this study was to ascertain the roles of selected members of the bcl-2 
protein family of proteins in the developing peripheral nervous system. Two 
experimental approaches were used: microlnjectlon of expression plasmids 
encoding these proteins into cultured neurons and studying the in vitro and in vivo 
development of neurons In mouse embryos with targeted null mutations In the 
genes encoding these proteins. Overexpression of bcl-2, bcl-xL, and bcl-xp In 
cultured embryonic sensory neurons prevented the death of these neurons 
following neurotrophin withdrawal. Accordingly, sensory neurons from bcl-2~ ~^ 
embryos survived less well in culture with neurotrophlns than neurons from wild 
type embryos and there were fewer neurons and more dying cells In the cranial 
sensory ganglia of bci-2~f~ embryos during the phase of naturally occurring 
neuronal death. In addition to demonstrating a role for bcl-2 in regulating the 
survival of embyronic sensory neurons, studies of neurons from of bcl-2~^~ 
embryos revealed new roles for bcl-2 In neuronal development, bcl-2-deflclent 
sensory neurons extended axons more slowly and underwent an early maturational 
change more slowly than wild type neurons, indicating that bcl-2 may regulate 
aspects of early neuronal development independently of Its effects on survival. 
Overexpression of bax In chicken sensory neurons also rescued some of these 
neurons following neurotrophin deprivation, contradicting the view that bax Is 
exclusively a pro-apoptotic member of the bcl-2 family. However, sensory neurons 
from bax-2~f~ embryos survived better In culture than neurons from wild type 
embryos and there were more neurons and fewer dying cells in the cranial sensory 
ganglia of bax-2~f~ embryos, suggesting that bax may play different roles In 
regulating the survival of certain neurons In these two classes of vertebrates.
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I. INTRODUCTION
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CHAPTER ONE 
INTRODUCTION
PROJECT AIMS
The aim of this project was to elucidate further the role that members of the bcl-2 
gene family play in regulating the survival of developing peripheral neurons. The 
studies were carried out in two species, the chicken, Gallus domesticus. and the 
mouse, Mus musculus. Two experimental approaches were taken in this study.
First, bcl-2 family members were overexpressed in cultured chick neurons using 
microinjection of appropriate cDNA expression constructs to achieve 
supraphysiological expression. Second, mice carrying null mutations in the genes 
encoding bcl-2 and bax were analyzed to determine the effect that the lack of 
these proteins has on neuronal survival both in vitro and in vivo.
CELL DEATH
There are two distinct forms of death that cells undergo. The first form is 
physiological cell death, which is widespread during the ontogeny of both 
vertebrates and invertebrates, and thereafter in postnatal and adult life as part of 
normal tissue homeostasis, and the second form is necrotic cell death, which occurs 
in response to pathogenic stimuli (Giarke, 1990; Ellis & Horvitz, 1991). Physiological 
cell death is an active process which in many cases requires gene transcription and 
protein synthesis (Martin et al.. 1988; Scott & Davies, 1990; Ellis & Horvitz, 1991) 
and can be blocked pharmacologically. In contrast, necrosis is a passive process, 
not requiring transcription or protein synthesis and is characterized by clumping 
of chromatin, swelling of organelles, floculent mitochondria, and membrane 
disruption (Martin et ai., 1988; Scott & Davies, 1990; Ellis & Horvitz,
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1991). Three main morphoiogically distinct forms of physioiogical cell death occur 
during development (Schwelchel & Merker, 1973).
Autophagic Degeneration
This form of programmed cell death is characterized by the formation of autophagic 
vacuoles. Mitochondria and endoplasmic reticulum dilate and the Golgi apparatus 
enlarges. Primary lysosomes discharge their hydrolytic enzymes into autophagic 
vacuoles which, in turn, spill their contents into the cytoplasm. The cell debris is 
cleared away by heterophagy.
Non-lysosomai Degradation
In this process the intracellular organelles swell and organelle-free "spaces" appear 
in the cytoplasm. These "spaces" fuse together and connect with the extraceliuiar 
cavity. The cell is destroyed by the breakdown of the cellular structure into smaller 
and smaller pieces. The ceil's own iysosomes seem not to be invoived and there is 
no detectable phagocytosis by neighboring ceils.
Apoptosis
The term apoptosis comes from the Greek and means failing of ieaves (Altman,
1992). This form of celi death begins with the condensation of cytoplasm and 
nuclear DNA. As a result of the latter, the nucleus appears condensed and is 
described as pyknotic. As the process continues, the nuclear and cellular 
membranes become convoluted, giving the ceil an Irregular appearance. Nuclear 
DNA becomes fragmented into oligonucleosomal iengths, although mitochondrial 
DNA remains intact. Finaliy, the ceil surface develops blebs that are phagocytosed 
by adjacent cells. Apoptosis is the process by which cell death occurs in the 
developing peripheral nervous system (Garcia et al., 1992; Allsopp et al., 1993).
30
BFigure 1.1 : Living and apoptotic neurons from the E1Q chick ciliary ganglion.
Scaie bar represents 50 pm.
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WHY DOES CELL DEATH OCCUR?
The theories of neo-Darwinism state that only individuals possessing characteristics 
that confer a selective advantage will out-compete other members of their species. 
Their 'good' characteristics will be maintained within the population whilst 
disadvantageous characteristics are selected against and will not be maintained in 
the gene pool. With this in mind, it initially seems counterintuitive that cell death 
might confer a selective advantage when energy is used to create cells that are 
then destroyed. It is highly unlikely, however, that a wasteful mechanism would be 
maintained throughout evolution from Volvox (Pommerville & Kochert, 1982) to the 
nematode Caenorhabditis eleaans (Ellis et al., 1991) and mammals such as Homo 
sapiens (Clarke, 1990). There are several hypotheses as to why cell death occurs 
and how it produces a selective advantage.
Cell death Purina Morphogenesis
Extensive cell death occurs to form the interdigital spaces in the foot of most 
amniotes (Saunders & Fallon, 1966). If this cell death process stops early, 
interdigital webbing occurs (Pautou, 1974) as occurs in the webbed feet of water 
fowl. The advantage of using cell death to form the individual digits therefore 
appears to generate scope for adaptability.
Harmful Cells
Cell death can eliminate cells that pose a danger to an organism. For example, some 
thymocytes carry T-cell receptors capable of recognising and attacking self (Dwyer,
1993). If these cells were to mature and leave the thymus, an autoimmune reaction 
would occur that could be fatal. Under normal circumstances, self-reactive 
thymocytes undergo apoptotic cell death whilst still in the thymus.
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Cells with a Transient Function
Some cells die at a time when they have completed their function within the 
developing organism. One of the best examples of this is the tail-spike of 
Caenorhabditis eleaans (Sulston et al., 1983). The tail-spike ceils generate filaments 
that shape the long tapering tail. Once these filaments are formed, the cells have 
completed their function and die.
Cells that Develop Improperly
In the developing visual system, cell death preferentially eliminates neurons that 
have formed Improper connections (Cowan et al., 1984). Early in the development 
of the isthmo-optic nucleus, a small number of neurons project their axons to the 
Ipsilaterai, rather than the contralateral eye. During the phase of naturally occurring 
cell death, essentially all the ipsilaterally projecting cells die as compared to less 
than 60% death in the neuronal population as a whole.
Cells Generated in Excess
During development, some celi types are produced in excess and only some of these 
ceils will survive. For example. In the developing dorsal root ganglia (DRG), neurons 
require trophic support from target-derived neurotrophic factors to survive.
Removal of the peripheral target field (limb bud) prior to Innervation substantially 
increases the magnitude of neuronal death (Hamburger & Levi-Montalcini, 1949; 
Prestige, 1967; Carr & Simpson, 1978; Hamburger & Yip, 1984). Conversely, 
increasing the size of the target field by grafting in an additional limb bud results in 
decreased ceil death in the DRG. Thus, the innervation is adjusted to suit the size of 
the target field. This size matching facilitates evolution such that if there is a 
mutation that changes the size of a body part the density of innervation can be 
adjusted accordingly. Again, cell death is conferring adaptability.
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THE REGULATION OF APOPTOSIS DURING DEVELOPMENT OF THE 
VERTEBRATE PERIPHERAL NERVOUS SYSTEM
Neurodevelopment
The development of the vertebrate nervous system is a multistage process 
beginning with neural induction in which the cells of the dorsal ectoderm are induced 
by the underlying precaudal mesoderm (Spemann, 1938) to form the neural plate 
(Lillie, 1908). A midline furrow subsequently forms and the neural folds lying on 
either side of this round up to meet each other in the dorsal midline (Copp et al,
1990; Schoenwolf & Smith, 1990). Cell surface protrusions and lamellipodia are 
extended just prior to fusion and these interdigitate as cells come into contact to 
form the intact neural tube. Finally, the neural tube sinks beneath the surface of the 
ectoderm and the overlying surface ectoderm is repaired. The neural tube gives rise 
to the central nervous system, i.e. the brain and spinal cord.
The peripheral nervous system is composed of the ganglia of the autonomic and 
sensory systems and the peripheral nerves which lie outside the brain and spinal 
cord. The cell bodies of peripheral sensory neurons lie within the dorsal root and 
cranial sensory ganglia. The cranial sensory neurons are segmented into ganglia on 
five of the twelve pairs of cranial nerves. The exception to this is the trigeminal 
mesencephalic nucleus which is a sub-population of sensory neurons located in the 
midbrain.
Most of the peripheral nervous system is derived from the neural crest. This is a 
transient structure comprised of cells that detach from the margin of the neural 
ectoderm at the time of neural tube closure. The cells migrate out into the 
periphery along well defined pathways and differentiate into most of the neurons 
and glia of the peripheral nervous system, as well as craniofacial mesenchyme, 
chromaffin cells of the adrenal medulla, and melanocytes in the skin (Weston,
1962). Some populations of cranial sensory neurons are also derived from placodes
34
that form as thickenings in the ectoderm of the cephalic region. The anterior 
pituitary gland, the olfactory sensory epithelium and the lens of the eye are also 
derived from placodes. The origins of the neurons of the avian cranial sensory 
neurons have been determined by a series of mapping experiments involving the 
transplantation of neural crest and placode derived cells (Weston, 1962; Le Douarin, 
1973; D'Amico-Martel, 1982). Table 1.1 shows the origins of avian cranial sensory 
neurons.
35
Neuronal Population Cranial Nerve Embryonic origin
Trigminal Mesencephalic 
Nucleus
V Neural Crest
Trigeminal Ganglion V
dorsomedial part Neural crest
ventrolateral part Trigeminal Placode
Geniculate Ganglion V II First Epibrachial Placode
Vestibular Ganglion V III Otic placode
Acoustic Ganglion V III Otic placode
Jugular-superior Ganglion IX /X Neural Crest
Petrosal Ganglion IX Second Epibrachial Placode
Nodose Ganglion X Third Epibrachial Placode
Table 1.1: Origins of avian cranial sensory neurons
Neurons are generated in excess during the development of the peripheral nervous 
system and shortly after they begin to innervate their target tissues, large numbers 
degenerate by a process bearing the histological features of apoptosis (Oppenheim, 
1991 ; Allsopp et al., 1993; Garcia et al., 1992) and which requires RNA and protein
36
synthesis (Martin et al., 1988; Scott & Davies, 1990). In the case of sensory 
neurons, the magnitude of this cell death ranges from 25% in the vestibular and 
cochlear ganglia (Ard & Merest, 1984) to over 73% in the trigeminal mesencephalic 
nucleus (Rogers & Cowan, 1974).
According to the neurotrophic hypothesis, neuronal target fields play an important 
role in regulating the number of neurons that survive the period of cell death by 
producing limited quantities of neurotrophic factors (Cowan et al., 1984; Davies 
1988b and c; Purves ,1988; Barde, 1989). Neurons that procure an adequate 
supply of these factors survive whilst those that do not die. The neurotrophic 
theory was Initially proposed on the basis of results of studies investigating the 
effects of nerve growth factor (NGF), the first neurotrophic factor to be identified 
(Cohen, 1960). The more recent discovery and characterisation of other members 
of the NGF family, and other unrelated molecules that also support neuronal 
survival, have provided further evidence to support the theory.
The Neurotrophins
NGF (Cohen, 1960), BDNF (Barde et al., 1982), NT-3 (Ernfors et al., 1990; Hohn et 
al., 1990; Jones & Reichardt, 1990; Maisonpierre et al., 1990a,b), NT-4/5  
(Berkemeier et al., 1991 ; Ip et al., 1992) and NT-6 (Gotz et al., 1994) are ail 
members of the neurotrophin family of structurally-related polypeptide neurotrophic 
factors. Elucidation of the primary structures of these molecules has revealed that 
their basic conformations are determined by strictly conserved cysteine-rich 
domains. Distinct regions of variation between the molecules are responsible for 
their binding to specific high-affinity receptors. Ail the neurotrophins also bind a 
low-affinity receptor that is common to all the factors.
These factors have many other effects distinct from promoting neuronal survival 
such as stimulating neurite outgrowth and promoting maturation and differentiation 
of neurons (Kalcheim & Gendreau, 1988; Wright et al., 1992).
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Nerve Growth Factor
Nerve growth factor (NGF) was initially isolated from a fraction of snake venom 
(Cohen, 1960). Thereafter, the murine submandibular salivary gland was discovered 
to be an extremely rich source of this protein (Cohen, 1960). Determination of the 
amino acid sequence of murine NGF (Angeletti & Bradshaw, 1971) led to the cloning 
of the murine NGF cDNA (Scott et al., 1983). Subsequently, human, bovine and 
chick NGF genes were cloned (Ullrich et al., 1983; Meier et al., 1986; Ebendal et al., 
1986).
A 307 amino acid precursor polypeptide is encoded by the murine NGF gene and 
this is further processed to give the mature 118 amino acid glycosylated protein 
(Berger & Shooter, 1977; Scott et al., 1983; Edwards et al., 1988). Two of these 
118 amino acid proteins interact to form a homodimer which is the biologically 
active form of NGF. Detailed analysis of the tertiary structure of NGF using X-ray 
diffraction has revealed that mature NGF contains a “cysteine knot” of three 
interchain disulphide bonds and two antiparallei p strands. Together these form a 
flat surface where the two subunits associate (McDonald et al., 1991). Four loop 
regions contain many of the amino acids that vary between neurotrophins, and this 
suggests that it is these regions which confer receptor binding specificity (Ebendal, 
1992).
There is much in vitro and in vivo evidence that NGF can promote the survival of 
sympathetic neurons, certain types of sensory neurons and basal forebrain 
cholinergic neurons (Chun & Patterson, 1977; Hamburger et al., 1981; Davies & 
Lindsay, 1985; Levi-Montaicini, 1987; Hartikka & Hefti, 1988; Barde, 1989; Davies, 
1994c). Furthermore, many tissues that synthesise NGF have been found to be the 
target tissues of NGF responsive neurons (Korsching & Thoenen, 1983; Heumann et 
al., 1984; Shelton & Reichardt, 1984; Korsching et al., 1985). A detailed study of 
the developing murine whisker pad first elucidated the exact identity of NGF 
secreting target cells (Davies et al., 1987a). The developing whisker pad was
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enzymatically dissociated into its main components: the presumptive epidermis and 
dermis. Subsequent analysis of NGF expression demonstrated that the highest levels 
of NGF are expressed in the epithelium (Davies et al., 1987a). Furthermore, the 
concentration of NGF mRNA in the epithelium of the opthalmic, maxillary and 
mandibular territories of the trigeminal ganglion of the mouse has been found to be 
related to the innervation density of those territories (Harper and Davies, 1990).
The timing of NGF synthesis in target tissues has been shown to coincide with the 
onset of target field innervation (Davies et al., 1987a; Korsching & Thoenen, 1988; 
Harper and Davies, 1990).
Mice with a targeted null mutation of the NGF gene have facilitated in vivo studies 
of NGF in the nervous system. Mice homozygous for such a mutation fail to respond 
to noxious mechanical stimuli due to an impaired nociceptive system (Crowley et al.,
1994). Neuronal loss in the trigeminal, dorsal root and sympathetic ganglia of these 
mice has been demonstrated using histological techniques. The cell loss within the 
dorsal root ganglia is restricted to a subset of neurons that convey nociceptive and 
thermoceptive information (Crowley et al., 1994). In the central nervous system, 
NGF null mutant mice do not suffer significant loss of basal forebrain neurons but do 
display lighter immunostaining for cholinacetyltransferase as compared to wild type 
mice. This suggests that NGF is required for regulation of the functional status 
rather than the survival of these cells (Crowley et al., 1994). In contrast, 
overexpression of NGF in the murine epithelium results in decreased neuronal loss in 
certain sensory and sympathetic ganglia (Albers et al., 1994). These studies provide 
in vivo evidence for the dependence of certain sensory and sympathetic neurons on 
NGF.
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Brain-derived Neurotrophic Factor
Brain-derived neurotrophic factor (BDNF) was the second member of the NGF family 
to be characterised. It was first isolated from porcine brain and is a 12kDa basic 
protein (Barde et ai., 1982). Like NGF, BDNF is synthesised as a precursor 
polypeptide that is further processed to give a mature 119 amino acid glycosylated 
protein. BDNF has approximately 50% sequence identity with NGF, including 
conservation of the six cysteine residues involved in the formation of the “cysteine 
knot” (Leibrock et al., 1989). The biologically active form of BDNF exists as a 
homodimer linked by three disulphide bonds (Radziejewski et al., 1992). BDNF has 
subsequently been cloned in other species including human, mouse and rat (Hofer et 
al., 1990; Jones & Reichardt, 1990; Maisonpierre et al., 1991).
BDNF has been shown to enhance the survival and differentiation of certain central 
nervous system neurons in vitro including embryonic basai forebrain cholinergic 
neurons, motoneurons, and retinal ganglion cells (Alderson et ai., 1990; Knusel et 
al., 1991; Oppenheim et ai., 1992; Korsching, 1993). In the peripheral nervous 
system, BDNF has been shown to promote the survival of certain sensory neurons 
(Lindsay et al., 1985; Davies et al., 1986b; Barde et al., 1987; Davies et al., 1987b; 
Hofer & Barde, 1988). Northern analysis of BDNF mRNA expression has revealed 
that the centrai nervous system is the predominant site of expression (Leibrock et 
al., 1989; Hofer et al., 1990; Maisonpierre et al., 1990a). The highest levels of 
BDNF mRNA are present in the hippocampus, cerebral cortex and cerebellum with 
appreciable levels in the spinal cord and hindbrain which are the central target fields 
of BDNF-responsive sensory neurons. In the peripheral nervous system, BDNF mRNA 
is found in neurons of sympathetic, dorsal root and trigeminal ganglia where it is 
expressed by NGF-dependent neurons suggesting a possible autocrine and/or 
paracrine mechanism (Schecterson & Bothwell, 1992; Robinson et al., 1996).
Outwith the nervous system, BDNF mRNA is found at low levels in muscle, heart, 
skin and lung (Maisonpierre et al., 1990a; Schecterson & Bothwell, 1992).
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The in vivo role of BDNF has been further elucidated utilising mice that are 
homozygous for a null mutation in the BDNF gene. These mice develop symptoms of 
nervous system dysfunction including ataxia and also display substantially reduced 
numbers of cranial and spinal sensory neurons. In particular, deficiencies are 
observed in trigeminal, geniculate, vestibular and nodose ganglia (Ernfors et al.,
1994; Jones et al., 1994). Although no gross structural abnormalities are observed 
in the central nervous system, the expression of neuropeptide Y and calcium binding 
proteins is altered in many neurons perhaps indicating abnormal functioning (Ernfors 
et al., 1994; Jones et al., 1994). Also, as these mice show early postnatal lethality, 
they may simply not survive long enough for a wider phenotype to be observed.
This suggests that BDNF is an essential factor for the survival of several populations 
of sensory neurons during ontogeny, yet it does not appear to be essential for 
central nervous system development (Ernfors et al., 1994; Jones et al., 1994).
Neurotrophin-3
Neurotrophin-3 (NT-3), the third member of the NGF gene family to be identified, 
was isolated using the polymerase chain reaction taking advantage of the nucleotide 
sequence homology between the members of the emerging gene family (Hohn et 
al., 1990; Maisonpierre et al., 1990b; Rosenthal et al., 1990). Mature NT-3 is 
cleaved from a 258 amino acid precursor polypeptide (Hohn et al., 1990; 
Maisonpierre et al., 1990b). NT-3 is related structurally to both NGF and BDNF 
sharing around 50-60%  amino acid identity with these two proteins including all six 
cysteine residues involved in formation of the "cysteine knot" (Hohn et al., 1990). 
Like NGF and BDNF, the biologically active form of NT-3 is a homodimer 
(Radziejewski et al., 1992).
NT-3 mRNA is expressed in heart, liver, kidney, spleen, lung and intestine and also in 
several regions of the central nervous system. In the fetal rat, NT-3 mRNA is 
detectable in the tissues of the inner ear, iris, and the target fields of the trigeminal 
ganglion, especially the epithelium of the whisker follicles (Hallbook et al., 1993;
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Pirvola et ai., 1992; Ernfors et al., 1992). Confirmation of the expression of NT-3 
mRNA in the developing trigeminal target territory has been shown in the mouse 
using quantitative Northern Blotting. NT-3 mRNA is expressed at the highest levels 
in the epithelium of the most densely innervated target field at El 3, the age at 
which naturally occurring cell death is occurring in the trigeminal ganglion (Buchman 
& Davies, 1993).
NT-3-deficient mice exhibit substantial neuronal loss in the dorsal root, nodose and 
trigeminal sensory ganglia, the trigeminal mesencephalic nucleus, spiral ganglion of 
the cochlea and the sympathetic superior cervical ganglion (Ernfors et al., 1994; 
Farinias et al., 1994; Tessarollo et al., 1994). Also, the main components of the 
proprioceptive system, that is the muscle spindles and Golgi tendon organs, are 
missing. These are the peripheral sense organs of the large-diameter proprioceptive 
neurons of the DRG. These neurons are absent in NT-3-deficient mice (Ernfors et al., 
1994). No effects have been observed in the central nervous system. However, like 
BDNF-deficient mice, this may be due to early postnatal lethality.
Neurotrophin-4/5
Neurotrophin 4 /5  (N T-4 /5) was identified taking advantage of the homology 
between NGF, BDNF and NT-3 (Hallbook et al., 1991). The NT-4 gene of Xenopus 
laevis encodes a 236 amino acid precursor protein that is processed to give the 
mature 123 amino acid protein. The mature protein has 50-60%  identity with NGF, 
BDNF, and NT-3 including conservation of all six of the structurally important 
cysteine residues (Hallbook et al., 1991 ). A mammalian homolog, designated 
Neurotrophin-5 was cloned in both human and rat (Berkmeier et al., 1991 ; Ip et al.,
1992). As mammalian NT-5 is believed to be the same molecule as Xenopus NT-4, 
the protein is now referred to as NT-4/5.
NT-4/5 has been shown to be a mammalian-specific survival factor for distinct 
populations of sensory neurons. For example, NT-4/5 supports the survival of NGF-
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dependent neurons of the murine trigeminal and jugular ganglia during the earliest 
stages of target field innervation in addition to supporting BDNF-dependent nodose 
neurons during the period of naturally occurring neuronal death. Mammalian NT-4/5  
has negligible survival promoting activity on chick neurons. Since Xenopus laevis NT- 
4 has greater activity on chick neurons than mammalian NT-4/5, this lack of activity 
of mammalian NT-4/5 on chick neurons may reflect sequence divergence between 
mammals and chick (Davies et al., 1993). In the central nervous system, NT-4/5  
supports the survival of embryonic rat motoneurons and cholinergic forebrain 
neurons in vitro (Henderson et al., 1993; Friedman et al., 1993).
NT-4/5-deficient mice show severe neuronal loss in nodose, petrosal and geniculate 
ganglia, whereas sympathetic neurons of the superior cervical ganglion, facial 
motoneurons and midbrain dopaminergic neurons are not affected (Conover et al.,
1995; Liu et al., 1995; Erickson et al., 1996).
Neurotrophin-6
To date, NT-6 has only been identified in the teleost Xiphophorus macuiatus (Gotz 
et al., 1994). The predicted structure of NT-6 suggests that the precursor 
polypeptide is comprised of 186 amino acids and has a molecular weight of 31.5 
kDa. This is proteolytically cleaved to give the mature 143 amino acid protein. All 
six of the structurally important cysteine residues are conserved. NT-6 mRNA is 
expressed in the developing and mature brain, the gill, liver, eye, skin, spleen, heart 
and skeletal muscle of adult fish (Gotz et al., 1994). Like NGF, NT-6 can support the 
survival of embryonic chick dorsal root ganglion neurons and sympathetic neurons 
but not nodose or ciliary neurons (Gotz et al., 1994), suggesting a spectrum of 
biological activity that is similar to that of NGF.
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Figure 1.2: Schematic diagram summarising the interaction of neurotrophins with 
members of the Trk family of tvrosine kinase receptors.
Neurotrophic Factor Receptors
The members of the NGF family recognise two type of receptors that can be 
distinguished according to their pharmacological properties (Meakin & Shooter,
1992). One of these types binds all the factors with equal low affinity, having a 
dissociation constant of 10'^M. In many cells, this receptor corresponds to a cell 
surface protein with a molecular weight of 75 kDa, and it is referred to as p75 
(Johnson et al., 1986; Radeke et al., 1987; Large et al., 1989). The precise role of 
p75 is as yet poorly understood, but it may act in some way to form part of a 
complex with, or interact in some other way with the second class of receptors 
(Bothwell, 1991 ; Thoenen, 1991). These are products of the tr/c oncogenes, a 
family of related tyrosine kinase-bearing receptors, Figure 1.2. They show specific, 
high affinity binding for the neurotrophins and are capable of internalising the bound 
factor, unlike p75 (Chao, 1992; Meakin et al., 1992). The binding of neurotrophins
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to the trk receptors induces phosphorylation of tyrosine residues in the kinase 
domain which in turn activate a number of Intracellular secondary messenger 
systems (Kaplan et al., 1991a, b; Klein et al., 1991a; Jing et al., 1992).
The p75 Receptor
The human p75 gene was discovered using gene transfer assays with subsequent 
immunological detection of the transfected NGF receptor-expressing cells (Chao et 
al., 1986). The gene encodes a glycoprotein consisting of a singie transmembrane 
domain polypeptide of 427 amino acid residues, 399 of which make up the mature 
protein (Johnson et al., 1986; Radeke et al., 1987; Large et al., 1989). The 
extracellular domain bears four conserved cysteine repeats which have been 
demonstrated to be responsible for ligand recognition. The cysteine repeats are 
common to members of a family of cell surface receptors that includes the Fas 
antigen and Type I and Type II receptors for tumor necrosis factor (Nagata & 
Golstein, 1995). The intracellular domain of p75 contains a small segment that is 
homologous to the death domain of Fas and Type I receptor for tumor necrosis 
factor (Nagata & Golstein, 1995; Chapman, 1995). A soluble, truncated form of 
p75 has been isolated from conditioned media of p75-producing cells and in various 
biological fluids (DiStefano & Johnson, 1988). This comprises the extracellular 
domain only and is thought to be produced by post-translational processing as 
opposed to differential splicing. The biological significance of this truncated form is 
unclear. It binds NGF, BDNF and NT-3 with equal affinity to the full length receptor. 
Truncated p75 may limit the activity of neurotrophins by competing for these 
factors with the full-length receptor or act as a neurotrophin transporter.
The initial characterisation of p75 indicated that it is insufficient for high-affinity 
binding of neurotrophins and NGF responsiveness (Chao et al., 1986; Radeke et al., 
1987; Hempstead et al., 1989). The finding that the trk tyrosine kinases are 
essential for high-affinity binding and biological function of the NGF family of
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neurotrophins and can mediate the effects of neurotrophins in the absence of p75 
has cast questions as to the relevance of p75 for neurotrophic function (Chao,
1990; Meakin et al,, 1992). The p75 neurotrophin receptor belongs to a family of 
transmembrane molecules including Fas and CD40 (Chao, 1994) which also serve as 
receptors for the tumor necrosis factor family of cytokines. Each receptor shares a 
common extracellular structure containing conserved cysteine-rich repeats. Because 
all the members of the NGF family bind p75 with similar affinity, p75 may either act 
as a common subunit in a neurotrophin receptor complex with the trk family 
members or it may mediate the actions of the neurotrophins by independent 
mechanisms. The role of the intracellular domain still remains to be fully elucidated. 
However, it has been shown that deletions in this region interfere with the ability of 
p75 to form functional high affinity NGF receptors (Hempstead et al., 1989).
Recent evidence suggests that the intracellular domain has sphingomyelinase 
activity and activates ceramide intracellular second messenger pathways 
(Dobrowsky et al., 1994).
Studies of p75-deficient murine neurons in vitro have shown that p75 is not 
required for the survival response of neurons to neurotrophins. However, the 
response of embryonic sensory and sympathetic postnatai neurons which are p75- 
deficient to NGF requires a higher NGF concentration that wild type cells. This 
suggests that p75 specifically enhances the sensitivity of NGF-responsive neurons 
to NGF (Davies et al., 1993; Lee et al., 1994a). The sensitivity of neurons to other 
neurotrophins is not reduced in the absence of p75. This is in keeping with the 
phenotype of p75 deficient mice which exhibit a partial loss of NGF-dependent 
sensory and sympathetic neurons with no major effects on neurons of the central 
nervous system (Lee et al., 1992; Lee et al., 1994b).
p75 has been shown to selectively modulate the actions of neurotrophins in cells 
expressing different Trk receptors. The ability of NT-3 to activate TrkA in PCI 2 cells
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is enhanced when p75 is prevented from binding to TrkA using antibodies or when 
p75 expression is very low. (Clary & Reichardt, 1994; Benedetti et al., 1993),
There is some experimental evidence to suggest that p75 is able to promote 
apoptosis in the absence of a ligand. In PCI 2 cells grown without NGF, p75 
expression appears to accelerate apoptosis (Rabizadeh et al., 1993). Likewise, 
antisense p75 oligonucleotides can promote the survival of postnatal rat dorsal root 
ganglion cells grown without NGF (Barrett & Bartlett, 1994). In contrast, antisense 
p75 oligonucleotides reduce the survival-promoting effects of NGF in embryonic rat 
DRG neurons suggesting that there is a developmental switch in the role that p75 
plays in regulating apoptosis (Barrett & Bartlett, 1994). p75 cytotoxicity has aiso 
been shown to be triggered by NGF binding (Farde et al., 1996; Casaccia-Bonnefil et 
al., 1996). Anti-NGF antibodies or antibodies that prevent NGF binding to p75 cause 
a significant reduction in apoptosis of chick embryo retina prior to innervation from 
the tectum (Farde et al., 1996). Mature oligodendrocytes grown in vitro rapidly 
undergo apoptosis when NGF is added to the culture medium (Casaccia-Bonnefil et 
al., 1996). In both cases, the cells express p75 but not TrkA. This raises the 
possibility that in the absence of TrkA, NGF-bound p75 conveys a death-promoting 
signal.
Trk Tyrosine Kinase Receptors
The human trk (tropomysosin kinase) proto-oncogene locus was first identified 
when it became malignantly active in a colon carcinoma patient (Martin-Zanca et ai., 
1986; Martin-Zanca et al., 1989). This proto-oncogene was found to encode two 
tyrosine protein kinase isoforms of 790 and 796 amino acid residues known as TrkA 
(Martin-Zanca et al., 1989; Meakin et al., 1992; Barker et al., 1993; Horigome et al.,
1993) which exhibits the structural characteristics of a growth factor receptor 
(Chao, 1992). The structure includes a signal peptide followed by an extracellular 
domain responsible for interaction with NGF, a single transmembrane domain and a
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cytoplasmic region that encompasses the tyrosine kinase catalytic domain (Martin- 
Zanca et a!., 1989).
The trkA gene was found, by in situ hybridisation, to be highly expressed in NGF 
dependent neurons in the mouse embryo (Martin-Zanca et ai., 1990). A large body 
of evidence has accumulated showing that TrkA is a component of the NGF high 
affinity receptor. For example, NGF stimulates tyrosine autophosphorylation of TrkA 
in P C I2 cells, in sensory neurons of spinal ganglia and in NiH 3T3 cells transfected 
with trkA cDNA (Kaplan et al., 1991a,b). Furthermore, ectopic expression of trkA in 
NGF non-responsive cells renders them responsive to NGF (Allsopp et al., 1993).
Low stringency hybridisation of cDNA libraries using trkA probes led to the 
subsequent isolation of two related receptors, trkB and trkC. The intracellular 
tyrosine kinase domains of TrkA, TrkB and TrkC share 85% sequence homology. 
trkB has been shown to be the signalling receptor for BDNF (Klein et al., 1991a; 
Glass et ai., 1991; Soppet et al., 1991; Squinto et al., 1991) and NT-4 (Berkemeier 
et al., 1991 ; Ip et al., 1992; Klein et al., 1992), whereas TrkC has been shown to be 
the signaling receptor for NT-3 (Lambelle et al., 1991). There appears to be some 
cross-talk between NT-3 and TrkA and TrkB (Klein et al., 1991b; Soppet et al.,
1991; Squinto et al., 1991).
Several isoforms of the receptor tyrosine kinases have been discovered. However, 
their physiological significance is not fully understood. The trkA gene encodes two 
proteins that differ due to the presence of six amino acids in the extracellular 
domain (Barker et al., 1993). The trkB gene generates several different transcripts 
that, apart from the full length receptor, encode two truncated receptors lacking 
the entire intracellular catalytic domain (Klein et al., 1990a,b; Middlemas et al., 
1991). TrkB also has several other isoforms that contain deletions in the leucine 
rich motifs of the extracellular domain (Ninkina et al., 1997). The trkC gene encodes 
at least four isoforms: the full length receptor, two isoforms with different
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insertions in the tyrosine kinase domain, and a truncated receptor that lacks the 
Intracellular tyrosine kinase domain (Valenzuela et al., 1993; Tsoulfas et al., 1993).
Studies on mice that have null mutations in either TrkA, TrkB or TrkC have further 
elucidated the role of these receptors in the nervous system. TrkA-deficient mice 
are insensitive to pain and show loss of neurons in distinct populations. They exhibit 
more than 90% neuronal cell loss in sympathetic ganglia at PC and at the same 
age show 70% loss of neurons in the trigeminal and dorsal root ganglia (Smeyne 
et al., 1994). Other deficiencies in the central nervous system have also been noted 
(Smeyne et ai., 1994). Likewise, TrkB-deficient mice display neuronal loss in distinct 
populations. These include more than 80% neuronal loss in the nodose ganglia and 
30% neuronal loss in the dorsal root ganglia at PO (Klein et al., 1993). TrkC- 
deficient mice exhibit 20% neuronal loss in the dorsal root ganglia and a range of 
deficiencies in the central nervous system at PO (Klein et al., 1994). These findings 
reaffirm the role of the Trk receptors in modulating neurotrophin function. The 
TrkA-deficient mice exhibit deficiencies in neurons that are NGF-dependent such as 
those of the trigeminal ganglia, and the phenotype is highly similar to that of NGF 
deficient mice. This is consistent with the role of TrkA as the high-affinity 
neurotrophin receptor for NGF. Likewise, TrkB-deficient and BDNF-deficient mice 
exhibit similar phenotypes. The phenotypes of TrkC and NT-3 Knockouts are not 
identical suggesting that there may be signalling of NT-3 via TrkA and TrkC during 
development. No gross phenotype is observed in structures of the central nervous 
system that express trkC transcripts, although TrkC null mutant mice generally do 
not survive until adulthood (Klein et al., 1994). Detailed neuroanatomicai analysis of 
these mice has revealed specific defects in the cochlear ganglion and in the 
innervation of hair cells within the inner ear (Schimmang et al., 1995). In addition, 
the vestibular ganglia of TrkC null mutant mice also have significantly reduced 
numbers of neurons (Schimmang et ai., 1995). These detailed studies have aiso 
revealed differences between the phenotypes of TrkC and NT-3 deficient mice. For
example, there is a 66% reduction in the complement of neurons within the lumbar
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DRG of neonatal NT-3 null mutant animals (Ernfors et al., 1994; Farinas et al., 1994) 
In contrast, In the lumbar DRG of trkC~/" animals, there Is only an 18% reduction 
(Klein et al., 1994 ; Mlnlchlello et al., 1995). Similarly, the number of neurons In the 
spinal ganglia of NT-3'/" mice Is reduced by around 86%, whereas the decrease 
seen In TrkC"/" neonates Is 51% (Schlmmang et a!., 1995). These differences may 
be due to the ability of NT-3 to signal via the TrkA or TrkB receptors, since NT-3 
has been demonstrated to promote the In vitro survival of mid-gestatlon trigeminal 
and nodose sensory neurons from TrkC"/" embryos, but not from embryos that also 
lack functional TrkA or TrkB receptors (Davies et al., 1995).
Neurotrophic Factors not Related to NGF
Other molecules not related to NGF have been shown to promote the survival of 
neurons of the peripheral and central nervous systems In vitro.
Ciliary Neurotrophic Factor
Ciliary neurotrophic factor (CNTF) was initially Identified as a result of its ability to 
promote the survival of the parasympathetic neurons of the chick ciliary ganglion in 
vitro (Adler et a!., 1979). CNTF was purified from extracts of embryonic chick 
intraocular tissue (Barbin et al., 1984) and subsequently from adult rat sciatic nerve 
(Manthorpe et al., 1986). Partial amino acid sequence data gave the basis for the 
cloning of the cDNAs for rat and rabbit CNTF (Stockll et al., 1989; Un et al., 1989). 
Subsequently, mouse and human clones were Identified (Kaupmann et al., 1991; 
Lam et al., 1991). CNTF Is a 200 amino acid protein with a molecular weight of 22.7 
kDa (Stockll et al., 1989; Lin et al., 1989). Although, no high degree of sequence 
homology has been found between CNTF and other known proteins, structural 
similarities have been Identified between CNTF and other cytokines such leukemia 
Inhibitory factor and lnterleukln-6 based on the tertiary structure of these proteins 
(Bazan, 1991).
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CNTF supports the survival of several population of Peripheral and Central Nervous 
System neurons In vitro. These Include the sensory neurons of the chick ciliary, 
nodose, trigeminal and dorsal root ganglia and the sympathetic neurons of the 
lumbar sympathetic ganglia (Barbin et al., 1984; Manthorpe & Varon, 1985). In the 
CNS, CNTF provides In vitro trophic support for spinal motoneurons (Arakawa et al., 
1990), hippocampal neurons (Ip et al., 1991) and Purklnje cells (Larkfors et al.,
1994).
CNTF binds to a multi-component receptor. The receptor complex Is believed to 
have two sub-units In common with the receptor complex for IL-6 (gp130) and one 
In common with the LI F receptor (LIFR p)( Davis & Yancopoulos, 1993). A third 
receptor component, CNTFR a, has been Identified as being essential for receptor 
functioning (Ip et al., 1993). In CNTF-responslve cells, the binding of CNTF to Its 
receptor Induces tyrosine phosphorylation of gp130 and LIFRp. The phenotype on 
CNTFRa Knockout mice Is much more severe than that of CNTF Knockout mice. This 
suggests that a second ligand for the CNTFRa exists which regulates embryonic 
motoneuron survival.
Fibroblast Growth Factor
The founder members of this growth factor family are basic and acidic fibroblast 
growth factors (aFGF and bFGF). These are cytosolic proteins of approximately 
16kDa, sharing about 55% amino acid sequence homology (Esch et al., 1985). They 
are both found In the embryonic brain (RIsau et al., 1988) and in aduit nervous 
tissues (Gospodarowicz, 1990) and were Initially Identified as mitogens for 
fibroblasts and myoblasts (Gospodarowicz, 1990). They were shown to Induce the 
division of endothelial cells, Indicating that FGFs may play a role In blood vessel 
formation (Folkman & Klagsburn, 1987).
A number of studies have also shown that FGF (mostly aFGF and bFGF) can promote 
the survival of embryonic neurons in vitro. These include neurons from the
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hippocampus (Waiicke et al., 1986), the cerebral cortex, late embryonic rat 
striatum, septum, and thalamus (Waiicke, 1988), and the chick ciliary ganglion and 
spinal cord (Unsicker et al., 1987). Both aFGF and bFGF have been shown to induce 
fibre outgrowth from several cell types, including PCI 2 cells, newborn rat chromaffin 
cells (Claude et al., 1988), and postnatal rat retinal ganglion cells (Upton et al., 
1988).
The exact role of aFGF and bFGF in the developing nervous system remains unclear. 
More recently, however, studies have been carried out using FGF-5 (Flughes et al.,
1993). This was originally isolated as the product of a human oncogene and later 
identified to be a member of the FGF family (Zhan et al., 1988) although unlike aFGF 
and bFGF it is thought to be a secretory protein. Recombinant human FGF-5 
promotes the survival of chick embryonic spinal motoneurons in vitro and both FGF- 
5 mRNA and protein can be detected in embryonic rat skeletal muscle during the 
time of naturally occurring motoneuron death as well as in adult muscle (Flughes et 
al., 1993). This indicated a potential role for FGF-5 as a survival factor during 
embryonic development for motoneurons and a putative role in maintenance in the 
adult.
Growth Promoting Activity
G PA is a chick growth factor which shows 57% amino acid sequence homology with 
rat CNTF and which can support the survival of ciliary neurons in vitro (Eckenstein et 
al., 1990; Leung et ai., 1992), suggesting that GPA is the chick homologue of 
mammalian CNTF (Eckenstein et al., 1990). The mRNA transcript for this 2 1 .5kDa 
protein is most highly expressed in the uvea of the eye which contains tissues 
innervated by the ciliary ganglion. GPA mRNA is also expressed in the El 8 sciatic 
nerve of the chick (Leung et al., 1992). Expression of GPA in the chick eye 
increases between El 1 and El 9 which is the period when neurons of the ciliary 
ganglion undergo naturally occurring neuronal death (Leung et al., 1992). In vitro 
GPA can support neurons of the ciliary ganglion and lumbar sympathetic chain. In
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contrast to CNTF, GPA also promotes the survival of E8 DRG neurons (Eckenstein et 
al., 1990; Manthorpe et al., 1982). GPA has a signal sequence in contrast to CNTF. 
Therefore it could be secreted and may be a target derived factor. The timing and 
localisation of its expression in the eye supports the notion that GPA is the target 
derived survival factor for chick ciliary neurons in vivo (Leung et ai., 1992). GPA 
signals through a GPI-anchored protein, G PAR a (Helier et ai., 1993). This receptor is 
expressed in several neuronal populations prior to the period of neuronal death and 
on cells not previously shown to be targets of either CNTF or GPA.
Glial Cell Line-Derived Neurotrophic Factor
Giial cell line-derived neurotrophic Factor (GDNF) was initially purified and cloned (Lin 
et al., 1993) from the rat B49 glial ceil line and identified as a distantly related 
member of the transforming growth factor-p (TGF-p) family (Massague et al.,
1994).
GDNF protects adult dopaminergic neurons from axotomy-induced degeneration in 
vivo (Tomac et ai., 1995; Beck et al., 1995). It also promotes the survival of 
embryonic motoneurons in vitro being more potent than any of the members of the 
NGF family or CNTF. In vivo, GDNF rescues facial motoneurons from axotomy- 
induced cell death (Henderson et al., 1994). GDNF mRNA has been detected in the 
vicinity of motoneurons during the period of naturally occurring neuronal cell death. 
More recent but similar studies on facial motoneurons have verified GDNF's 
importance in motoneuron survival (Van et al., 1995; Oppenheim et al., 1995). 
Likewise, GDNF has been shown to have survival promoting effects on the certain 
chick sensory and sympathetic neurons in vitro (Buj-Bello et ai., 1995).
More recently two further members of the GDNF family have been Identified, these 
are neurturin and persephin (Kotzbauer et al., 1996). Neurturin has been shown to 
promote the survival of embryonic chick sensory neurons in vitro but persephin has
53
not shown any neurotrophic effects to date (A. Forgie and A.M. Davies, unpublished 
observations).
Intracellular Mechanisms Regulating Neuronal Survival
Until recently, little was known about the intracellular mechanisms regulating 
neuronal survival whilst much was known about the role of extrinsic factors. To 
date, the intracellular mechanisms involved in the suppression of apoptosis in 
neurons by neurotrophic factors are still unknown. The recent discovery of the bcl-2 
protein family has enabled some progress to be made in the understanding of the 
regulation of apoptosis in this system.
The bcl-2 Protein Family
In 1985, the human bcl-2 (B-cell lymphoma/leukaemia -2) gene was identified at 
the breakpoint of the transiocation between chromosomes 14 and 18 found in a 
high proportion of human follicular B-cell lymphomas (Tsujimoto & Croce, 1986). 
This translocation moves bci-2 from its normal position at 18q21 into juxtaposition 
with the immunoglobulin heavy chain locus at 14q32 which results in its 
transcriptional activation and the overproduction of the 26kDa bcl-2 protein in 
lymphoma cells.
Traditionally, oncogenes were thought to control tumourigenesis by increasing cell 
proliferation, however, evidence has accumulated that bcl-2 overexpression leads to 
tumorogenesis by suppressing the signals that would otherwise lead to apoptotic 
cell death. For example, overexpression of bcl-2 can prevent apoptosis after growth 
factor withdrawal in certain haematopoitic cell lines (Nunez et al., 1990; Vaux et al., 
1992; Cuende et al., 1993; Otani et ai., 1993) and in primary cultures of neuronal 
cells (Allsopp et al., 1993; Garcia et ai., 1992).
The regulation of cell death by the bcl-2 protein family has been conserved through 
evolution. The nematode Caenorhabditis eleaans undergoes developmental cell
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death which Is regulated by several proteins, one of which, ced-9, shows 
considerable amino acid homology with bci-2, particularly in the BH1 and BH2 
domains. These are the regions of highest homology between bcl-2 family members 
within a given species as well as between species (Oltvai et al., 1993; Yin et al.,
1994). Overexpression of human bcl-2 in Caenorhabditis eleaans prevents ceil 
death in cells which rely on the actions of ced-3 and ced-4 to induce death 
(Hengartner & Horvitz, 1994b). ced-3 is related to the mammalian caspase 
proteins indicating further evolutionary conservation in the death pathway. The bcl- 
2 gene itself has been isolated in mammals and chick (Eguchi et al., 1992), and two 
homologues have been discovered in the anuran Xenopus laevis (Cruz-Reyes &
Tata, 1995), both of which contain BH1 and BH2.
bcl-2 is the founder member of a growing family of genes that regulate cell survival 
(Steller et al., 1995; Thompson, 1995; Vaux, 1993) (Table1.2) including bcl-x (Boise 
et al., 1993; Fang et al., 1994), bad (Yang et al., 1995), bak (Kiefer et ai., 1995; 
Chittenden et ai., 1995), bax (Oltvai et al., 1993), bik (Boyd et al., 1995), bfl-1 
(Choi et al., 1997), BRAG-1 (Thompson, 1996), mcl-1 (Kozopas et al., 1995) and 
Al (Lin et al., 1993). Homology between family members is greatest in two regions, 
the BH1 and BH2 domains. Recent work suggests another two homology regions: 
BH3 found in all family members and BH4 which is thought to be important for the 
action of the death-inducing family members. In addition to this, the a  or full-length 
forms of the bcl-2 family proteins contain a hydrophobic stretch of amino acids at 
their C-termini which appears to be important for membrane attachment.
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Pro-apoptotic Anti-apoptotic
bax bcl-2
bad bcl-xL
bak Mcl-1
bik A1
bcl-xs BRAG-1
Bfl-1
Table 1.2: Members of the bd-2 protein family
bcl-2
The murine bcl-2 gene is located on Chromosome 1 and contains two exons 
separated by more than 15kb. There are two mRNAs produced by alternative 
splicing. A 7.5kb transcript encodes the 236 amino acids that encodes bcl-2a 
which has a molecular mass of 26kDa. A second smaller 2.4kb transcript encodes 
the 199 amino acids of bcl-2^. This smaller protein has a molecular mass of 22kDa 
and lacks the C-terminal hydrophic domain (Negrini et al., 1987). bcl-2p does not 
prevent apoptosis, suggesting that the carboxy terminal hydrophobic domain has 
functional significance (Tanaka et ai., 1993).
Gene transfer experiments have shown that bcl-2 expression is able to prevent 
apoptosis in certain haematopoietic cell lines following cytokine deprivation (Nunez 
et ai., 1990; Vaux et al., 1992; Cuende et al., 1993; Otani et al., 1993). Also, 
microinjection of a bcl-2 expression vector into embryonic neurons that are 
dependent on one or more members of the NGF family of neurotrophic factors for 
their survival has shown that these neurons can be rescued by bcl-2 
overexpression after neurotrophic factor deprivation (Allsopp et al., 1993; Garcia 
et al., 1992). CNTF-dependent ciliary neurons cannot be rescued by bcl-2
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following removal of CNTF from the culture medium. By growing neurons of the 
trigeminal mesencephalic nucleus In CNTF instead of BDNF these cells also become 
refractory to the effects of bcl-2, indicating that there at least two death pathways 
operating in neurons that can be distinguished by their susceptibility to bcl-2. 
Moreover, neurons can die by either pathway depending on which factors they have 
been exposed to.
Further evidence for a role for bcl-2 in regulating neuronal survival comes from 
studies of dorsal root ganglion neurons from mice constituitively overexpressing bci 
2. These show extended survival in vitro without trophic support as compared to 
wild type neurons (Farlie et al., 1995). In addition, overexpression of bcl-2 can 
prevent motor neuron death induced by facial nerve axotomy (Dubois-Dauphin et 
al., 1994) and sciatic nerve axotomy (Farlie et al., 1995). Not only are motor 
neurons preserved by increased expression of bcl-2, but also the surviving neurons 
retain functional electrophysiological properties including a functional second 
messenger system for at least 20 days after injury (Alberi et ai., 1996).
bci-2 overexpression can also rescue cells following various other apoptotic stimuli 
(Zhong et al., 1993a) such as baculovirus infection (Alnemri et al., 1992), 
glutamate toxicity (Behl et al., 1993; Zhong et al., 1993b), c-myc induced 
apoptosis (FanidI et ai., 1992; Vaux et al., 1988), etoposide-induced apoptosis 
(Kamesaki et al., 1993), adenovirus infection (Rao et ai., 1992a,b), 
chemotherapeutic drugs (Miyashita & Reed, 1993; Dole et al., 1994), and retinoic 
acid (Okazawa et al., 1996).
The bcl-2 protein is found in the aduit mouse within various ceil types and tissues 
characterised by high ceil turnover, such as the spleen and thymus (Negrini et ai., 
1987; Hockenbery et al., 1991). Within these areas it is topographically restricted 
to long-lived progenitor cells that renew cell lineages such as the germinal centres 
of lymphoid follicles. In the adult, bcl-2 is also found in several postmitotic cells that
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require an extended life span such as neurons (Abe et al., 1993). In the peripheral 
nervous system, Bcl-2 expression is maintained throughout life but in the central 
nervous system it declines with age (Merry et al., 1994).
Immunohistochemical techniques have shown that Bcl-2 protein is found in a wide 
variety of tissues other than neurons and lymphocytes in the human embryo (Lu et 
al., 1993) such as breast duct epithelium, liver and the lower crypts of the small 
and large intestines. Interestingly, in the adult, long-lived cells of mesodermal origin 
such as muscle, frequently do not express bcl-2 (Hockenbery et al., 1991). In the 
chick embryo, there is expression in muscle and the bursa as well as in the other 
tissues described for mammalian embryos (Lu et al., 1993).
The localisation of the Bcl-2 protein within cells has also been closely studied. In cell 
lines, Bcl-2 has been found to be integrated into the lipid bilayer of microsomal 
membranes, in particular those of the perinuclear endoplasmic reticulum (Chen-Levy 
et al., 1990). A 19 amino acid COOH-terminal hydrophobic signal anchor sequence is 
responsible for membrane localisation (Nguyen et al., 1993). Protease protection 
assays have shown that Bcl-2 is predominantly localised to the cytoplasmic face of 
membranes (Chen-Levy et al., 1990). This localisation is consistent with the theory 
that Bcl-2 may control apoptosis by regulating calcium fluxes through the 
endoplasmic reticulum (Lam et al., 1994). Direct evidence of ion channel activity of 
Bcl-2 and B cI-x l has been obtained from recent in vitro studies (Minn et al., 1997, 
Schendel et al., 1997). The structure of B c I-x l reveals a compact seven a-helical 
bundle, at the centre of which lies a hairpin comprised of two long hydrophobic core 
a-helices surrounded by five amphipathic a-helices (Muchmore et al., 1996). The 
two core a-helices are presumed to insert perpendicularly across the lipid bilayer 
with the surrounding amphipathic helices folding upwards and resting on top of the 
membrane (Schendel et al., 1997). Further in vitro data indicates that Bax, a pro- 
apoptotic member of the Bcl-2 family, also has channel activity (Reed, 1997). As 
Bax can heteodimerise with either Bcl-2 or B cI-x l, when they are in their compact a-
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helical bundles in aqueous environments, these proteins may produce heterodlmeric 
channels when integrated into membranes.
Other work has shown that Bcl-2 is a mitochondrial membrane protein (Hockenbery 
et al., 1990; Krajewski et al., 1993; Nakai et al., 1993; Nguyen et al., 1993; Tanaka 
et al., 1993; Tsujimoto & Croce, 1986), suggesting that Bcl-2 may protect cells 
from apoptosis by altering mitochondrial function. However, in human mutant cell 
lines lacking mitochondrial DNA, Bcl-2 still prevents apoptosis (Jacobson et al.,
1994). The location of Bcl-2a at the inner surface of the cell membrane could imply 
a putative role in signal transduction. Indeed Bcl-2a has GTP-binding activity in 
cellular extracts from both human and murine pre-B cells. Sequence analysis has 
indicated some weak similarities between the Bcl-2a sequence and the sequences of 
several small G proteins, particularly in regions that are important for GTP/GDP 
binding. Six proteins with homology to Bcl-2 include Rho (31% ), Ral (33% ), Arf2B 
(31% ), Smg-21(36%), Smg-25A(31%) and Ha-Ras (35%) (Haider et al., 1989).
There is evidence to suggest that Bcl-2 may exert its anti-apoptotic effect by 
protecting cells from oxidative stress. Oxidative stress can lead to apoptosis and 
certain stimuli of apoptotic death are known to lead to oxidative stress within cells 
due to excess production of reactive oxygen species (Hockenbery et al., 1993; 
Buttke & Sandstrom, 1994). Furthermore, antioxidants have been shown to inhibit 
cell death not suspected to be associated with oxidative stress. For instance, N- 
acetyicysteine, a weak antioxidant, inhibits apoptosis in hematopoetic cell lines 
following IL-3 withdrawal (Hockenbery et al., 1993). Cellular antioxidant enzymes 
protect against several types of apoptotic cell death. Overexpression of manganous 
superoxide dismutase has been shown to block cell deaths induced by tumour 
necrosis factor, several chemotherapeutic agents and ionising radiation (Wong et 
al., 1989; Hirose et al., 1993). Bcl-2 has been shown to localise to the 
mitochondrial membrane, endoplasmic reticulum and the nuclear envelope all of 
which are sites implicated in the production of reactive oxygen species (Hockenbery
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et al., 1990; Krajewski et al., 1993; Nakai et al., 1993; Nguyen et al., 1993; Tanaka 
et al., 1993). Bcl-2 can block cell death that results from exposure to hydrogen 
peroxide, t-butyl peroxide, menadione or the glutathione stynthetase inhibitor 
buthionine sulfoxide (Hockenberry et al., 1993; Zhong et al., 1993b). Furthermore, 
direct oxidative damage to lipid membranes which can occur during apoptosis can 
be blocked by Bcl-2 (Hockenbery et al., 1993; Hockenbery, 1995). The enhanced 
resistance of cells overexpressing Bcl-2 to oxidative stress could be due to a 
mechanism that limits free radical production or it may function downstream to limit 
the effects of free radicals. Evidence exists to support both scenarios. Bcl-2 has 
been shown to inhibit lipid peroxidation, a downstream event in oxidative stress 
(Hockenbery et al., 1993), suggesting that Bcl-2 functions to limit the deleterious 
effects of free radicals. However, Bcl-2 overexpression has also been shown to 
directly reduce the generation of reactive oxygen species (Shimizu et al., 1995; 
Jacobson et al., 1995). Of course, it is possible that Bcl-2 has no direct effects on 
the oxidant pathway but that the observations made are due to indirect effects of 
Bcl-2 on this system.
A further putative role for Bcl-2 during cellular morphogenesis has recently been 
reported. Overexpression of Bcl-2 in a dopaminergic cell line has been shown to 
induce robust neurite outgrowth without a cessation of cell division (Oh et al.,
1996). Most molecular markers of neuronal and or dopaminergic maturation remain 
unchanged, although levels of the synaptosomal associated protein SNAP-25, which 
has previously been implicated in playing a role in neuite extension (Osen-Sand et 
al., 1993) were Increased 3 fold (Oh et al., 1996). Further to this, cells of a human 
tumorogenic neural crest cell line show extensive neurite outgrowth at low serum 
concentration when transfected with Bcl-2 whilst there is no appreciable effect on 
survival (Zhang et al., 1996). Expression of neuron-specific enolase was also 
increased by overexpression of Bcl-2 (Zhang et al., 1996). It is possible that Bcl-2 
plays a role in both neurite outgrowth and neuronal differentiation. In accordance
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with this, Bcl-2 expression is enhanced during differentiation of neuroblastoma cells 
(Hanada et al., 1993; Lasorella et al., 1995) and PCI 2 cells undergo differentiation 
after Bcl-2 overexpression in serum-free medium (Sato et al., 1994), but not in the 
presence of serum (Batistatou et al., 1993). The effect of Bcl-2 on differentiation is 
also observed in other ectodermal derivatives. Cells of the mammary epithelium 
undergo a morphogenetic, but not a tumorogenic change following Bcl-2 
overexpression. Furthermore, there is elevated expression of markers indicative of 
epithelial-mesenchyme conversion (Lu et al., 1995). In support of a role for Bcl-2 in 
differentiation, Bcl-2 is expressed during embryogenesis in cells undergoing a 
morphological transition from undifferentiated stem cells to committed precursor 
cells, including skin, cartilage and kidney (Lu et al., 1993).
A number of studies have provided data suggesting that Bcl-2 can influence the cell 
cycle (Willingham & Bhalla, 1994). In human epithelial cell lines, Bcl-2 localises to 
mitotic nuclei, in particular to the chromosomes. There is strong Bcl-2 expression 
during mitosis which is most intense during prophase and metaphase and declines 
during telophase (Lu et al., 1994). However, other workers have found that Bcl-2 is 
not a cell cycle regulated protein (Reed et al., 1992). Bcl-2 overexpression results in 
the inhibition of cell division and cell cycle progression. The effects of Bc!-2 seem to 
be focused at the Gi to S phase transition giving between 30 and 60% increase in 
the length of Gi. This is a critical point in the decision between cell cycle 
progression or induction of physiological cell death (Mazel et al., 1996). Induced Bcl- 
2 expression results in a retardation of cell proliferation and protection from 
apoptosis. Both effects can be reversed by Bax (Borner et al., 1994). Furthermore, 
there is some evidence that Bcl-2 may mediate its effects on the cell cycle through 
interaction with the tumour suppressor protein p53. A non-conserved region of Bcl- 
2 (residues 51 to 85) has been found to permit p53-induced apoptosis and inhibit 
cell proliferation. Deletion of this region reverses these effects (Uhlmann et al., 
1996).
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Bcl-2-deficient mice appear normal at birth (Nakayama et al., 1993, 1994; Veis et 
al., 1993; Kamada et al., 1995) and are at first Indistinguishable from their litter 
mates. By 1 week post partum they are smaller, have small external ears and 
immature facial features. The size of mutant mice varies from between 30 - 90% of 
the weight of their litter mates. The mutation is lethal and there is a wide range in 
the onset of morbidity from 10 days to 10 weeks, with a clustering at 2-3 weeks. 
The mice develop polycystic kidney disease and have blood urea and serum 
creatinine levels significantly higher than their wild type and heterozygous litter 
mates. The number of lymphocytes markedly decreases within a few weeks of birth 
while other haematopoietic lineages remain unaffected. Mutant mice initially have 
black hair but this turns grey at 4 - 5 weeks of age. There are decreased numbers of 
oocytes and primordial follicles established in postnatal females (Ratts et al., 1995), 
suggesting a role for Bcl-2 in preventing follicular atresia. The problems with the hair 
and kidneys suggest that Bcl-2 may have a role where interactions between 
epithelium and mesenchyme are important. Furthermore, El 2 Bcl-2-deficient 
kidneys grow and develop less well in culture than wild type kidneys, suggesting 
that the problems observed during kidney development are cell autonomous 
(Sorenson et al., 1995). Results so far show that the nervous system, intestines, 
and skin appear normal despite the fact that these organs show high levels of 
endogenous Bcl-2 expression In wild type mice.
In summary, since the discovery of the Bcl-2 protein, numerous examples of its role 
in preventing apoptosis have been published (Korsmeyer, 1995). More recent 
reports have implicated Bcl-2 in other cellular events including differentiation 
(Hanada et al., 1993; Lasorella et al., 1995) and the cell cycle (Lu et al., 1994). 
However, the biochemical basis of the actions of Bcl-2 remains elusive.
Bax
Bax (Oltvai et al., 1993) is a Bcl-2-associated protein showing 21% homology with 
Bcl-2 at the amino acid level. It is a 21 kDa protein initially identified by
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coimmunoprecipitation with Bcl-2. The human Bax gene is located on chromosome 
19 and has four possible transcripts. The full transcript is Baxa whilst Baxp lacks the 
transmembrane anchor domain. BaxT lacks the transmembrane anchor domain, BH1 
and BH2 whilst Baxy lacks exon 3 about which little is known (Apte et al., 1995).
Bax can heterodimerise with Bcl-2, Bcl-x^, Mcl-1 and A1 (Sato et al., 1994; Sedlak 
et al., 1995), and can also form homodimers. Bax is widely expressed in the 
neonatal rat central nervous system but the levels are 20 to 140 fold lower in the 
adult with the decrease occurring after the period of naturally occurring neuronal 
death (Vekrellis et al., 1997). Bax overexpression in IL-3 dependent hematopoetic 
cell lines accelerates apoptosis following factor withdrawal and inhibits the death 
repressor action of Bcl-2 in these cells (Oltvai et al., 1993). Analysis of point 
mutations in Bcl-2 suggests that direct binding of Bcl-2 to Bax is essential for the 
death-repressor activity of Bcl-2 (Yin et al., 1994). A model has been proposed In 
which the ratio of Bcl-2 to Bax determines whether cells survive or die following 
exposure to an apoptotic stimulus (Korsmeyer et al., 1993). Bax-Bax and Bax-Bcl-2 
dimer formation require the presence of a conserved domain distinct from BH1 and 
BH2, termed BH3 (Zha et al., 1996). All members of the Bcl-2 protein family 
possess this domain except Bad. Overexpression of Bcl-2 increases the half-life of 
Bax protein, by a process involving post-translational modification (Miyashita &
Reed, 1995). Bax also interacts with and antagonises the survival promoting effects 
of B cI-x l. However, mutational analysis has shown that B cI-x l can suppress 
apoptosis by a mechanism that does not require binding to Bax (Cheng et al.,
1996).
The glutamate analogue, kainic acid, causes seizures and neuron damage in rodents. 
In the murine brain, bax is upregulated and bcl-2 is down-regulated in response to 
kainic acid treatment (Gillardon et al., 1995), suggesting that Bax is involved in the 
apoptosis that occurs in the central nervous system in response to this stimulus. 
Likewise, Bax protein is up-regulated by p53 in Ml myeloid leukaemia cells as an
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immediate response p53 expression whilst Bcl-2 is down-regulated. Furthermore, 
TGFpi down-regulates Bcl-2 but does not up-regulate Bax. in this case, the cells still 
undergo apoptosis even when Bax is not upregulated. (Selvakumaron et al., 1994; 
Zhan et al., 1994).
Transgenic mice overexpressing Baxa, specifically in T cells, show accelerated 
apoptosis in response to a wide variety of apoptotic stimuli (Brady et al., 1996). 
Mice with a null mutation in the bax gene (Knudson et al., 1995) are viable but 
exhibit lineage-specific aberrations in cell death. For example, superior cervical 
ganglia and facial nuclei displayed an increased neuron number. In addition, neonatal 
sympathetic neurons and facial motor neurons from Bax-deficient mice survive NGF 
deprivation and axotomy (Deckwerth et al., 1996). Thymocytes and B cells from 
Bax null mutants display hyperplasia and ovaries display unusual atretic follicles with 
excess granulosa cells. Males are infertile as a result of disordered seminiferous 
tubules with an accumulation of atypical premeiotic germ cells but no mature 
haploid sperm. Multinucleated giant cells and dysplastic cells are accompanied by 
massive cell death in the testis (Knudson et al., 1995). Thus lack of bax expression 
can result in either hyperplasia or hypoplasia depending upon the cellular context.
Bcl-X
Bcl-X was discovered due to its high sequence homology with Bcl-2 (Boise et al., 
1993; Fang et al., 1994). There are three Bcl-x variants , BcI-xl, Bcl-xp, and Bcl-Xs 
(Boise et al., 1993) which arise due to alternative splicing. B cI-x l is a 233 amino 
acid protein that has the highest homology to Bcl-2 and acts in a similar manner 
rescuing cells from apoptosis. Bcl-xp lacks a C-terminal hydrophobic domain required 
for membrane attachment. Bcl-xg is a 170 amino acid protein that lacks BH1 and 
BFI2 which are the regions of greatest homology between the family members and 
which have been implicated in Bcl-2 function (Yin et al., 1994). In contrast to the 
other Bcl-x variants, Bcl-Xs has consistently been shown to promote apoptosis. It
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can sensitise MCF-7 human breast carcinoma cells, which highly express B cI-x l, to 
chemotherapy-induced apoptosis (Sumantran et al., 1995).
The structure of B cI-x l, as determined using both X-ray crystallography and nuclear 
magnetic resonance, consists of two central primarily hydrophobic a-helices which 
are surrounded by amphipathic helices (Muchmore et al., 1996). The three 
conserved region, BFI1, BFI2, and BH3 are in close spatial proximity and form an 
elongated hydrophobic cleft which may represent the binding site for other family 
members.
B c I-x l and Bcl-xp are expressed in both embryonic and postnatal tissues of the 
central nervous system (Gonzalez-Garcia et al., 1995). As well as expression in the 
brain, bcl-x expression has been observed in the dorsal root ganglia, various cells of 
the immune system, reproductive tissues and a variety of epithelial cells (Krajewski 
et al., 1994). Intracellularly, bc/-xgene products appear to be cytosolic and closely 
associated with intracellular organelles (Krajewski et al., 1994). In particular the Bcl- 
x l protein has been found to be localised to mitochondria (Gonzalez-Garcia et al.,
1994).
Microinjection of both B cI-x l and Bcl-xp into primary sympathetic neurons inhibits 
apoptosis following growth factor withdrawal. This suggests a role for Bcl-x proteins 
in regulating neuronal survival (Gonzlez-Garcia et al., 1995). B cI-x l has also been 
shown to support the survival of thymocytes (Ma et al., 1995), to protect cells of a 
cancer cell line, T47D, from p53-mediated apoptosis (Schott et al., 1995), and to 
prevent apoptosis in murine myeloma cells (Gauthier et al., 1996). When human 
leukaemia cells differentiate they die by apoptosis. However, B cI-x l can prevent this 
apoptosis indicating that down-regulation of B cI-x l may be a component of the 
apoptotic response that is coupled to cell differentiation in leukaemia cells (Benito 
et al., 1996). Contrary to these findings, rat Bcl-xp has been shown to promote 
apoptosis in promyeloid cells (Shiraiwa et al., 1996)
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Studies on Bcl-x-deficient mice (lacking all isoforms) have helped to elucidate its 
function (Motoyama et al., 1995). The Bcl-x-deficient mice die around El 3, 
exhibiting extensive apoptotic cell death in postmitotic immature neurons of the 
brain, spinal cord and dorsal root ganglia. Haematopoietic cells in the liver also show 
increased apoptosis. In addition, Bcl-x null mutant immature lymphocytes have a 
shortened lifespan in Bcl-x chimeric mice. This suggests a role for Bcl-x promoting 
the viability of immature cells during the development of the nervous and 
haematopoietic systems.
Bad
Bad is a 204 amino acid, 22kDa protein containing several PEST motifs (Yang et al.,
1995). These are amino acid sequences commonly found in rapidly degraded 
proteins, and therefore suggest that Bad has a short half life (Rogers et al., 1986). 
Bad shows limited homology to Bcl-2 and other family members. Homology is 
restricted to BH1 and BH2 domains where only amino acids that are universally 
conserved within the family are present in Bad. Bad can dimerise with Bcl-2 and Bcl- 
x l but not with Bax, Bcl-Xs, Mcl-1, A1, or itself. It inhibits the death repressor 
activity of B cI-x l but not Bcl-2 in mammalian cells and acts by displacing and 
replacing Bax in BcI-xl: Bax dimers. Since, Bad lacks the C-terminal anchor domain 
which other Bcl-2 proteins possess. It exists free in the cytosol, bad mRNA has been 
found in the central and peripheral nervous systems, but how this expression 
changes during development is not known (Yang et al., 1995; Merry & Korsmeyer,
1997).
Bad is a possible candidate for linking signal transduction events to the Bcl-2 protein 
family and so to the regulation of apoptosis. Phosphorylated Bad complexes with 
the protein 14-3-3 in the cytosol, whilst non-phosphorylated Bad heterodimerises 
with B cI-x l at intracellular membrane sites. When IL-3 is withdrawn from 
hematopoetic cell lines that are dependent upon it for their survival. Bad is de-
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phosphorylated and binds to BcI-xl- It may be that in so doing Bad inactivates the 
survival promoting effects of B cI-x l (Zha et al., 1 9 9 6 ).
Bak
Bak was identified using degenerate primers to clone cDNA fragments encoding Bel- 
2 homologues (Kiefer et al., 1995; Chittenden et al., 1995). The new homologous 
sequence was used to isolate full-length cDNA sequences form human heart and 
Epstein Barr (EBV)- transformed human B-cell libraries. Bak has 53% amino acid 
sequence homology with Bcl-2 and shows marked similarity to other family members 
particularly in BH1 and BH2. Expression of Bak reverses the protective effects of 
El B 19K in primary cultures of rat sympathetic neurons deprived of NGF (Farrow et 
al., 1995). it also reverses the survival promoting effects of Bcl-2 in a pro-B cell line 
(Chittenden et al., 1995). In cell lines derived from neoplastic colon, apoptosis is 
accompanied by an increase in bak mRNA without consistent changes in other Bcl-2 
family members, suggesting a role for Bak in intestinal cell apoptosis (Moss et al.,
1996). FI owe ver, Bak is also able to prevent some cell deaths (Kiefer et al., 1995). 
Bak interacts with Bcl-2 and more strongly with B cI-x l. The pro-apoptotic action of 
Bak is dependent on it binding to B cI-x l indicating that it may act by binding to Bcl- 
x l and inhibiting its death repressor function. A screen of Bak deletion mutants has 
shown that the BFI3 domain is required both for interaction with B cI-x l and 
promotion of cell death. This has lead to the identification of BFI3 as the important 
domain for this interaction (Chittenden et al., 1995). bak mRNA expression is 
widespread in many tissues (Kiefer et al., 1995). Although there is widespread bak 
mRNA expression in the adult brain (Kiefer et al., 1995) there is little or no Bak 
protein detected (Krajewski et al., 1996).
Other Bcl-2 Related Proteins
There are other proteins that have been found to be homologous to Bcl-2 but about 
which only a small amount of information is available. These include A1, BRAG-1,
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Mcl-1, Bik and Bfl-1. A1 is a Bcl-2-related haematopoietic tissue specific gene that is 
induced during myeloid cell differentiation (Lin et al., 1993). It has been shown to 
prolong cell survival and permit myeloid differentiation (Lin et al., 1996). A l has a 
restricted pattern of expression compared to other members of this protein family.
It is expressed in murine thymus and spleen, but not in a variety of non- 
hematopoietic mouse tissues (Lin et al., 1993).
BRAG-1 was isolated from a human glioma cell line and is a 31 kDa protein sharing 
significant homology with Bcl-2 in the BH1 and BH2 regions. BRAG-1 mRNA is 
predominantly expressed in brain. The transcript expressed in brain is larger than 
that expressed in glioma cells suggesting that a truncated variant of the BRAG-1 
protein may play a role in oncogenesis in glial cells (Thompson, 1996).
Mcl-1 is a 37 kDa protein that was initially isolated from the ML-1 human myeloid 
leukaemia cell line that had been induced to differentiate along the 
monocyte/macrophage pathway. Mcl-1 can function as a survival promoting factor 
(Reynolds et al., 1994). It is localised to the mitochondrial and light membrane 
fraction in ML-1 cells. In the same cells, Bcl-2 is found predominantly in 
mitochondrial and nuclear membranes (Yang et al., 1995). Mcl-1 protein has also 
been detected in the soma of sympathetic and dorsal root ganglion neurons 
(Krajewski et al., 1995). However, little or no protein has been detected in the 
central nervous system.
Bik is a 160 amino acid, 18kDa protein that can heterodimerise with the anti- 
apoptotic members of the Bcl-2 protein family promoting cell death. It displays very 
little homology to other Bcl-2 protein family members lacking both BH1 and BH2 
regions. However, Bik does contain the C-terminal hydrophobic domain and the BH3 
region, suggesting that BH3 may be critical in modulating death promoter activity 
(Boyd et al., 1995; Chittenden et al., 1995).
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Bfl-1 was initially isolated from the liver of human embryos. It has 72% amino acid 
identity with murine A1, with BH1, BH2, BH3 and BH4 all highly conserved although 
the C-terminal anchor domain is not highly conserved. Bfl-1 is highly expressed in 
bone marrow and also at low levels in the lung, spleen and oesophagus (Choi et al.,
1995). Bfl-1 is able to suppress p53-induced apoptosis (D'Sa-Eipper et al., 1996).
Other Proteins that Regulate Cell Survival
In addition to the bcl-2 family members, a number of proteins have been found to 
play a role in the regulation of apoptosis. One such protein is E2F-1 which is a 
member of a family of transcription factors that are believed to be regulators of cell 
cycle progression. Mice which are E2F-1-deficient have excessive T cells due to a 
lack of apoptosis, yet show testicular atrophy and exocrine gland dysplasia. They 
also exhibit aberrant cell proliferation (Fieid et al., 1996; Yamasaki et al., 1996; 
DeGregori et al., 1995) This phenotype suggests a function both in regulating 
apoptosis and in regulating cell proliferation. There is no suggestion of an 
Interaction between E2F-1 and any of the genes already characterised as having a 
role in apoptosis. However, it is likely that as the roles of this protein are further 
elucidated, some activation of other genes involved in apoptosis will be discovered.
A protein that appears to play a key role in regulating cell survival is p53 (Holstein 
et al., 1991). In normal cells, p53 acts as a tumour suppressor protein and loss of 
p53 function appears to play a role in the majority of human tumours. There is some 
evidence for interaction between bcl-2 family members and p53. The bcl-2 gene 
contains a 195bp segment In the 5' untranslated region that Is necessary for p53 
mediated down-regulation of bcl-2 expression (Miyashita et al., 1994). In addition, 
bci-2 overexpression is able to prevent p53-dependent apoptosis (Chiou et al.,
1994). This suggests that p53 may function upstream of bcl-2 and is critical in 
determining whether a cell undergoes physiological cell death by apoptosis or enters 
the ceil cycle.
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Many proteins can interact with bcl-2 to regulate cell survival. For example, BAG-1 
(Takayama et al., 1995) is a bci-2-binding protein with no significant homology to 
any family members. Co-expression of bcl-2 and BAG-1 increases protection from 
apoptosis compared to expression of either protein alone, bcl-2 also interacts with 
a member of the Ras superfamily of small GTPases, p23-R-Ras (Wang et al., 1995; 
Fernandez-Sarabla & Bischoff, 1993). A correlation has been found between 
increased levels of R-Ras protein and faster rates of cell death following growth 
factor deprivation, bcl-2 can counteract this effect implying that bcl-2 acts 
downstream of Ras to promote cell survival.
c-myc has been shown to induce apoptosis under certain conditions (Vaux et al., 
1988). Inappropriate c-myc expression under conditions such as heat shock or 
serum-deprivation leads to rapid onset of apoptosis (Bissonnette et al., 1992). 
Constitutive expression of bcl-2 is able to prevent Myc-induced apoptosis 
(Bissonnette et al., 1992; Fanldl et al., 1992).
Caspases are the mammalian homologues of the nematode Caenorhabdidits 
eleaans gene ced-3 and are likely to act downstream of the bcl-2 protein family In 
the cell death pathway. The first of these proteins identified was ICE (Yuan et al., 
1993). Apart from the structural correlation with Ced-3, overexpression of ICE in 
Rat-1 fibroblasts induces apoptosis suggesting a functional correlation with the 
nematode protein (Miura et al., 1993). Eight homologues of Ced-3 and ICE have 
been characterised to date: ICH-1 (Kumar et al., 1994; Wang et al., 1994); CPP-32 
(Fernandes-Alnemri et al., 1994; Nicholson et al., 1995; Tewari et ai., 1995); ICH-2 
(Faucheu et al., 1995; Kamens et al., 1995; Munday et al., 1995); ICErel-lll (Munday 
et al., 1995); Mch-2 (Fernandes-Alnemrl et al., 1995a); Mch-3 (Duan et ai., 1996; 
Fernandes-Alnemri et al., 1995b; Lipke et al., 1996); FLICE (Muzio et al., 1996) and 
ICE-LAP6 (Duan et ai., 1996). Ectopic expression of these proteins in a variety of 
cells promotes apoptosis. There is no evidence for a direct link between the bcl-2 
protein family and the caspases. However, in the nematode Caenorhabditis eleaans
7 0
where the cell death pathway is well understood, the bcl-2 homolog, Ced-9, 
influences the action of the caspase homologue Ced-3 via Ced-4. Very recently the 
mammalian homolog of ced-4, Apf-1 has been reported.
In light of the recent developments in elucidating the intracellular pathways involved 
in the control and execution of apoptosis, this project considers the role of one 
particular family of proteins, the bcl-2 protein family, during the development of the 
peripheral nervous system. Here, using DNA microinjection, bcl-2, bcl-xL, and 
bcl-xp were found to support neuronal survival following growth factor withdrawal. 
Surprisingly, this was also true for bax. bcl-xs did not show any survival 
promoting effects when overexpressed in this way. bcl-2 Knockout mice were also 
used to investigate the effects of the absence of bcl-2 on murine neurons both in 
vitro and in vivo. Cells derived from bcl-2 knockout mice were able to respond as 
well as their wild type counterparts to neurotrophins but showed poor long-term 
survival In culture at specific stages In their development. Counts of neuron number 
In vivo using histology showed a clear difference in neuron number later in 
development after the period of neuronal death. Furthermore, the neurons of the 
knockout mice are morphologically less mature than those of the wild type mice.
In addition, bcl-2-deficient neurons were shown to have shorter neurites than wild 
type neurons. Therefore, bcl-2 seems to have more than one role in the developing 
peripheral nervous system with effects reported here on survival, neurite outgrowth 
and maturation. A further study using bax Knockout mice showed that neurons 
derived from animals homozygous for a null mutation In the bax gene survive 
better than their wild type counterparts long-term In vitro at E18 and P1. Also, the 
cells from the mutant animals were able to survive without neurotrophic factors 
and Indeed after a few days in culture were surviving better without factors than 
with factors. Furthermore, a proportion of these cells had very short neurites 
which extended considerably if factors were added to the dish. Although the 
precise nature of the role played by bax during the development of sensory 
neurons has not been fully elucidated, the evidence presented here clearly does 
indicate a role for bax. The role of the bcl-2 protein family in regulating the survival
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of developing neurons is complex and, these proteins may play more than one role 
in the developing nervous system. They not only regulate survival but also may have 
a role in neuronal maturation and stimulation of neurite outgrowth.
7 2
II. MATERIALS AND METHDHS
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CHAPTER TWO 
MATERIALS AND METHODS
TISSUE CULTURE 
Dissection Techniques 
Instruments
A number of instruments were used in the course of each dissection, including 
toothed forceps, straight and curved watchmakers forceps, and fine scissors. 
Instruments were sterilised by flaming after soaking in 100% industrial methylated 
spirits (IMS). Tungsten needles were used for the final stages of dissection and to 
remove adherent mesenchymal tissue and nerves from ganglia. Tungsten needles 
were made from 0.5 mm diameter tungsten wire which was cut to 3 to 5 cm 
lengths and the terminal 1 cm was bent at an angle of approximately 60°. This end 
was immersed for a few minutes in 0.5 M potassium hydroxide and a 3 to 12v AC 
current passed through the wire as shown in figure 2.1. The tungsten was 
electrolyticaliy etched away to form a taper from the bend to the tip of the needle. 
To make the point sharp, the needle was held vertically in the solution for the last 
30 seconds. After the needle was made it was washed in water to remove the 
alkali. For dissection, the needles were held In chuck-grip platinum wire holders and 
sterilised by flaming.
Chick Dissections
All procedures were carried out in a laminar flow cabinet using standard sterile 
technique. Embryos for chick dissections were obtained from fertile White Leghorn 
eggs incubated at 38°C in a forced-draft incubator (Western 0-100). Prior to 
opening, the eggs were washed twice in 70% IMS to sterilise the surface. To open 
the eggs, the shell was cracked by tapping with toothed forceps in a line around the
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airspace, which is located at the blunt end of the egg if the egg is incubated with 
this end uppermost. The shell above the cracked line, along with the inner shell 
membrane, was carefully removed and the embryo extracted by placing a pair of 
curved forceps beneath the neck. The embryo was then decapitated and all the 
embryos collected in a 100 mm sterile petri dish containing filter-sterilised Leibovitz 
L-15 medium (Gibco). All dissections were also carried out in this medium.
Jo power supply Holder
lungsten needleElectrode
Figure 2.1:Makinq Tungsten Needles (from Davies. 1988)
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Dorsal Root Ganglia (DRG^
The thoracic and abdominal viscera were removed using curved watchmakers 
forceps, and the posterior abdominal and thoracic walls washed with Hanks Balanced 
Salt Solution (HBSS) (Gibco) using a Pasteur pipette. The DRG were removed from 
the lumbosacral region. This was done by passing the points of a pair of straight 
watchmakers forceps between the ganglia and the spinal cord to sever the spinal 
roots. The ganglia were then collected by holding the nerve distal to each ganglion 
with forceps and transferring to a small petri dish containing sterile HBSS. Finally, 
attached nerves were removed using tungsten needles.
Trigeminal Mesencephalic Nucleus (TMN^
The TMN was dissected by firstly removing the cranial vault, with a pair of 
watchmakers forceps, to expose the brain. This was then removed by carefuiiy 
passing a small spatula between it and the cranial base. The midbrain was isolated 
by two coronal incisions (figure 2.2) and the pia mater, which is the membrane 
surrounding the brain and spinal cord, was peeled off initially from the ventral 
aspect. Next, the roof of the cerebral aqueduct was dissected from the midbrain. 
Finally, the median portion of the nucleus which contains all the TMN neurons, was 
dissected out using tungsten needles and transferred to sterile HBSS.
Ciliary Ganglion
To dissect the ciliary ganglion, the head was anchored firmly with a pair of 
watchmakers forceps through the beak and the skin covering of the developing eye 
carefully removed by scoring around the edge of the eyeball with watchmakers 
forceps. The eyeball was then extracted as a whole with watchmakers forceps, 
taking care not to damage It, and the ciliary ganglion simply plucked from it. The 
spherical ganglion can be easily recognised as distinct from the flattened stalk of 
the optic nerve, which can also be seen coming out of the rear of the eye. Finally,
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the ganglia were collected in sterile HBSS and any attached nerves removed with 
tungsten needles.
Figure 2.2: The Successive Stages in the Dissection of the Median Part of the TMN
(a) dorsal aspect of the brain showing location of the two coronal incisions 
(interrupted lines) for isolating the midbrain.
(b) caudal aspect of the two parasaggital incisions for removal of the roof of the 
cerebral aqueduct after stripping of the pia mater.
(c) dorsal aspect of the roof of the cerebral aqueduct showing the location of the 
incisions for cutting out the median portion of the TMN. R= rostral; M= medial; 
C=caudal; TV= tectal vesicle; TC= tectal commissure; PC= posterior commissure; 
CA= cerebral aqueduct (from Davies, 1988).
Dorso-medial Portion of the Trigeminal Ganglion (DMTG)
The small-diameter cutaneous sensory neurons of the dorsomedial portion of the 
ganglion (DMTG) were dissected by first removing the brain, as described for the 
TMN dissection, to reveal the cranial sensory ganglia (figure 2.3). The trigeminal 
ganglia were removed with a pair of watchmakers forceps, and the ophthalmic lobe 
removed using tungsten needles, figure 2.3. The dosomedial portion of the
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remaining maxillomandibular lobe contains the NGF-responsive cells, whilst the cells 
of the ventrolateral portion are BDNF-responsive. The two parts were separated as 
shown in figure 2.3 using tungsten needles and the DMTGs collected in HBSS.
1 mm
OL
MML
DM
VL
Figure 2 .3 : Dorsal aspect of the cranial base after removal of the brain showing the 
lines for subdissecting the tissue into blocks that contain the trigeminal ganglion (T) 
(block A), the vestibulo-acoustic ganglion (V) and geniculate ganglion (block B), and 
the Jugular (J) and petrosal ganglia (block C). Subdissection of the trigeminal 
ganglion is achieved by separating the opthalmic lobe (OL) from the 
maxillomandibular lobe (MML) along the interrupted line (A). The dorsomedial 
portion (DM) can be separated from the ventrolateral as shown (B).
78
Mouse Dissections
isolation of Mouse Embrvos
The abdomen of the pregnant female was washed with 70% IMS and a small incision 
made in the skin at the front of the abdomen. The skin just above and below the 
incision was grasped between the index finger and thumb of each hand and the skin 
pulled away from the incision exposing the abdominal muscles. Using fine scissors, a 
small hole was made in the anterior abdominal wall allowing air to enter the 
peritoneal cavity, and so enabling the incision was able to be extended without the 
risk of cutting the intestines and contaminating the dissection with bacteria. Next, 
each uterine horn was carefully removed and placed in a sterile petri dish containing 
L-15. The embryos were removed from the horn and transferred to fresh L-15. For 
El 3 and older embryos this was done by making a single continuous incision along 
the anti-mesometrial border of each uterine horn exposing the embryos enclosed 
within their membranes, which were then removed with watchmaker's forceps. 
Younger embryos were removed by making a small hole in the musculature of the 
anti-mesometrial border of the uterine horn. The embryo, enclosed within its 
membranes, was then extruded through this hole due to contraction of the 
remaining uterine muscles.
Trigeminal Ganglion
For embryos older than El 3, a pair of forceps was used to steady the embryo whilst 
the top of the skull was cut off using fine iris scissors in a plane just above the eyes. 
A second cut was made parallel to the first passing through the mouth. Two further 
cuts were made with the scissors, just in front of and just behind the trigeminal 
ganglion, and the ganglia were then cleaned up using tungsten needles.
For younger embryos, tungsten needles were used to make two coronal incisions 
through the head, one just above the eye and the other between the maxillary and 
mandibular processes of the first branchial arch (Figure 2.4). The trigeminal ganglion
79
can be seen as two opaque structures in the tissue slice obtained. The ganglia were 
then cut out of the tissue slice and freed of any adherent mesenchymal tissue using 
tungsten needles.
m
Mn
Figure 2.4: Dissection of the mouse trigeminal ganglion. Transverse incisions are 
represented by interupted lines. Mx= maxillary process; Mn= mandibular process; IV= 
4th ventricle; TG= trigeminal ganglion.
Nodose Ganglion
The top of the skull and underlying forebrain were removed using the same plane of 
section as described for the first incision of the trigeminal dissection. The embryo 
was decapitated and the head cut in half along the saggital plane using tungsten 
needles up to E12 and fine scissors thereafter (figure 2.5). The hindbrain was 
removed using tungsten needles. The slit-like jugular foramen was opened up with 
tungsten needles to reveal the nodose ganglion lying at the base of this foramen.
The ganglion was then dissected out and cleaned of any attached nerves using the 
tungsten needles, before being transferred to HBSS.
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Figure 2.5: Dissection of the Mouse Nodose Ganglion at E14 . A. The incision passing 
from the jugular foramen (J) to the midline is shown by an interrupted line. The 
direction in which the large ossified part of the occipital bone (O) should be 
reflected to open up the jugular foramen after making the previous incision is shown 
by an arrow. T= tongue; ACF= anterior cranial fossa; R= root of the trigeminal nerve;
IE= inner ear. B. The nodose ganglion (N) and the superior cervical ganglion (S) are 
revealed.
Svmoathetic Chain Ganglia
To dissect the sympathetic chain ganglia, the abdominal and thoracic viscera were 
removed from embryos as described previously for the chick DRG dissection 
revealing the sympathetic chain lying ventral to the DRG. This was then carefully 
removed with sharp watchmakers forceps and cleaned of attached nerves and
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adherent tissue using tungsten needles, before being transferred to HBSS as 
described previously.
Tissue Dissociation
For the purpose of this project, it was important that the tissue be dissociated to 
single cells prior to plating. This ensures that any observed effects are not due to 
signals passed through intercellular contacts but by direct effects of factors added 
to the dish or injected into the cells.
Using a Pasteur pipette, the dissected tissue was transferred to a sterile 10 ml 
conical tube containing 1 to 2 ml of calcium- and magnesium- free HBSS. Balanced 
salt solutions, such as Hanks contain a combination of salts and glucose which 
control osmotic pressure and pH whilst providing an energy source. Calcium and 
magnesium free Hanks was used because calcium and magnesium ions can prevent 
the trypsin from working. The tissue was centrifuged briefly at 2000 rpm, to pellet 
the ganglia, and the supernatant removed. 900 /il of fresh HBSS and 100 jlvI of 1 % 
Worthington's trypsin were added, and the tube transferred to a water bath, at 
370c for the appropriate amount of time depending on the age of the tissue and 
ganglia. For instance for chick embryo ciliary ganglia, 15 minutes trypsinisation was 
required at El 0, 12 minutes is required at E8 and only 10 minutes at EG. The tube 
was then centrifuged briefly, and as much trypsin solution as possible removed prior 
to the addition of approximately 10 ml of filter-sterilised Ham's FI 2 medium (Gibco) 
+ 10% heat inactivated horse serum (HIHS) (Gibco). This solution inactivates any 
remaining trypsin. This wash in FI 2 +10% HIHS was repeated twice, followed by two 
washes in 10ml HBSS. In the washing procedures, ganglia were gently pelleted by 2 
min centrifugations at 2000 rpm. The ganglia were triturated in 1 ml HBSS to give a 
single cell suspension. This was accomplished by taking the tissue up into a flame- 
polished siliconised Pasteur pipette, placing the tip against the bottom of the tube, 
and slowly expelling the contents using firm pressure. This was done 6 to 8 times 
and the extent of dissociation was checked by examining a drop of the cells under
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inverted phase contrast microscope. The trituration had to be monitored closely as 
over-trituration can damage the neurons and detach neurites from their cell bodies.
Differential Sedimentation
Differential sedimentation was used to separate neurons from non-neuronal cells 
prior to plating. This technique depends on the differences in sedimentation rates of 
cells in a liquid medium such that larger cells, such as neurons sediment more 
quickly than smaller ones (Davies, 1988a). Differential sedimentation was only used 
for chick neurons as mouse neurons are too small to give good separation until 
postnatal ages. Also, for transgenic experiments the use of columns would be 
impractical as each embryo was dissected and the tissue from it dissociated, 
separately. Because this particular separation technique allows the cells to sediment 
through a culture medium it gives high neuronal viability at the end of the 
procedure. It is also very efficient, giving recovery of around 60% of the neurons in 
the starting tissue, mostly uncontaminated by other cells.
Sedimentation was carried out in a 100ml cylindrical, siliconised, glass dropping 
funnel with a ground glass outlet tap. This was autoclaved prior to use and 
assembled under sterile conditions before being clamped vertically to a stand. The 
funnel was filled with sterile FI 4 (Gibco) + 10% heat inactivated horse serum to a 
height of approximately 10 cm and placed on a vibration-free surface, at 2°C, where 
it was left overnight. The next day, dissociated tissue, prepared as described above, 
was layered onto the culture medium in the funnel by taking the cell suspension up 
in a siliconised, flame-polished Pasteur pipette and carefully running it down the 
inside of the funnel. After one hour, 5ml aliquots were run off into sterile tubes and 
0.5ml samples of these fractions placed in a 24 multi-well dish for examination with 
phase contrast microscopy to determine which fractions contain only neurons. The 
neuronal fractions were then pooled for plating.
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Plating the cells
Neurons were grown on a laminin/polyornithine substratum in 35mm or 60mm 
diameter plastic petri dishes (Nunc). To prepare these plates, 1 ml or 2ml, of 
0.5mg/ml poly-DL-ornithine (Sigma) in 0.5M borate buffer (pH 8.7) was placed on 
each dish for 12 hours. This changes the hydrophobicity of the dish allowing the 
laminin to attach. After 12 hours, the polyornithine was aspirated and the dishes 
washed three times in sterile distilled water before being left to air-dry in a laminar 
flow hood. 120jL/l of 10ug/ml laminin (Gibco) in FI 4 was placed in the centre of 
each dish and spread with a pipette tip to cover about two-thirds of the dish 
surface. The dishes were then placed in a CO2 incubator at 37°C for at least 4 
hours. Thereafter, the dishes were washed twice with FI 2 +  10% HIHS and finally 
1 ml of the appropriate culture medium added to each dish. For embryonic chick 
neurons, this medium was F14 + 10% HIHS and for mouse neurons, FI 4 with Sato 
additives (2mM Glutamine, 0.35%  bovine albumin (Pathocyte-4, ICN), 60ng/ml 
progesterone, 1 G^/g/ml putrescine, 400ng/ml L-thyroxine, 38ng/ml sodium selenite, 
340ng/ml tri-iodo-thyronine, 60/vg/ml penicillin and 10Ojug/ml streptomycin) was 
used. At this point the neurotrophins were also added to the culture dish at their 
required concentrations. The dishes were now ready for the cells to be plated. The 
pooled neuronal fractions were placed in a suitable volume of culture medium and 
rocked gently within the tube to evenly distribute the neurons within the culture 
medium. Then, 1 ml was added to each culture dish using a circular movement. The 
culture medium was not touched by the tip of the pipette as this could transfer 
small amounts of neurotrophic factors between the dishes.
Preparation of Neurotrophins
Neurotrophins were received as concentrated stocks from Genentech Inc. and were 
diluted in FI 2 + 10% HIHS, at pH 5.0, to give a more dilute stock at 1jL/g/ml. This 
stock was then used to supplement the dishes for experiments. For example.
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addition of 10ji/i of the stock neurotrophins to 2ml of culture medium gave a 
concentration of 5ng/ml.
DNA MICROINJECTION
Preparation of DNA
cDNAs for microinjection experiments, in appropriate expression vectors, were kindly 
donated by Gabriel Nunez, University of Michigan Medical School. In order to obtain 
sufficient quantities of DNA for microinjection, cDNAs were transformed into 
competent E. Coli and amplified in 500ml cultures. Alkaline lysis was then used to 
extract cDNA from the bacterial cultures.
Preparation of Competent E. Coli
This method gave a transformation frequency of 10® transformant colonies per pg 
supercoiled DNA. As far as possible, all procedures were carried out in a laminar flow 
cabinet to maintain sterility. The E. Coli strain used was XL1 Blue and stocks of 
these cells were kept at -80°C in Luna broth (LB broth) (Gibco) with 15% glycerol.
In order to produce single colonies, cells were scraped from the surface of a frozen 
stock aliquot, streaked across a Luna agar (LB agar) (Gibco) plate using a flamed 
inoculating loop and incubated at 370C, in an inverted position, for 12 hours.
A single colony was used to innoculate 25ml of LB broth which was subsequently 
incubated overnight at 37°C in a rotary incubator. The 25ml overnight culture was 
diluted into 250ml sterile LB broth and incubated at 370C, in a rotary incubator until 
the OD550 was 0.48. The 250ml culture was then chilled on ice for 5 minutes 
before pelleting the bacteria by centrifuging in sterile, ice-cold tubes at 6000 rpm, 
for 10 minutes, at 4°C. From this point on the cells had to be kept as cold as 
possible and so were put on ice whenever possible. The supernatant broth was 
discarded and the cells resuspended in 100ml of filter-sterilised ice-cold buffer I 
(30mM potassium acetate, 10OmM rubidium chloride, 50mM manganese chloride,
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and 15% glycerol, pH5.8). The resuspended cells were left on ice for 3 minutes 
before being pelleted by centrifugation for 5 minutes, at 6000 rpm at 4°C.
Following this, the supernatant was discarded and the cells resuspended in 10ml of 
filter-sterilised, ice-cold buffer II (lOmM MOPS, 75mM calcium chloride, lOmM 
rubidium chloride and 15% glycerol, pH6.5). After incubation the cells were 
dispensed in ZOO^ jI aliquots and placed on a mixture of dry ice and IMS to snap 
freeze them prior to storage at -80°C.
The competent cells were transformed with a known concentration of plasmid DNA, 
typically 1 -2ng, to test their efficiency.
Transformation of Competent Cells
A 200)l/I aliquot of competent cells was split to give 1 OOjul for transformation and 
10Ofjl of control cells and these aliquots placed on ice. I/jI of the required plasmid 
DNA, at 10 ng/ml, was added to the cells to be transformed and these were placed 
back on ice for 30mins. Following this, the cells were heatshocked at 42^0 for 2 
minutes and immediately returned to ice. 500/vl of LB broth was added to each tube 
before transferring to the shaking incubator at 370C. After a 30 minutes incubation 
at 37°C, to allow time for the plasmid protein giving ampicillin resistance to be 
expressed, the cells were plated onto LB agar plates containing 1 OO^g/m\ ampicillin. 
100fj\ of non-transformed control cells were spread on one plate, to check for 
contamination of the stock by any bacteria possessing innate antibiotic resistance, 
and the remaining plates spread with either: 100/vl of neat transformed cells, a 
1:10 dilution in sterile distilled water, a 1:100 dilution, or a 1:200 dilution. The 
plates were incubated, upside down, at 37°C overnight. There should be no colonies 
on the control plate, as the cells did not contain the plasmid with the ampicillin 
resistance gene, but colonies should be observed on all the other plates.
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Small-scale isolation of Plasmid DNA by Alkaline Lysis (Miniprep)
This procedure was carried out to ensure that the colonies selected for the large 
scale isolation of DNA contained the correct plasmid. Each plasmid miniprep was 
carried out on a single colony selected from one of the plates and for each 
transformed plasmid, 6 colonies were selected to ensure that a clone containing the 
correct plasmid was isolated for the subsequent procedure. The small-scale isolation 
allows for quick, convenient isolation of plasmid DNA without column purification or 
banding in caesium chloride gradients. The resultant plasmid DNA is suitable for 
restriction enzyme analysis. Each single colony picked from the agar plate was 
grown overnight, at 37oC in a rotary incubator in 5ml of LB broth containing 
10OjL/g/ml ampicillin. The next day, 1.5ml samples of each overnight culture were 
dispensed into microfuge tubes and the bacteria were pelleted by centrifuging at 
13000 rpm for 3 minutes. The supernatant was discarded and the bacterial pellet 
resuspended in 300jul of solution I (25mM Tris HCI pHB.O, lOmM EDTA pHB.O,
50mM Glucose). Following this, the resuspended bacteria were placed on ice, and 
400/vl of solution II (0.2M sodium hydroxide, 10% sodium dodecyl sulphate) was 
added and the tubes gently mixed. The SDS in solution II denatures bacterial 
proteins whilst the sodium hydroxide denatures chromosomal but not plasmid DNA. 
Immediately, 300jul of solution III (3M potassium acetate solution pH 5.5) was added 
to neutralise solution II, and again the tubes were mixed gently before being placed 
on ice for 10 minutes.
The samples were centrifuged for 5 minutes, at 13000 rpm and 4°G, to pellet the 
cell debris and chromosomal DNA. Subsequently, the supernatant was transferred to 
a fresh microfuge tube and after the addition of 0.5ml of isopropanol, the tubes 
were placed at -20°C, for 10 minutes, to precipitate the plasmid DNA.
The DNA was pelleted by centrifugation, at 13000 rpm, for 3 minutes and the 
supernatant was discarded. This pellet was washed in 70% ethanol to dissolve any 
salts, and allowed to air-dry. After resuspending the pellet in 50jl/I sterile distilled
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water, 100p1 of 7.5M sodium acetate were added, the tubes mixed and the tubes 
left at -20°C for 10 minutes. Protein was pelleted by centrifuging for 5 minutes at 
13000 rpm to pellet the protein and the supernatant was transferred to a fresh 
tube. 80pl of isopropanol was added to the supernatant and the tubes were placed 
at -20‘^ C for 10 minutes, to precipitate the DNA. Following a 5 minute centrifugation 
at 13, OOOrpm, the supernatant was removed and the pellet was washed in 70% 
ethanol. After drying the DNA pellet and resuspending it in 25p.l sterile distilled 
water, 2/il was taken for a restriction digest to check the identity of the plasmid. 
The DNA derived from this procedure is best stored at -20°C or lower as it is prone 
to degradation by contaminating nucleases. Once the identity of the plasmid was 
confirmed, the remaining 2ml of overnight culture could be used to innoculate media 
for the large-scale alkaline lysis.
Restriction Digests and Agarose Gel Electrophoresis
2ji.l of the DNA obtained from the above mini prep procedure were digested in a 
reaction containingl pi 10x restriction endonuclease buffer, 5-10 units of the 
restriction endonuclease and sterile deionised water to give a total volume of lOpl. 
The reaction was carried out at the recommended optimum temperature for each 
endonuclease (usually 37°C). The products of the digest were visualised by 
electrophoresis on a 1% agarose gel. DNA, which Is negatively charged at neutral 
pH, will migrate from the cathode to the anode when a potential difference is 
applied across the gel. The rate of migration of linear duplex DNA molecules is 
inversely proportional to logio their molecular weight. It is also affected by the 
agarose concentration of the gel, DNA conformation (i.e. linear, circular, or 
supercoiled), the voltage applied across the gel and the composition and ionic 
strength of the electrophoresis buffer. Tris-acetate electrophoresis buffer (TAE) 
was used for agarose gel electrophoresis. This was prepared as a 50x stock (2M 
Tris HCI pH8.0, 0.05M EDTA pH 8.0, 6% concentrated glacial acetic acid) which was 
then diluted to a 1x solution for use. To cast an agarose gel, the desired amount of
8 8
ultra pure agarose (Gibco) was completely melted in the TAE, in a microwave, and 
ethidium bromide was added to a final concentration of O.Sjug/ml. Ethidium bromide 
binds to the DNA during electrophoresis and fluoresces in UV light, allowing DNA 
bands to be seen on the gel. When the molten gel had cooled to around 60°C, it 
was poured into a gel-casting plate whose ends had been sealed with masking tape, 
the well-forming comb was put in position, and the gel was allowed to set. The set 
gel was placed in the electrophoresis tank and covered with TAE buffer and the 
comb removed. The DNA samples were mixed with 6x gel-loading buffer (40mM 
EDTA; 0.1% Bromophenol Blue; 20% glycerol) and loaded onto the gel. A molecular 
weight standard was loaded into one well to allow the size of the DNA bands to be 
measured. A voltage of 1 -5v/cm  was applied across the tank. After electrophoresis 
was complete, a permanent record of the gel could be made by photographing it on 
the UV transilluminator.
Large-scale Preparation of Plasmid DNA by Alkaline Lysis (Maxiprep)
Two 21 flasks, each containing SOOmIs of LB broth with ampicillin (lOOjug/ml), were 
inoculated with the cultures that were not used in the miniprep and incubated 
overnight at 37^0 in a rotary incubator. The next day, the cells were collected by 
centrifugation, at 10000 rpm for 10 minutes. They were then washed in 50ml Tris- 
HCI, pH 8.0, to remove traces of LB broth and centrifuged again for a further 10 
minutes, at 10000 rpm. Next, the pelleted cells were resuspended in 50ml of 
Solution I + lysosyme and left on ice for 30 minutes. Following this, 80ml of 
denaturing Solution II were added and after careful mixing, the tubes were 
transferred to ice for 10 minutes. The DNA solution was neutralised by the addition 
of 40ml of cold Solution III. Following gentle mixing, the tubes were placed on ice for 
15 minutes. The tubes were then spun at 8000 rpm, for 5 minutes, and the 
supernatant filtered into a fresh tube through 2 layers of gauze. Approximately 0.6  
volumes of isopropanol at -20°C were added to precipitate the DNA. After mixing, 
precipitated DNA was immediately recovered by centrifuging at 8000 rpm for 5
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minutes and aspirating the supernatant. After alkaline lysis, plasmid DNA was 
purified away from chromosomal DNA, protein and RNA by ultracentrifugation on a 
Caesium chloride/ ethidium bromide gradient. In this process ethidium bromide 
intercalates into the DNA becoming inserted between adjacent base pairs in the 
helix. This results in a slight untwisting of the helix and a decrease in the buoyant 
density of the DNA in CsC! solution. The physical constraints of a double-stranded 
supercoiled DNA molecule limit the amount of dye which can be bound per unit 
length. Consequently, the density decrease is less in a super-coiled molecule than in 
linear or relaxed circular DNA and so supercoiled forms such as plasmid DNA can be 
readily separated from other DNA on a caesium chloride gradient. The gradient is 
formed when a CsCI solution is centrifuged at very high speed. The air-dried pellet 
was dissolved in 3.81ml of sterile distilled water before adding 4.016g of caesium 
chloride added and 150pl of ethidium bromide (lOmg/ml). The resultant solution 
was transferred to a Beckman ultracentrifuge tube and mineral oil added to exclude 
any air which could shatter the tube whilst spinning. The tubes were spun in a 
Beckman Ultracentrifuge (L-7) at 40000 rpm for at least 16 hours.
After centrifugation, 2 bands could be seen, the lower one representing the 
covalently closed circular DNA of the plasmid and the other containing the relaxed 
chromosomal DNA. The plasmid DNA was harvested using a Pasteur pipette. 
Ethidium bromide was removed by repeated extraction with caesium chloride 
saturated isopropanol. An equal volume of CsCI saturated isopropanol was added to 
the plasmid DNA, the tube was mixed, the layers allowed to separate, and the upper 
layer containing the ethidium bromide was discarded. This process was repeated 
until no colour remained in the isopropanol layer. Next an equal volume of sterile 
distilled water was added plus 0.1 volumes of 3M sodium acetate (pH 5) and 0.6 
volumes of isopropanol. After mixing, precipitated DNA was recovered by 
centrifuging at 14000 rpm for 2 minutes. The supernatant was removed and the 
pellet was washed in 70% ethanol prior to vacuum drying and resuspending In 200pl
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of sterile distilled water. Finally, the identity of the plasmid DNA was checked by 
restriction analysis.
To ascertain the concentration of the DNA obtained, the absorption of diluted 
plasmid was measured at 260nm in a spectrophotometer. The ratio of OD260 to 
OD28O gives a measure purity of the plasmid DNA. If the DNA is pure the ratio will 
be about 1.8. A higher figure would indicate the presence of too much RNA and a 
lower figure would indicate protein contamination. To calculate the concentration of 
the plasmid, the following formula was used
2 X 50 X OD26O
where 2 is the inverse of the light path length through the cuvette
50 is the mathematical constant used for plasmid DNA
This gives a concentration in jug/ml and the plasmid was then diluted to 10O/zg/ml 
for microinjection. Plasmids were stored at -80°C prior to microinjection.
Tissue culture for microinjection
Cultures were set up as described previously, but the cells were plated on 60mm 
diameter Nunc dishes rather than 35mm dishes. Nine square grids were scribed onto 
the bottom of these dishes with a scalpel blade. The total area of the grid was 
144mm2, each square of the 9 square grid was 4mm x 4mm. Cells were plated 
about 12 hours before injection in the presence of their appropriate neurotrophic 
factor. Cells were plated at a density such as to give approximately 50 cells per 
square of the grid.
DNA microinjection
Needles were made from Narishige 1 mm x 90mm glass tubing using a 
microelectrode puller. 0.7/71 of the plasmid to be injected was loaded into the needle 
using an Eppendorf microloader. Before loading the plasmid DNA solution was spun
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at 13000 rpm for three minutes to sediment any particulate matter which could 
block the microinjection needle. During the injection procedure, the vial containing 
the plasmid was kept on ice to inhibit the action of any nucleases present. Prior to 
injection, each loaded needle was checked under a dissection microscope for the 
presence of any air bubbles which could block the needle. If present, these were 
easily removed by shaking the needle firmly. Finally, the needle was the placed in 
the micromanipulator arm (Narishige) which was attached to a Nikon inverted phase 
contrast microscope.
The dish to be Injected was prepared by washing 5 times in 10 ml of FI 2 + 10% 
HIHS to remove the neurotrophins. Following this, 8ml of FI 2 +10% HIHS were 
added to act as the medium during injection. The dish was then placed on the stage 
of the microscope and a square of the grid was selected for microinjection. Turning 
the microscope to dark field, the needle was positioned to lie centrally within the 
field of view and at a low level near the cells. The microscope was then turned to 
phase bright x400 and the bottom of the dish was brought into focus. Next, the tip 
of the needle was broken against the bottom of the dish to allow the plasmid DNA 
solution an exit from the needle. The cells were then brought into focus, ready for 
injection.
As the cell membrane is most resilient in the area overlying the nucleus, the DNA 
was injected directly into the nucleus by pressure from a pressure system. After 
penetration, the needle was left in the nucleus until the nucleus was seen to swell, 
and then the needle was withdrawn. When all the cells in a given square were 
injected, the dish was washed a further 3 times with FI 2 + 10% HIHS. Finally 8ml 
of FI 4 + 10% HIHS + 5% Fetal calf serum (FCS) (Gibco) containing the required 
neurotrophic factors was added to the culture dish and the culture was returned to 
the CO2 incubator at 37^0.
The cells were counted 1 hour post-injection because by this time any cells which 
were likely to die from the effects of the injection would have done so. Also, at this
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time, the number of cells In another uninjected square of the dish was counted to 
give an internal control for any neurotrophic factors remaining In that particular dish.
TRANSGENIC MICE
Breeding
bcl-2 Knockout Mice
An original small colony comprising 12 male and 9 female mice of C57/BL6 
background strain and heterozygous for a null mutation in the bcl-2 gene was 
received from the Paterson Institute for Cancer Research in Manchester, bcl-2 
knockout mice show early postnatal lethality (Nakayama et al., 1993; Veis et al., 
1993; Kamada et al., 1995) and so embryos homozygous for the mutation were 
obtained from heterozygote crosses. Early indications were that the colony showed 
a male bias in its sex ratio and this was confirmed statistically using a t-test. The 
sex ratio at birth is approximately 2:1 males : females (n=317). The average 
gestation period is 20 days(n=77) and the average litter size is 6.8 (n=77). 
Approximately 15-20 heterozygous females had to be time mated each month to 
give adequate pregnant animals for experimentation, since the vaginal plugging 
efficiency (i.e. the percentage of vaginal plugs noticed which resulted in a 
pregnancy) was 32% (n= 69). Given the above data, quite a large breeding stock 
was required to provide adequate females for experiments. Owing to the difficulty In 
telling whether an individual mouse was pregnant post coitus, a pregnancy test was 
devised whereby the mice were weighed on the day that the vaginal plug was found 
and thereafter the percentage change in body weight from this original weight could 
then be calculated (Fig 2.6). This test could reliably indicate whether a mouse was 
pregnant by 8 days post coitus.
From the above statistics it can be seen that of each 24 individuals bom, 8 will be
female and of these eight there will be two homozygotes, four heterozygotes, and
two wild type individuals. Therefore to get twenty heterozygous females per month,
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we require that 120 mice are born, that is approximately 17 litters. To help to build 
up stock initially, wild type females were also used for stock breeding, crossing 
them with heterozygous males. As the colony expanded this practice became 
obsolete.
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Figure 2.6: Percentage increase in body weight with time for pregnant and non 
pregnant C57/BL6 bcl-2 +/- mice
Because C57/BL6 mice are poor breeders, the original bcl-2 knockout mice were 
crossed with GDI mice which are renowned as good breeders. The resultant mice 
were seen to be inbred after three generations. The mice used for the survival 
studies in Chapter Four were C57/BL6 backgroung strain. Those used in Chapter 
Five were of GDI background strain.
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bax Knockout Mice
Two male and two female mice heterozygous for a null mutation in the bax gene 
were received from Stanley Korsmeyer, Howard Hughes Medical Institute. The bax 
colony was derived from a series of heterozygous crosses whilst the mice were in 
rabies quarantine. The average gestation period for these mice was 21 days (n=54) 
with an average litter size of 8 (n=54).
Genotvplng 
DNA Extraction
By the constraints of our animal license, the mice could not be genotyped until they 
were at least 4 weeks old. At this age, the mice were sedated, using diethyl ether or 
halothane and 1.5cm was clipped from the tip of the tail and transferred to a 
labelled 1.5ml microfuge tube. An ear tag (IMS) was then fitted so that individuals 
could be identified. Very few homozygotes survived to genotyping, most were 
sacrificed prior to this on phenotypic grounds. Heterozygotes were used for matings 
both for experiments and to supplement breeding stock. Wild type individuals were 
eliminated.
For embryos, DNA was extracted form any tissue that remained after dissection of 
the relevant ganglia for tissue culture, or subdissection of the embryos for 
histology.
The tissue obtained was chopped into small pieces and placed in an Eppendorf tube 
with 500pl proteinase K solution (50mM Tris HCI pHB.O; lOmM EDTA; 0.1 M sodium 
chloride; 1% sodium dodecyl sulphate and 500|ig/ml proteinase K) incubated 
overnight at 55°C in a water bath.
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(i) Phenol Extraction
First, SOOj^ l of basic phenol were added to the tube following Proteinase K digestion 
and the contents of the tube were thoroughly mixed. The tube was then 
centrifuged, at 13000 rpm for 10 minutes, to separate the mixture into an upper 
aqueous phase containing DNA and a lower phenolic phase containing proteins and 
much of the RNA. 250 jl/I of the upper aqueous phase was transferred to a fresh 
tube and 25jul 3M sodium acetate pH 5.4 were added followed by 675/1/1 absolute 
ethanol. Following thorough mixing, the ethanolic mixture was left at -20°C for 1 
hour to allow the DNA to precipitate. Next, the samples were centrifuged, at
13000 rpm for 10 minutes, to pellet the DNA and the supernatant was discarded. 
The DNA pellet was washed with 70% ethanol, to remove any salts in the pellet, and 
finally and resuspended in 200jl/I of sterile ddHzO or TE buffer. The DNA solution 
was triturated several times through a 25G needle attached to a 1 ml syringe. The 
purpose of this was to break up the DNA allowing the PCR primers better access to 
their binding sites.
(ii) High Salt DNA Extraction
Following Proteinase K digestion, 210//I of 5M sodium chloride solution was added to 
each tube and the contents of the tubes mixed thoroughly by vortexing for 15 
seconds. This step was followed by a 10 minute centrifugation, at 13000 rpm, to 
pellet the proteins. The resultant supernatant was transferred to a fresh microfuge 
tube and an equal volume of 100% ethanol was added. DNA was pelleted by 
centrifugation, at 13000 rpm for 10 minutes, and the supernatant was discarded. 
The DNA pellet was washed in 1 ml of 70% ethanol to remove any salts present in 
the pellet. It was then centrifuged, at 13000 rpm, for 5 minutes. Again the 
supernatant was discarded and the pellet allowed to air-dry before it was 
resuspended as described for the phenol extraction method.
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Polymerase Chain Reaction
To produce bol-2 and bax knockout mice, a segment of both genes was replaced by 
a neomycin resistance gene cassette by homologous recombination in embryonic 
stem cells. In addition to preventing production of functional bcl-2 or bax, this 
allows selection of embryonic stem cells carrying the transgene. The polymerase 
chain reaction (PCR) can be used to distinguish which of the two possible bcl-2 or 
bax alleles mice carry (i.e. wild type or neomycin casette disrupted). A three primer 
PCR reaction was used to allow identification of both wild type and mutated alleles 
in a single PCR reaction. One primer was located in the bcl-2 or bax coding 
sequence and was common to both alleles. For detection of the wild type allele, a 
second primer was located in the bcl-2 or bax coding region in the region replaced 
by the Neo gene in the mutant. To detect the mutant allele, a third primer was 
designed that wouid bind to the Neo gene. The use of these primers together gave 
ampiification of one single PCR product for wild type animals, another unique single 
PCR product for Knockout animals, and both PCR products for heterozygotes. The 
PCR products were of different sizes and were easily resolved on an agarose gel.
Oligonucleotide primers were synthesised on an Applied Biosystems DNA 
synthesiser. The sequence required was typed in and the synthesised 
oligonucleotide collected on an oligopak column (Applied Biosystems). To cieave 
oligonucleotides from the column, the column was flushed through with 3ml 40% 
ammonium hydroxide (Applied Blosystems) many times over the course of 3 hours 
taking care not to allow the filter to dry out. The ammonium hydroxide containing 
the eluted primers was transferred to a screw-top glass vial and deprotected by 
incubating at 55 °C overnight. The next day the liquid was allowed to cool down and 
transferred to microfuge tubes for rotary evaporation of the ammonium hydroxide. 
The primers were resuspended in 200pl sterile ddH20 and spectrophotometer 
readings of a 1:100 dilution were used to calculate the concentration:
100 X 2 X 33 X OD260 = concentration in pg/ml
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where  ^00 is the dilution factor
2 is the inverse of the light path length through the cuvette
33 is the mathematical constant used for oligonucleotides 
(OD260 X 20)
xmer = concentration in nmol/ji/l.
where xmer is the length in bases of the primer
For each individual animal, two reactions were carried out to safeguard against 
wrong genotyping. If two consistent genotypes were not found then the reactions 
for that individual were repeated to obtain consistent results.
Bcl-2 Knock Out Mice
Each reaction was carried out in a 20jul reaction volume. Each tube contained:
2/il 10x reaction buffer ( Buffer B, Promega)
I .2/l/I 25mM magnesium chloride 
1/L/l 5mM dNTPs (Pharmacia)
1/L/l CDNA3
1/L/l CDNA5 
IjL/l PGKNM
0.5jL/l Tag thermostable DNA polymerase (Promega) 
ljul template DNA
I I  .3a/1 ddH20
The primer sequences were: 
pGKNM (5 ') GCC TAG CCG CTT CCA TTG CTC AGC 
CDNA5 (S’) TAG AGA CCA ACT TAG TCA GAG CCG 
CDNA3 (S') CGT CGC GCC TCT TCA CCT TTC AGC
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The PCR reaction itself consisted of 33 cycles, following an initial 5 min denaturing 
step at 94°C. Cycle conditions were: 1 minute at 94°C (denature), followed by 1 
minute at 64°C (primer annealing), followed by 1 minute 30 seconds at 72°C 
(elongation). There was also a final elongation stage of 7 mins at 72°C. The 
products of the reaction were visualized on a 1 % agarose gel containing ethidium 
bromide. The mutant band, which was amplified by pGKNM and cDNAS, was 400bp 
and the wild type, which was amplified by primers cDNA3 and cDNAS, was 950bp. 
Fig 2.7 shows how the three possible genotypes appear on such a gel.
Figure 2.7: Gel showing the results of genotyping reactions
Lane 1 
Lane 2 
Lane 3 
Lane 4 
Lane 5 
Lane 6 
Lane 7 
Lane 8
Molecular weight standard 
Bcl-2 + /+
Bcl-2 - / -  
Bcl-2 + /-
Molecular weight standard 
Bax + /+
Bax + /-  
Bax - /-
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Bax Knock Out Mice
Each reaction for the Bax genotyping was carried out in a 20^1 reaction volume, 
each reaction containing as follows:
IjL/l 5mM dNTPs ( Pharmacia)
2/71 10x reaction buffer ( Promega buffer B)
1.2/71 25mM magnesium chloride
0.5/71 Tag thermostable DNA Polymerase (Promega)
1/L/l 16uMBaxEx5F 
1/7l 4uM NeoR 
Ijul 16uMBaxlN5F
I ml template DNA
I I  .3jl/I ddHzO
The primers for this reaction were:
Bax IN5R (S') GTT GAC CAG AGT GGC GTA GG
BaxEXSF (S') GTA CTA CCA AGA CTA GTC GA
Neo (S') GGC GAC TCG TTA CCT TCG CC
After and initial denaturing step of 94°C for S minutes, 35 cycles were carried out 
consisting of: 1 minute at 94°C, followed by 1 minute at 55°C, followed by 1 minute 
at 72°C. A final 7 minute elongation at 7Z°C was followed by refrigeration at 4°C.
The PCR products were visualized on a 2% agarose gel containing ethidium bromide. 
The mutant band, which was amplified by Bax INSR and Neo, was S07bp and the 
wild type, which was amplified by Bax INSR and Bax EXSF, was 307bp. All three 
possible genotypes are seen in Figure 2.7.
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Tissue Culture
At the time of setting up the cultures, the genotype of each individual embryo was 
unknown therefore it was impossible to pool the ganglia for dissociation and 
trituration as described previously. When the embryos were removed from the 
mother they were placed in individual numbered 60mm dishes, containing sterile 
LI 5 ,for dissection. Once the ganglia were dissected from an individual, they were 
placed in a labelled 10ml tube with 975pl HBSS and the remains of the embryo was 
taken for genotyping.
To dissociate the tissue, 25ul of 0.1% Worthington's trypsin was placed In each 
tube and the tubes were placed in a water bath, at 37°C, for a length of time that 
was dependent on embryonic age. Thereafter, the HBSS containing the trypsin was 
aspirated and 10ml FI 2+10% HIHS was added to each tube to inactivate residual 
trypsin. Following this, the tube was centrifuged briefly to sediment the ganglia, the 
FI 2 was discarded and 1 ml FI 4+Sato was added to each tube. The ganglia of the 
first embryo were then triturated with a flame polished siliconised pipette. After 2 
or 3 passages, a drop was observed under the microscope to check the level of 
dissociation. The pipette was then rinsed in LI 5 to flush out any cells from the first 
embryo remaining in the pipette, allowing the same pipette to be used for all the 
ganglia. After the ganglia of the other embryos were dissociated, the cells were 
diluted to an appropriate concentration and volume before being plated and finally 
placed in the CO2 incubator at 37°C.
To assess cell survival, the number of neurons were counted at three hours after 
plating and at regular intervals thereafter. Percent survival was calculated relative to 
the three hour count. Each dish was centrally positioned over a 12mm by 12mm 
graticule, comprising 2mm squares and the number of neurons located on the grid 
counted using an inverted phase contrast microscope at xIOO. Each condition was 
studied in triplicate in each experiment for each embryo.
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Cohort experiments were also carried out to follow the fates of individual cells with 
regards to proliferation, maturation and survival. This was done by scibing a 6mm by 
6mm grid, comprising sixteen 1.5mm by 1.5mm squares, on the bottom of a 60mm 
Nunc petri dish. The cells were plated within this dish at low density to give a final 
density of around 20 to 50 cells on the grid. The cells in the grid were drawn at 
various time intervals and the data evaluated to calculate the percentage of new 
neurons that mature during the experiment, taking the figures from 18 hours after 
plating as 100%. In addition the survival of individual neurons, and the state of 
maturation was assessed. Neurons were classified as immature if they had phase 
dark, spindle-shaped cell bodies and short neurites, whilst mature neurons had 
phase-bright cell bodies and long neurites. Intermediary neurons were only classified 
as mature if they possessed a phase-bright cell body and definite neurites.
Cohort experiments were also used to quantify neurite outgrowth. To examine 
growth rates, accurate serial camera lucida drawings of the same individual neurons 
over a set time period were made using a drawing tube. From these drawings, total 
neurite length was calculated using the NIH Imager graphics package. To exclude 
any differences in growth rate that could arise as a consequence of differences in 
neuronal viability, only neurons that survived throughout the culture period were 
included in the analysis.
Histology
Fixation and Embedding
Embryos for histology were sub-dissected by making a transverse cut rostral to the 
upper limbs and a second rostral to the eyes. The lower portion of the body was 
used for genotyping and the upper portion fixed in neutral buffered formalin for 3-4 
days. After fixation, the tissue was washed in tap water for 2-4 hours to wash out 
the fixative. Older tissue (El 6 and older) was then transferred to 10% EDTA for 1 
week to decalcify. Thereafter, the tissue was dehydrated through a graded alcohol
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series before being transferred to an alcohol/chloroform mix which in turn was 
followed by 2 changes of chloroform. Chloroform was used as a clearing agent as 
this bleaches the tissue prior to cresyl fast violet staining. If another clearing agent 
such as xylene was used, the staining criteria were altered. Finally, the tissue was 
embedded in paraffin after 3 changes in paraffin wax at 56°C.
Cresyl fast Violet Staining
8/7m sections were cut using a microtome. These were cleared in xylene before 
rehydration through a graded alcohol series and staining with 0.025%  cresyl fast 
violet. The length of time that the sections were stained for varied with embryonic 
age. Younger specimens took up the stain more readily reflecting the increased 
water content of these cells. After staining the cells were differentiated in 96%  
alcohol until the nucleoplasm of the neurons was seen to be free of stain. The 
sections were then dehydrated and cleared in xylene before mounting with DPX.
Estimation of Neuronal Number
To count the number of neurons per ganglion, camera lucida drawings were made of 
every tenth section and the area of the drawn section was measured using the NIH 
Imager software package in conjunction with a graphics pad. The average number of 
cells per 0.01 mm^ was counted at x1000 using an eyepiece graticule. On average 
five fields were counted per section drawn. Using this and the area measurement, 
the approximate number of cells in that section could be calculated and all the 
sections analysed added together to give the approximate number of cells in 10% 
of the ganglion. By simply multiplying by 10 the approximate number of cells in the 
ganglion could be obtained.
Neurofilament Staining
The heads of El 2 embryos were fixed in Carnoy's fluid (60% ethanol, 30%  
chloroform, 10% acetic acid) for 20 minutes prior to dehydration and wax
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embedding. The bodies were retained for genotyping. Serial sections of the heads 
were cut at 8/vm and mounted on polysine coated microscope slides. The sections 
were cleared in xylene and dehydrated before quenching (10% methanol, 3% 
hydrogen peroxide in PBS). Non-specific interactions were blocked using 10% horse 
serum in PBS with 0.4% Triton X-100. The sections were incubated in primary 
antibody (Monoclonal anti-Neurofilament 160, Sigma Immunochemicals, used at 
1:500) for 1 hour and then labelled using biotinylated secondary antibody (1 :200) 
and avidin and biotinylated horse radish peroxidase macromolecular complex 
(Vectastain ABC Kit, Vector Laboratories). The substrate used for the peroxidase 
reaction was 1 mg/ml diaminobenzidine tetrachloride (Sigma). After staining the 
sections were washed in tap water prior to rehydration and mounting. Estimation of 
neuronal number was carried out as for cresyl fast violet stained sections. Here, 
neurons were identified as neurofilament positive cells.
Estimation of Number of Pyknotic Neurons
To evaluate the extent of cell death, all pyknotic nuclei were counted at x400  
magnification in every fourth section along the entire rostrocaudal length of the 
trigeminal ganglion. Estimates of the total number of pyknotic nuclei in the ganglion 
were obtained by multiplying this number by four.
Immunocvtochemistrv
Tissue culture
Cells were plated in 4-well dishes, each well being of 10mm diameter. This allows 
plating at high density in a small area thus minimizing the quantity of reagents used.
Cell Fixation
After growing cells in culture in a 4% CO2 incubator at 37°C, for 24 hours, the 
medium was carefully removed from each well with a pipette and 1.5ml of pre­
warmed (3 7 ^ 0  4% paraformaldehyde solution added to each dish. After incubation
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at 4°C for 2 hours, the cells were washed twice with PBS/glycine (1 xPBS, 0.1 M 
glycine, pH 7.2) at room temperature for 5 minutes each wash. This solution 
neutralizes the un reacted paraformaldehyde. The two PBS/glycine washes were 
followed by a single wash in PBS (pH7.2), at room temperature, for 5 minutes.
Permeabilised Staining for Neurofilament
The fixed cells were preincubated in 1.5ml P blocking buffer (1x PBS, 1% bovine 
serum albumin, 2% goat serum, 0.4% saponin) to permeabilise the cells. After this 
was removed, the cells were incubated with 70ji/l of a 1:100 dilution of the primary 
antibody in P blocking buffer, at room temperature, for 1 hour. At the end of this 
incubation period, the cells were washed in three changes of PBS/saponin ( Ix  PBS, 
0.4% saponin) for 5 minutes each wash. Meanwhile, the secondary antibody was 
centrifuged at 3000 rpm for 5 minutes, at 4°C, to remove any aggregates before 
being diluted 1:100 in P blocking buffer. 70fj\ of secondary antibody solution was 
added to each well and incubated at room temperature, for 1 hour, in the dark. The 
cells were washed with 2 changes of PBS/saponin and one of PBS, for 5 minutes 
each change, before mounting with citifluor (Agar). Cells were visualised using an 
Axioscope fluorescent microscope.
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III. OVEREXPRESSION STUDIES
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CHAPTER THREE 
OVEREXPRESSION STUDIES
INTRODUCTION
bcl-2, bcl-x, and bax are members of a family of cytoplasmic proteins that Influence 
cell survival. Whereas increased expression of bcl-2 or bcl-x promotes cell survival 
following withdrawal of survival factors, Increased expression of bax is thought to 
suppress survival. To investigate the potential roles of these proteins in regulating 
the survival of developing neurons, the effects of overexpressing these proteins in 
embryonic neurons, deprived of different neurotrophic factors, in vitro, were 
compared.
bcl-2 is a 26 kDa, intracellular, membrane-associated protein of vertebrates (Nunez 
& Clarke, 1994; Davies, 1995) that is homologous to the nematode ced-9 protein 
which functions as a negative regulator of ceil death (Hengartner & Horvitz,
1994b). Overexpression of bcl-2 prevents the death of several cytokine-deprived 
haematopoietic cell lines following cytokine withdrawal (Vaux et al., 1988; Nunez et 
al., 1990) and rescues embryonic neurons deprived of the neurotrophlns: Nerve 
Growth Factor (NGF) (Garcia et al., 1992), Brain-Derived Neurotrophic Factor 
(BDNF) and Neurotrophin-3 (NT-3) (Allsopp et al., 1993). Examination of 
transgenic mice carrying a bci-2 gene that is over-expressed in the immune system 
(McDonnell et al., 1989), and mice with bci-2 null mutations, (Nakayama et ai.,
1993, 1994; Veis et al., 1993) has shown that bcl-2 plays an important role in 
promoting and regulating the survival of B and T lymphocytes (Linette & Korsmeyer,
1994). bcl-2 is not, however, universally effective in counteracting signals that 
induce apoptosis. For example, bci-2 overexpression does not protect ail cytokine- 
dependent haematopoietic cell lines following cytokine withdrawal (Nunez et ai., 
1990) and does not protect neurons following withdrawal of Ciliary neurotrophic 
factor (CNTF) (Allsopp et al., 1993).
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Several genes have recently been identified that are homologous with bcl-2, 
including bcl-x (Boise et al., 1993), bax (Oltvai et al., 1993), bad (Yang et al.,
1995) and bak (Chittenden et al., 1995; Farrow et al., 1995; Kiefer et al., 1995). 
The Bcl-x variant, B cI-x l has the highest homology with Bcl-2, and like Bcl-2 is able 
to prevent apoptosis of IL3-dependent cells following IL3 withdrawal (Boise et al.,
1993). Bcl-Xs lacks BH1 and BH2 which are the regions of highest homology 
between family members and cannot rescue haematopoietic cells from apoptotic 
cell death following cytokine withdrawal (Boise et al., 1993). Another Bcl-x variant, 
Bcl-xp (Gonzalez-Garcia et al., 1994) lacks a C-terminal hydrophobic domain that is 
necessary for membrane attachment. Mice with a null mutation in the bcl-x gene 
die in utero by excessive apoptosis in the immune and nervous systems (Motoyama 
et al., 1995). Bax has 21% amino acid sequence homology with Bcl-2 (Oltvai et al.,
1993). Bax heterodimerises with Bcl-2 and also forms homodimers. Bax 
overexpression in IL3-dependent cells accelerates apoptosis following IL3 withdrawal 
and inhibits the death repressor action of Bcl-2 in these cells (Oltvai et al., 1993). 
Consequently, it is thought that the ratio of Bcl-2 to Bax determines survival or 
death following an apoptotic signal; excess Bcl-2 leading to survival, excess Bax 
causing death (Oltvai et al., 1993; Oltvai & Korsmeyer, 1994; Korsmeyer, 1995). 
Mice with a null mutation in the bax gene display both hyperplasia and hypoplasia 
depending upon the cellular context. In the immune system, both thymocytes and B 
cells display hyperplasia, whilst in the male reproductive system there is a 
disordering of the seminiferous tubules and an accumulation of atypical premeiotic 
germ cells, but no mature haploid sperm. There are multinucleated and giant cells 
accompanied by massive cell death (Knudson et al., 1995). Bak was identified by 
using PCR with degenerate primers to clone cDNA fragments encoding Bci-2 
homologues. The new homologous sequence was subsequently used to isolate full- 
length cDNA sequences from human heart and Epstein Barr (EBV)- transformed 
human B-cell libraries. Bak was found to have 53% amino acid sequence homology 
with Bcl-2 and shows marked similarity to other family members particularly in BH1
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and BH2. Bak interacts with Bcl-2 and more strongly with B cI-x l. Bak has been 
shown to promote or inhibit apoptosis, depending on the cellular context 
(Chittenden et al., 1995; Farrow et al., 1995; Kiefer et al., 1995). The Bad protein 
(Yang et al., 1994) only shows homology to Bcl-2 in BH1 and BH2. It can dimerise 
with Bcl-2 and B cI-x l but not with Bax, Bcl-Xg, MCL-1, A1, or itself. It inhibits the 
death repressor activity of B cI-x l but not Bcl-2 in mammalian cells, and acts by 
displacing Bax from B c I-x l/ Bax heterodimers and thus inducing apoptosis.
To test the generality of the Bcl-2/Bax rheostat model (Korsmeyer, 1995) and to 
clarify the role of Bcl-2-related proteins in regulating neuronal survival, 
microinjection was used to introduce expression vectors for Bcl-2, B cI-x l, BcI-Xs, BcI- 
xp, and Bax into cultures of embryonic chicken neurons that were deprived of 
different neurotrophic factors. Four populations of neurons were studied at El 0 
and El 2. These were the neurons of the trigeminal mesencephalic nucleus, 
dorsomedial portion of the trigeminal ganglion, lumbar dorsal root ganglia, and ciliary 
ganglion.
The Trigeminal Mesencephalic Nucleus (TMN) consists a slender strand of cells that 
extend from the pontine trigeminal nucleus through the midbrain. The 
proprioceptive sensory neurons of the TMN are the only primary sensory neurons 
incorporated into the central nervous system rather than being in the cerebrospinal 
ganglia. The neurons of the TMN are supported by BDNF (Davies et al., 1986b).
The trigeminal ganglion is the most rostral of the cranial sensory ganglia and is 
associated with Cranial Nerve V. The neurons of the ganglion are derived from both 
neural crest and epidermal placodes. The cutaneous sensory neurons of the 
dorsomedial part of the trigeminal ganglion (DMTG) are supported by NGF (Davies & 
Lindsay, 1985).
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The sensory neurons of the dorsal root ganglia (DRG) are derived from the neural 
crest and from each cell body, two processes arise. One passes medially into the 
dorsal horn of the spinal cord and the other outwards to form a sensory fibre which 
terminates at a sensory ending. The mixed sensory neurons of dorsal root ganglia 
(DRG) are supported by NGF or BDNF (Lindsay et al., 1985).
The parasympathetic ciliary ganglion is located behind the eye and is the target of 
the axons of the preganglionic parasympathetic neurons of the Edinger-Westphai 
nucleus of the oculomotor complex. The cells of the ganglion innervate the 
constrictor pupillae muscles of the iris and the ciliary muscles. The neurons of the 
ciliary ganglion are supported by CNTF, glial-cell derived neurotrophic factor (GDNF) 
(Buj-Bello et al., 1995), growth promoting activity (GPA) and basic fibroblast 
growth factor (bFGF) (Barbin et al., 1984; Unsicker & Westermann, 1992; Allsopp 
et al., 1995).
Using these four populations of neurons, those of the ciliary ganglion, DMTG, DRG 
and TMN, primary neuronal cultures were set up and these neurons microinjected to 
overexpress a number of proteins at two ages in embryonic development - El 0 and 
El 2, that is after 10 or 12 days incubation.
RESULTS
Overexpression of Bcl-2. Bcl-xL. Bcl-xb and Bax rescues neurotrophin 
deprived sensorv neurons
El 0 and El 2 DRG, El 0 and El 2 DMTG and El 0 TMN neurons were purified free of 
non-neuronal cells and were grown with either NGF (DRG and DMTG neurons) or 
BDNF (TMN neurons) for 12 hours. Neurons were then deprived of neurotrophic 
factors by extensive washing before being microinjected with expression vectors for 
Bcl-2, B cI-x l, Bcl-xp, Bcl-Xs, or Bax. The survival of injected neurons was compared
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at intervals with the survival of neurons injected with the pSFFV expression vector 
without inserted cDNA.
Confirming previous findings (Allsopp et ai., 1993), Bcl-2 overexpression prevented 
the death of many NGF-deprived E10 and El 2 chick DRG and DMTG neurons and 
BDNF-deprived TMN neurons (Figs. 3.1, and 3.2). Overexpression of B cI-x l and Bcl- 
xp also rescued neurotrophin-deprived neurons as effectively as Bcl-2 
overexpression (Figs. 3.1, and 3.2). Surprisingly, Bax overexpression also prevented 
the death of neurotrophin-deprived neurons (Figs. 3.1, and 3.2). Although Bax 
overexpression did not rescue as many neurons as Bcl-2, B cI-x l or Bcl-xp 
overexpression, there were over 3-fold more Bax-injected neurons surviving 
compared with vector-injected neurons 24 hours post-injection in cultures of El 0 
DRG and DMTG neurons deprived of NGF, and the difference between Bax-injected 
and control-injected neurons increased to between 4 and 6 fold after 72 hours 
(Figs. 3.1 and 3.2). Although Bax overexpression did not rescue BDNF-deprived 
TMN neurons as effectively as NGF-deprived DRG and DMTG neurons (Figs. 3.1, and
3.2), there were significantly more Bax-injected TMN neurons surviving 24 hours 
post-injection compared with control injected neurons (p < 0.001, t-test). In 
contrast to the other Bcl-2 family members, overexpression of Bcl-Xs in the pSFFV 
expression vector was not able to rescue embryonic sensory neurons deprived of 
neurotrophic factors at El 0 or El 2 (Figures 3.1 and 3.2). It is not possible to tell if 
overexpression of Bcl-Xs is having a negative effect on survival in the absence of 
factors as the neurotrophin-deprived sensory neurons die so quickly.
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Figure 3.1a: The effects of injecting NGF-deprived ElO DRG neurons with Bcl-2. Bel- 
Bcl-xj .^ Bcl-Xg or Bax expression vectors or the pSFFV vector without an insert 
(control injections! After 12 hours incubation with 5 ng/ml NGF, the neurons were 
washed extensively to remove these factors before being injected with expression 
vectors. The number of neurons surviving at intervals after injection is expressed as 
the percentage of the initial number of neurons injected. Each graph shows the 
results of three separate experiments. In each experiment, three petri dishes were 
used for each condition and between 50 and 70 neurons were injected in each dish. 
The means and standard errors for the combined results of these experiments are 
shown.
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Figure 3.1b: The effects of injecting NGF-deprived El 0 DMTG neurons with Bcl-2. 
Bcl-xi_. Bci-x^. BcI-Xq or Bax expression vectors or the pSFFV vector without an 
insert (control injections! After 1 2 hours incubation with 5 ng/ml NGF, the neurons 
were washed extensively to remove these factors before being injected with 
expression vectors. The number of neurons surviving at intervals after injection is 
expressed as the percentage of the initial number of neurons injected. Each graph 
shows the results of three separate experiments. In each experiment, three petri 
dishes were used for each condition and between 50 and 70 neurons were injected 
in each dish. The means and standard errors for the combined results of these 
experiments are shown.
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Figure 3.1c: The effects of injecting BDNF-deprived ElO TMN neurons with Bcl-2. 
Bcl“Xi_. Bcl-Xc or Bax expression vectors or the pSFFV vector without an
insert (control injections! After 12 hours incubation with 5 ng/ml BDNF, the 
neurons were washed extensively to remove these factors before being injected 
with expression vectors. The number of neurons surviving at intervals after 
injection is expressed as the percentage of the initial number of neurons injected. 
Each graph shows the results of three separate experiments. In each experiment, 
three petri dishes were used for each condition and between 50 and 70 neurons 
were injected in each dish. The means and standard errors for the combined results 
of these experiments are shown.
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Figure 3.2a: The effects of injecting NGF-deprived El 2 DRG neurons with Bcl-2. Bci- 
x\_. Bcl-xj .^ Bcl-Xg or Bax expression vectors or the pSFFV vector without an insert 
fcontrol injections). After 12 hours incubation with 5 ng/ml NGF, the neurons were 
washed extensively to remove these factors before being injected with expression 
vectors. The number of neurons surviving at intervals after injection is expressed as 
the percentage of the initial number of neurons injected. Each graph shows the 
results of three separate experiments. In each experiment, three petri dishes were 
used for each condition and between 50 and 70 neurons were injected in each dish. 
The means and standard errors for the combined results of these experiments are 
shown.
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Figure 3.2b: The effects of injecting NGF-deprived El 2 DMTG neurons with Bcl-2. 
Bcl-xi_. Bcl-x^. Bcl-Xg or Bax expression vectors or the pSFFV vector without an 
insert (control injectionsT After 12 hours incubation with 5 ng/ml NGF, the neurons 
were washed extensively to remove these factors before being injected with 
expression vectors. The number of neurons surviving at intervals after injection is 
expressed as the percentage of the Initial number of neurons injected. Each graph 
shows the results of three separate experiments. In each experiment, three petri 
dishes were used for each condition and between 50 and 70 neurons were injected 
in each dish. The means and standard errors for the combined results of these 
experiments are shown.
116
Overexpression of bax but not bci-2. bci-xL. bcl-xp. or bcl-x« 
transiently rescues a subset of CNTF-deprived parasympathetic 
neurons
It has previously been shown that overexpression of bcl-2 is ineffective in rescuing 
embryonic chicken ciliary ganglion neurons deprived of CNTF (Allsopp et al., 1993). 
To determine if overexpression of bcl-xL, bcl-xp, bcl-Xg, or bax is able to rescue 
CNTF-deprived ciliary neurons, ElO and E l2 ciliary neurons were grown with CNTF 
for 12 hours before washing and injection with expression vectors containing bcl-2, 
bcl-xL, bcl-xp, bcl-Xg, and bax cDNAs. Ciliary neurons injected with bcl-2, bcl-xL, bcl- 
xp, or bcl-Xg expression vectors died rapidly and there was no significant difference 
between the number of neurons injected with these constructs or vector alone (Fig.
3.3) or uninjected CNTF-deprived neurons. These results suggest that bcl-2, bcl-xL 
and bcl-xp have similar specificity in rescuing neurons deprived of different 
neurotrophic factors. In contrast, bax overexpression rescued a small number of 
ciliary neurons following CNTF withdrawal. Although this effect of bax was smaller 
and more short-lived than its effect on NGF-deprived neurons, this effect was 
consistently observed and was statistically significant at 12 and 24 hours post­
injection for both ElO and E l2 neurons (p < 0.001, t-test). These findings clearly 
demonstrate that bax overexpression does not invariably cause apoptosis, but can 
rescue neurons following neurotrophic factor deprivation. Moreover, bax seem to 
have a broader spectrum of activity among neurons in this respect than bcl-2, bcl- 
xL and bcl-xp. Again, bcl-Xg had no survival promoting effect and again it is 
impossible to tell from these data if there is any negative effect on cell survival.
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Figure 3.3a: The effects of injecting CNTF-deprived ElO ciliary neurons with Bcl-2. 
Bci-xK Bci-xj^ Bcl-xc. or Bax expression vectors or the pSFFV vector without an 
insert (control injections). After 12 hours incubation with 5 ng/ml CNTF, the 
neurons were washed extensively to remove this factor and were injected with 
expression vectors. The number of neurons surviving at intervals after injection is 
expressed as the percentage of the initial number of neurons injected. The graph 
shows the results of three separate experiments. In each experiment, three petri 
dishes were used for each condition and between 50 and 70 neurons were injected 
in each dish. The means and standard errors for the combined results of these 
experiments are shown.
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Figure 3.3b: The effects of injecting CNTF-deprived El 2 ciliary neurons with Bcl-2. 
Bcl-xi_. Bcl-xjj  ^Bcl-xc. or Bax expression vectors or the pSFFV vector without an 
insert (control injections! After 12 hours incubation with 5 ng/ml CNTF, the 
neurons were washed extensively to remove this factor and were injected with 
expression vectors. The number of neurons surviving at intervals after injection is 
expressed as the percentage of the initial number of neurons injected. The graph 
shows the results of three separate experiments. In each experiment, three petri 
dishes were used for each condition and between 50 and 70 neurons were injected 
in each dish. The means and standard errors for the combined results of these 
experiments are shown.
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Bax overexpression partially inhibits the survival response of neurons 
to neurotrophic factors
To investigate whether overexpression of Bax modulates the survival response of 
neurons to NGF and BDNF, a comparison was made of the survival of neurons 
injected with the Bax expression vectors grown with and without these 
neurotrophins. For comparison, neurons were also injected with the Bcl-2 
expression vector to determine if this protein affects the neurotrophin survival 
response differently. DRG, DMTG and TMN neurons were initially grown for 12 hours 
with either NGF (DRG and DMTG neurons) or BDNF (TMN neurons) before being 
deprived of these neurotrophins and injected with expression vectors for Bcl-2 or 
Bax. Following microinjection, neurons were grown with or without the same 
neurotrophin for a further 3 days. Figure 3.4 shows that Bcl-2 overexpression does 
not interfere with the neurotrophin survival responses of these neurons. Neurons 
that were injected with the Bcl-2 expression vector and grown with NGF or BDNF 
survived slightly better than uninjected neurons grown with these neurotrophins. In 
marked contrast, injection of the Bax expression vector reduced the number of 
neurons surviving in neurotrophin-supplemented medium to virtually the same 
number that is sustained by Bax overexpression in the absence of neurotrophins.
Similar studies were carried out to see if Bax also antagonises the survival response 
of ciliary neurons to neurotrophic factors. As with sensory neurons, Bax 
overexpression reduced the number of neurons surviving in medium containing CNTF 
to the same number that are supported by Bax overexpression in medium that does 
not contain CNTF (Fig. 3.5). Taken together, the results of this set of experiments 
clearly show that Bax can partially oppose the response of neurons to neurotrophic 
factors and that the effects on survival are dominant to that of neurotrophic 
factors.
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Figure 3.4a: The effects of overexpressing Bci-2 and Bax on the survival responses 
of El 2 DRG neurons to NGF (Sna/mh. The number of neurons surviving at 
intervals after washing is expressed as the percentage of the initial number of 
neurons at the time of washing. Each graph shows the results of three separate 
experiments. In each experiment, three petri dishes were used for each condition 
and between 50 and 70 neurons were injected in each dish. The means and 
standard errors for the combined results of these experiments are shown.
1 2 1
3.4b: E12 DM TG  Neurons
I
cn
5o
6  A
120
100
80
60
40
20
40 60 80200
Bax
Bax + NGF 
Bcl-2
Bcl-2 + NGF 
control + NGF 
control - NGF
time in culture (hours)
Figure 3.4b: The effects of overexpressing Bcl-2 and Bax on the survival responses 
of El 2 DMTG neurons to NGF (5ng/mh. The number of neurons surviving at 
intervals after washing is expressed as the percentage of the initial number of 
neurons at the time of washing. Each graph shows the results of three separate 
experiments. In each experiment, three petri dishes were used for each condition 
and between 50 and 70 neurons were injected in each dish. The means and 
standard errors for the combined results of these experiments are shown.
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Figure 3.4c: The effects of overexpressing Bcl-2 and Bax on the survival responses 
of El 0 TMN neurons to BDNF (5ng/mh. The number of neurons surviving at 
intervals after washing is expressed as the percentage of the initial number of 
neurons at the time of washing. Each graph shows the results of three separate 
experiments. In each experiment, three petri dishes were used for each condition 
and between 50 and 70 neurons were injected in each dish. The means and 
standard errors for the combined results of these experiments are shown.
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3.5: E12 Ciliary Neurons
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Figure 3.5 The effects of overexpressing Bax on the survival response of E12 ciliary 
neurons to CNTF (Sng/mh. The number of neurons surviving at intervals after 
washing is expressed as the percentage of the initial number of neurons at the time 
of washing. Each graph shows the results of three separate experiments. In each 
experiment, three petri dishes were used for each condition and between 50 and 70  
neurons were injected in each dish. The means and standard errors for the 
combined results of these experiments are shown.
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The ratio of co-iniected Bcl-2 and Bax expression vectors affects 
survival
Because Bax has been reported to inhibit the death repressor action of Bcl-2 in 1L3- 
dependent cells (Oltvai et a!., 1993), these experiments investigated whether Bax 
has a similar function in neurons by co-injecting neurotrophic factor-deprived DMTG 
neurons with Bcl-2 and Bax expression vectors. In these experiments, the ratio 
between the Bcl-2 and Bax expression vectors was altered whilst keeping the 
combined concentration of injected vectors the same (100 mg/ml). When either 
expression vector was injected in excess (2 : 1 or 1 : 2, Bcl-2 vector : Bax vector) 
many NGF-deprived neurons were rescued compared with control injected neurons, 
an excess of Bcl-2 over Bax being more effective than an excess of Bax over Bcl-2 
(Figure 3.6). However, when the expression vectors were injected at a ratio of 
1 : 1 ,  very few neurons survived compared with control injected neurons.
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Figure 3.6: Effects of co-injecting NGF-deprived DMTG neurons with Bcl-2 and Bax 
expression vectors. The number of surviving neurons was monitored for 3 days 
following injection and is expressed as a percentage of the number of injected 
neurons. The graph shows the results of three separate experiments. In each 
experiment, three petri dishes were used for each condition and between 50 and 70  
neurons were injected in each dish. The means and standard errors for the 
combined results of these experiments are shown.
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DISCUSSION
Microinjection was used to introduce expression vectors synthesising members of 
the bcl-2 family of intracellular proteins into cultured neurons in order to better 
understand how these proteins might influence neuronal survival or modulate the 
survival response of neurons to neurotrophic factors. Previous microinjection studies 
have shown that overexpression of bcl-2 is able to prevent the death of many 
sympathetic and sensory neurons deprived of members of the NGF family of 
neurotrophlns, but is ineffective in rescuing neurons that were initially grown with 
ONTF, or G PA with bFGF (Garcia et al., 1992; Allsopp et al., 1993, 1995). These 
data presented here demonstrate that overexpression of bcl-xL or bcl-xp Is as 
effective as bcl-2 overexpression in rescuing NGF-deprived and BDNF-deprived 
neurons. Like bcl-2, neither bcl-xL nor bcl-xp are able to rescue CNTF-deprlved ciliary 
neurons. These results suggest that bcl-2, bcl-xL and bcl-xp have similar potency 
and specificity in rescuing neurons deprived of different neurotrophic factors.
The similar efficiency of bcl-xL and bcl-xp in preventing the death of neurotrophin- 
deprived neurons indicates that the C-terminal hydrophobic domain of bcl-x Is not 
required for its death-suppressor function in neurons. Studies of bcl-2 suggest that 
its C-terminal hydrophobic domain is necessary for the attachment to the protein 
cytosolic side of cell membranes (Nguyen et al., 1993; Tanaka et al., 1993) but 
does not appear to be required for its death-suppressor function (Borner et al.,
1994). The data presented in this study shows that bcl-Xg is as Ineffective in 
rescuing growth factor deprived neurons as it is in rescuing growth factor deprived 
hematopoetic cells (Boise et al., 1993).
The most unexpected result of this study is that overexpression of bax is also able
to prevent the death of some neurons deprived of neurotrophic factors. Not only
does bax rescue some sensory neurons deprived of either NGF or BDNF, but also it
was able to rescue some ciliary neurons deprived of ONTF. Although bax is not as
effective as bcl-2, bcl-xL and bcl-xp in rescuing neurotrophin-deprlved sensory
neurons and the effect on CNTF-deprived ciliary neurons is transient, this survival-
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promoting effect of bax is statistically significant. Thus, contrary to the widely 
accepted view that bax promotes cell death based on studies of an IL-3-dependent 
cell line (Korsmeyer et al., 1993; Oltvai et al., 1993; Oltvai and Korsmeyer, 1994), 
these findings suggest that bax overexpression need not Invariably cause 
apoptosis, but can promote the survival of neurons following neurotrophic factor 
deprivation. Moreover, bax seems to have a broader spectrum of survival- 
promoting activity among neurons than bcl-2, bcl-xL or bcl-xp. However, because 
the effects of human bax are studied in chicken neurons one cannot rule out the 
caveat that evolutionary divergence in the bax genes might result in human bax 
acting as a dominant negative in chicken cells.
This study has shown that bax overexpression is also able to inhibit the survival 
response of neurons to neurotrophic factors; bax overexpression reduces the 
number of neurons surviving with neurotrophic factors to the number that survive 
when bax is overexpressed in the absence of neurotrophic factors. In contrast, bcl- 
2 overexpression does not antagonise the survival response of neurons to 
neurotrophic factors; the survival of bcl-2-overexpressing neurons is slightly better 
in the presence of neurotrophic factors. The mechanism by which bax promotes 
neuronal survival in the absence of neurotrophic factors whilst at the same time 
inhibiting the survival effect of these factors is unclear. Cultured neurons might 
express one or more members of the bcl-2 family of proteins that may be required 
for the survlvai response of neurons to neurotrophic factors. Sensory neurons and 
ciliary neurons, for example, are known to express bcl-2 mRNA (Allsopp et al.,
1995). The demonstration that antisense bcl-2 RNA reduces the level of 
endogenous bcl-2 mRNA and inhibits the survival response of sensory neurons to 
BDNF but does not affect the survival response of ciliary neurons to ONTF, G PA or 
bFGF (Allsopp et al., 1995), suggests that endogenously expressed bcl-2 is required 
for the long-term survival response to BDNF but not to ONTF, G PA or bFGF. It is 
possible that overexpressed bax protein may compete with other members of the 
bcl-2 family of proteins and form heterodimers with these proteins which may 
interfere with their function and compromise the survival response to neuro^ophic
factors. Although bax contains BH1 and BH2 domains, which are thought to be 
required for the survival effect of bcl-2 family members (Yin et al., 1994), and can 
promote neuronal survival in the absence of neurotrophic factors, bax is less 
effective in doing so than bcl-2 or bcl-x. Unfortunately, the small numbers of purified 
embryonic neurons available for these studies precludes direct measurements of the 
relative levels of bcl-2-related proteins in these neurons.
In contrast to the demonstration that bax inhibits the death repressor action of 
bcl-2 in lL3-dependent cells (Oltvai et al., 1993), this study has shown that co­
injection of bax and bcl-2 expression vectors in sensory neurons does not 
accelerate cell death. When either expression vector was in excess (2 : 1 or 1 : 2, 
bcl-2 vector : bax vector) many NGF-deprived neurons were rescued (excess bcl-2 
vector being more effective than bax vector). However, when the expression 
vectors were injected at a ratio of 1 : 1, very few additional neurons survived 
compared with uninjected controls. Although the relative levels of bcl-2 and bax 
proteins expressed in injected neurons are unknown and cannot be assessed 
because of the very small number of neurons available for analysis, these results 
raise the possibility that when either bcl-2 or bax proteins are expressed in excess 
in neurotrophic factor-deprived neurons, cell death is delayed.
Site-directed mutagenesis of Gly 145 in the BH1 domain or Trp 188 in the BH2 
domain of bcl-2 prevents bcl-2 from forming heterodimers with bax but does not 
impede the formation of bcl-2 homodimers. Because these mutations inactivate the 
death repressor action of bcl-2, it has been proposed that bcl-2 must bind to bax 
in order to exert its death-repressor activity (Yin et al., 1994). However, there are 
alternative explanations for the effects of these mutations. First, it is possible that 
the bcl-2 homodimer rather than the bcl-2/bax heterodimer is the active 
suppressor of cell death and that these mutations inactivate the death-repressor 
function of bcl-2 without affecting homodimerisation. The demonstration that 
overexpression of bax prevents the death of neurotrophic factor-deprived neurons
raises the possibility that bax homodimers may have a death-repressor function.
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Second, mutations in the BH domains may not only prevent the formation of bcl- 
2/bax heterodimers but prevent bcl-2 from associating with other proteins that 
might be important for suppressing ceil death. For example, bcl-2 has been shown 
to associate with the ras-related protein R-ras p23 (Fernadez-Sarabia & Bischoff,
1993) and with a novel protein, BAG-1, that enhances the survival-promoting effect 
of bcl-2 (Takayama et al., 1995).
The generation of mice with a null mutation in the bax gene has been reported 
(Knudson et al., 1995). These mice display both hyperplasia (increased numbers of 
B and T cells) and hypoplasia (testis atrophy associated with an increased numbers 
of apoptotic cells). These findings provide additional new evidence that, in addition 
to promoting celi death, bax may promote the survival of certain cell types.
Analysis of the nervous system of these mice and studies of their neurons in culture 
will clarify the extent to which bax acts as a positive or negative regulator of cell 
survival in the nervous system.
bax is not the only family member that can cause death or survival depending on 
the assay system used. Anti-apoptotic effects of bak (Keifer et al., 1995) and pro- 
apoptotic effects of bcl-2 have also been observed. Thus it is possible that these 
proteins can have positive or negative effects on cell survival depending upon the 
cellular context.
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CHAPTER FOUR 
BCL-2 TRANSGENIC MICE: 
NEURONAL SURVIVAL STUDIES
INTRODUCTION
The Bcl“2 protein is widely expressed in a number of different tissues and there is 
considerable evidence to suggest that it plays an important role in regulating cell 
survival in the immune system. Whereas mice with targeted null mutations in the 
Bcl-2 gene have markedly reduced number of B and T cells due to increased 
apoptosis (Nakayama et al., 1993, 1994; Veis et al., 1993), mice carrying a 
transgene causing high levels of Bcl-2 expression in the immune system show 
extended survival of B and T cells (McDonnell et al., 1989, 1990).
Experimental overexpression of Bcl-2 in developing neurons has shown that Bcl-2 is 
capable of influencing neuronal survival. Microinjection of a Bcl-2 expression vector 
into cultured sympathetic and sensory neurons prevents their death following 
neurotrophin deprivation (Allsopp et al., 1993; Garcia et al., 1992), and mice 
expressing a bcl-2 transgene under the control of a neuron-specific enolase 
promoter have enlarged brains and increased numbers of neurons in several regions 
(Martinou et al., 1994).
Although Bcl-2 is capable of influencing neuronal survival in vitro and its 
overexpression can prevent naturally occurring cell death in vivo, it is not clear to 
what extent Bcl-2 plays a role in regulating neuronal survival in the embryo. In the 
developing nervous system, Bcl-2 is expressed in proliferating neuroepithelial cells of 
ventricular zones and in postmitotic cells of several other regions including the 
cortical plate, cerebellum, hippocampus and spinal cord (Merry et al., 1994). Bcl-2
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expression decreases in CNS neurons postnatally, but is retained in sensory and 
sympathetic neurons throughout life. Although this pattern of expression is 
consistent with a role for Bcl-2 in regulating neuronal survival during development 
and sustaining the survival of some neurons in the adult, bcl-2 mice appear to 
have grossly normal nervous systems and do not exhibit any obvious neurological 
abnormalities (Nakayama et al., 1993, 1994; Veis et al., 1993). Statistically 
significant deficiencies in sensory, motor and sympathetic neurons have, however, 
recently been described in postnatal Bcl-2-deficient mice (Michaelidis et al., 1996). 
Neurotrophlns have not been shown to influence either Bcl-2 mRNA levels or those 
of the other members of this gene family in hippocampal and cerebellar granular 
cells (Ohga et al., 1996). Focusing on the sympathetic nervous system. In vitro 
analysis of primary neuronal cultures from superior cervical ganglia of Bcl-2-deficient 
mice has shown that Bcl-2 is an important regulator of sympathetic neuron survival 
after NGF deprivation during the period of naturally occurring neuronal death 
(Greenlund et al., 1995).
To clarify the role of Bcl-2 in regulating the survival of primary sensory neurons 
during embryonic development, the in vitro and in vivo survival of sensory neurons 
from animals carrying a null mutation in the Bcl-2 gene has been compared with the 
survival of sensory neurons from wild type littermates, at several embryonic ages. In 
particular, this study has focused on two well-characterised population of cranial 
sensory neurons; those of the trigeminal and nodose ganglia. From El 2 onwards, 
the majority of mouse trigeminal ganglion neurons are supported by NGF in culture 
(Buchman & Davies, 1993). The total number of neurons in the trigeminal ganglia 
peaks between El 3 and El 4 and falls by half by birth as a result of naturally 
occurring cell death (Davies & Lumsden, 1984). These neurons that survive this 
period of cell death do so because they acquire adequate supplies of NGF from their 
peripheral targets (Buchman & Davies, 1993, Davies et al., 1987b; Pinon et al.,
1996). The majority of nodose ganglion neurons are supported by BDNF in culture
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from El 2 onwards and depend upon BDNF for survival in vivo during embryonic 
development (Davies et al., 1993; Ernfors et al., 1994; Jones et al., 1994).
The results presented in this chapter show that the survival response of Bcl-2- 
deficient trigeminal and nodose neurons to neurotrophlns is less sustained than that 
of wild type neurons during the early fetal period, and that there is a significant 
reduction in the number of neurons in the trigeminal ganglia of bcl-2 mice during 
embryonic development. Together these data suggest a role for Bcl-2 in maintaining 
the survival of some embryonic sensory neurons. The in vivo investigation was 
carried out in collaboration with Luzia G.P. Pinon.
RESULTS
Response of Bci-2-defîcient sensorv neurons to neurotrophlns in vitro
Mice that were heterozygous for a Bcl-2 null mutation (Nakayama et al., 1993,
1994) were crossed to obtain bc/-2"A bci-2+^~ and bcl-2 +/+  embryos. Separate, 
low-density, dissociated cultures were established from the trigeminal and nodose 
ganglia of each embryo and the survival of the neurons growing with and without 
neurotrophlns monitored for three days in culture. The genotypes of the embryos 
were subsequently determined by a PCR-based approach using DNA extracted from 
embryonic tissues.
Trigeminal Neurons
Dissociated cultures of trigeminal ganglion neurons were established from embryos 
at El 4, El 6 and El 8. The neurons were grown with or without NGF for 72 hours, 
and the number of surviving neurons counted at intervals during this time. At El 4, 
which is at the peak of naturally occurring neuronal death in the trigeminal ganglion 
(Pinon et al., 1996), about half the initial number of neurons from wild type 
embryos were still surviving with NGF after 72 hours incubation (Fig. 4.1 ). In marked 
contrast, neurons from embryos died much more rapidly in the presence of
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NGF, and all were dead by 48 hours. Neurons from embryos died at an
intermediate rate In the presence of NGF, and all were dead by 72 hours. Although 
Bcl-2-deficient neurons died rapidly in the presence of NGF, they survived better 
than neurons grown without NGF in the culture medium. In these control cultures, all 
neurons were dead by 24 hours, and there was no difference in the rate of neuronal 
death between neurons from wild type and Bcl-2-deficient embryos (Fig. 4.1b). 
These results suggest that endogenous Bcl-2 expression is required for the 
sustained survival response of trigeminal neurons to NGF at El 4.
In El 6 cultures, the bcl-2 mutation had a much smaller effect on the NGF survival 
response (Fig.4.2a). Although, there were significantly fewer Bcl-2-deficient 
neurones surviving with NGF after 24,48 and 72 hours incubation compared with 
wild type neurones (p<0.05. t-test), there was on average only a 20% reduction in 
the number of surviving neurons at these time points. Both wild type and Bcl-2- 
deficient neurons died rapidly in the absence of NGF at this stage, and the bcl-2 null 
mutation did not effect the rate of death in control cultures (Fig. 4.2b).
By El 8, which is near the end of the period of naturally occurring neuronal death in 
the trigeminal ganglion (Davies & Lumsden, 1984; Pinon et al., 1996), there were 
no significant differences between the numbers of wild type and Bcl-2-deficient 
neurones surviving in the presence of NGF (Fig. 4.3a). Again there were no 
differences between the three genotypes in the control cultures (Fig. 4.3b). These 
results suggest that by the end of the period of naturally occurring neuronal death, 
bcl-2 is not required for a sustained survival response of trigeminal ganglion neurons 
to NGF.
135
4.1a: E14 Trigeminal Neurons + NGF (5ng/ml)
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Figure 4.1 a: Percent survival of El 4 trigeminal neurons from bcl-2-/- (n= 11). bcl~ 
Z + /-  (n= 25). and bc\-2 + /+  (n= 12) embryos grown for 72 hours in culture with 
NGF (5na/m n. The means and standard errors of the means are shown. Each point 
in the graph represents the mean of a number of embryos. For each embryo 
triplicate cultures were established for all conditions studied.
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4.1b: E14 Trigeminal Neurons, without factors
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Figure 4.1 b: Percent survival of E14 trigeminal neurons from bcl-2-/- (n= 11 ). bcl- 
2 + /-  (n= 251  and bcl'2 + /+  (n= 1Z) embryos grown for 72 hours in culture without 
factors. The means and standard errors of the means are shown. Each point in the 
graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied.
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4.2a: E16 Trigeminal Neurons + NGF (5ng/ml)
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Figure 4.2a: Percent survival of El 6 trigeminal neurons from bcl-2-/- (n= 61 bel- 
2 + /-  (n -  131 and bcl-2 + /+  (n= 7) embryos grown for 72 hours in culture with NGF 
(5ng/mn. The means and standard errors of the means are shown. Each point in the 
graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied.
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4.2b; E16 Trigeminal Neurons, without factors
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Figure 4.2b: Percent survival of El 6 trigeminal neurons from bch2V- (n= 61 bel- 
2-hA fn= 131 and bd-2  - f / f  (n= 7) embryos grown for 72 hours in culture without 
factors. The means and standard errors of the means are shown. Each point in the 
graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied.
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4.3a: E18 Trigeminal Neurons + NGF (lOng/ml)
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Figure 4.3a: Percent survival of El 8 trigeminal neurons from bcl-2-A  (n= 61 bcl- 
2 + /-  fn= 13). and bcl-Z + /+  (n= 7) embrvos grown for 72 hours in culture with NGF 
n O n g /m ll The means and standard errors of the means are shown. Each point in 
the graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied.
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4.3b: E18 trigeminal neurons, without factors
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Figure 4.3b: Percent survival of El 8 trigeminal neurons from bcl-2-/- (n - 8). bcl- 
2+ A  (n= 141 and bcl-2 + /+  (n= 5) embryos grown for 72 hours in culture without 
factors. The means and standard errors of the means are shown. Each point in the 
graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied.
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Nodose Neurons
Very similar trends were observed in the BDNF survival responses of nodose neurons 
from bch2"'^~, bcl-2 and + embryos at El 4, El 6 and El 8 as were seen
in the NGF survival responses of trigeminal neurons over this period in development.
In El 4 cultures, the majority of nodose neurons from wild type embryos were still 
surviving in the presence of BDNF after 72 hours incubation, whereas neurons from 
bci-2~^~ embryos died much more rapidly in the presence of BDNF, and all were 
dead by 48 hours (Fig 4.4). Neurons from bci-2+^- embryos died at an 
intermediate rate with less than 10% surviving by 72 hours. Although Bcl-2- 
deficient neurons died rapidly in the presence of BDNF, they survive better than 
those grown without BDNF. In these control cultures, all neurons were dead by 24 
hours irrespective of the genotype of the embryo from which they were obtained. 
Like the survival response of El 4 trigeminal neurons to NGF, these results suggest 
that endogenous Bcl-2 expression is required for the sustained survival response of 
early fetal nodose neurons to BDNF.
In El 6 cultures, the bcl-2 null mutation had a less dramatic effect on the response 
of nodose neurons to BDNF (Fig. 4.5). Although there were 10 to 15% fewer 
neurons from bcl-2 null mice surviving with BDNF compared neurons from wild type 
mice at 24 and 48 hours, by 72 hours there was a greater than 3 fold difference in 
the number of neurons from bc/-2‘/ “ and bcl-2 +/+ embryos surviving with BDNF.
At all time points, these differences were statistically significant (p<0.05).
By El 8, there were no clear differences between the numbers of neurons from bcl- 
Z-Z-and bcl-2+^+ embryos surviving in the presence of BDNF, whereas in the 
absence of BDNF all neurons die rapidly (Fig. 4.6). As with the survival response of 
developing trigeminal neurons to NGF, these results suggest that by he late fetal 
period, Bcl-2 is not required for a sustained survival response of nodose neurons to 
BDNF.
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4.4a: E14 Nodose Neurons + BDNF (5ng/ml)
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Figure 4.4a : Percent survival of El 4 nodose neurons from bcl-Z-A  (n= 11 ). bcl- 
2 + /-  (n= 25). and bcl-2 + /+  (n= 12) embryos grown for 72 hours in culture with 
BDNF (5ng/mn. The means and standard errors of the means are shown. Each point 
in the graph represents the mean of a number of embryos. For each embryo 
triplicate cultures were established for all conditions studied
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4.4b; E14 Nodose Neurons, without factors
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Figure 4.4b : Percent survival of E l4 nodose neurons from 6c/-2-/- (n= bcl- 
2 + /-  (n - 2 5 \  and bc\~2 + /+  (n= 1 2  ^ embrvos grown for 72 hours in culture without 
factors. The means and standard errors of the means are shown. Each point in the 
graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied
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4.5a: E16 Nodose Neurons, with BDNF (5ng/ml)
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Figure 4.5a : Percent survival of El 6 nodose neurons from bcl-2-/- (n= 6). bcl-2+/- 
(n= 1 3). and bcl-2 + /+  (n= 7) embrvos grown for 72 hours in culture with BDNF 
(Sng/mh. The means and standard errors of the means are shown. Each point in the 
graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied.
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4.5b: E16 Nodose Neurons, without factors
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Figure 4.5b : Percent survival of El 6 nodose neurons from bcl-2-/- (n= 61 bcl-2+/- 
(n -  131. and bcl-2 + /+  fn= 71 embrvos grown for 72 hours in culture without 
factors. The means and standard errors of the means are shown. Each point in the 
graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied
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4.6a: E18 Nodose Neurons, + BDNF (lOng/ml)
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Figure 4.6a : Percent survival of E18 nodose neurons from b d -2 -/-  fn= 51 b d -2 + /-  
Tn= 141. and bcl-2 + /+  (n= 81 embrvos grown for 72 hours in culture with BDNF 
(IQng/m n. The means and standard errors of the means are shown. Each point in 
the graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied.
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4.6b: E18 Nodose Neurons, without factors
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Figure 4.6b : Percent survival of El 8 nodose neurons from 6c/-2-/- (n= 51 bcl-2+/- 
(n - 141 and bcl-2 + /+  (n= 8) embryos grown for 72 hours in culture without 
factors. The means and standard errors of the means are shown. Each point in the 
graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied
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Bcl-2-deficient sensorv neurons have normal neurotrophin dose 
response
Although Bcl-2 expression was required for the sustained survival response of early 
fetal trigeminal neurons to NGF it did not appear to affect the sensitivity to these 
neurons when this was counted at 12 hours after plating. The graph in Figure 4.7 
show that there is no obvious difference in the dose responses of these neurons to 
NGF; the EC50 for all three genotypes was approximately 10pg/ml.
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4.7: E14 Trigeminal Neurons : Dose Response
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Figure 4.7: Dose responses of El 4 trigeminal ganglion neurons from bcl-2-/- (n -  
11). bcl-2+/- (n= 25). and bcl-2+/+  (n= 12) embryos to a range of concentrations 
of NGF. Each point in the graph represents the mean of a number of embryos. For 
each embryo triplicate cultures were established for all conditions studied.
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Survival with cvtokines
At El 8, nodose and trigeminal neurons from wild type mice show a very limited 
response to cytokines such as CNTF, IL-6 and LIF. To ascertain whether cytokines 
had any survival effects in mice with a targeted null mutation in the Bcl-2 gene, 
triplicate control dishes and dishes supplemented with CNTF were set up for El 8 
trigeminal and nodose neurons. Under control conditions, there was no difference 
between the genotypes reflecting the results shown in figures 4.3 and 4.6. In the 
presence of CNTF, at 10ng/ml, there was no statistically significant difference 
between the survival of neurons from jbc/-2"A. bcl-2 +/- or bcl-2 embryos 
(Fig. 4.8). These results indicate that, at El 8, there would appear to be no in vitro 
evidence for bcl-2 having a role in the survival response of sensory neurons to 
cytokines.
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4.8a: E18 Trigeminal Neurons + CNTF (lOng/ml)
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Figure 4.8a: Graph of the percent survival of El 8 trigeminal neurons from bcl-2-/- 
(n= 8). bcl-2+/- (n= 14). and bcl-2 + /+  (n -  S) embrvos grown for 72 hours in 
culture with CNTF (10ng/m n. The means and standard errors of the means are 
shown. Each point in the graph represents the mean of a number of embryos. For 
each embryo triplicate cultures were established for all conditions studied
152
4.8b: E18 Nodose Neurons + CNTF (lOng/ml)
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Figure 4.8b: Graph of the percent survival of El 8 nodose neurons from (n=
8). b d -2 + /-  (n= 14). and bcl-2 + /+  (n -  5) embryos grown for 72 hours in culture 
with CNTF (lOng/m l). The means and standard errors of the means are shown. Each 
point in the graph represents the mean of a number of embryos. For each embryo 
triplicate cultures were established for all conditions studied
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Sympathetic Neurons from bcl-2 null embrvos show reduced survival 
In vitro
A very small study was carried out Into the effects of a null mutation in the bcl-2 
gene on the neurons derived from the sympathetic chain of embryos which were 
bcl-2 bcl-2 +/■ or bcl-2+/+- At E14, there is decreased survival of neurons 
derived from bcl-2“/“ embryos as compared neurons from wild type embryos, with 
neurons from bcl-2+ "^ embryos showing intermediary survival. This effect can be 
seen both in the presence of NGF at a concentration of 5ng/ml (Fig. 4.9a) and in 
the absence of growth factors (Fig. 4.9b). These results indicate a role for bcl-2 in 
the survival of sympathetic neurons at this time in development both in the 
presence and in the absence of NGF.
154
4.9a: E14 Symapthetic Chain Neurons, with NGF (5ng/ml)
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Figure 4.9a: Percent survival of El 4 sympathetic chain neurons from bcl‘-2-/--(r\- 
3), b d -2 + /- (r\= 8 ). and bch2 + /+  (n= 4) embrvos grown for 72 hours in culture 
with NGF (5nq/ml). The means and standard errors of the means are shown. Each 
point in the graph represents the mean of a number of embryos. For each embryo 
triplicate cultures were established for all conditions studied.
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4.9b: £14 Sympathetic Chain Neurons, no factors
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Figure 4.9b: Percent survival of El 4 sympathetic chain neurons from bcl-2-/--(n=
3). bch2+/~ (n -  8). and bcl-2 + /+  (n= 4) embryos grown for 72 hours in culture 
without factors. The means and standard errors of the means are shown. Each point 
in the graph represents the mean of a number of embryos. For each embryo 
triplicate cultures were established for all conditions studied.
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Bcl-2 null embrvos have reduced numbers of sensory neurons
To determine if the short-lived survival responses of Bcl-2-deficient neurons to 
neurotrophins in vitro are physiologically relevant, a comparative study was made 
both of the number of neurons undergoing apoptosis and the total number of 
neurons in the trigeminal ganglia of wild type and Bcl-2 mutant embryos at El 4 and 
at later stages during the period of naturally occurring neuronal death (Davies & 
Lumsden, 1984; Pinon et al., 1996). Embryos were prepared for routine histology 
and the number of neurons with pyknotic nuclei and the total number of neurons 
counted in serial sections of the trigeminal ganglia. All histology slides were coded 
so that these estimates were made without prior knowledge of the genotype.
The estimates of total numbers of neurons in the trigeminal ganglia of wild type 
embryos over the age range were very similar to previously reported estimates 
(Davies & Lumsden, 1984; Pinon et al., 1996), showing an approximate 50%  
decrease between El 4 and El 8 (Fig. 4 .10). Although there were fewer neurons in 
the trigeminal ganglia of bcl-2~^~ embryos compared with wild type embryos at 
El 4, this difference was not statistically significant (p<0.1, t-test n=22). There 
were, however, statistically significant reductions of approximately 25% in the 
number of neurons in the trigeminal ganglia of ibc/-2"/" embryos compared with wild 
type embryos at El 6 (p<0.05, t-test, n=28) and El 8 (p<0.001, t-test, n=18). 
There was also a significant increase in the number of neurons with pyknotic nuclei 
in the trigeminal ganglia of bci-2~^~ embryos compared with wild type embryos at 
El 4 (28%  increase, p<0.01, t-test, n=18). Although there were slightly more 
pyknotic neurons in the trigeminal ganglia of bci-2'/~ embryos as compared to wild 
type at El 6 and El 8, these differences were not statistically significant. These 
results suggest that in the absence of Bcl-2, a proportion of trigeminal neurons 
undergo apoptosis at El 4 and this is reflected in a reduction in the total number of 
neurons in the ganglia at later ages.
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4.10a: Number of Trigeminal Neurons
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Figure 4.10a: Estimated number of neurons in the trigeminal ganglia of bd-2  - / -  and 
b d -2 + /+  embryos at El 4. El 6 and El 8. The means and SEMs of counts are shown. 
At El 4, 16 wild type and 14 Bcl-2-deficient ganglia were studied; at El 6, 10 wild 
type and 13 knock out ganglia were studied and at e l 8, 13 wild type and 16 knock 
out ganglia were studied.
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4.10b: Number of pyknotic Trigeminal Neurons
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Figure 4.10b: Estimated number of pyknotic neurons in the trigeminal ganglia of bcl- 
2  - / -  and bch2+/+  embrvos at El 4. El 6 and El 8. The means and SEMs of the 
counts are shown. At El 4, 16 wild type and 14 Bcl-2-deficient ganglia were studied; 
at El 6, 10 wild type and 13 knock out ganglia were studied and at e l 8, 13 wild 
type and 16 knock out ganglia were studied.
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DISCUSSION
The data presented in this chapter reveals that bcl-2 Is required for the sustained 
survival of E14 trigeminal, nodose and sympathetic neurons in the presence of 
neurotrophins. bcl-2 deficient trigeminal neurons initially display a survival response 
to neurotrophins that has similar dose response characteristics to that of wild type 
neurons, but these neurons die more rapidly in the presence of neurotrophins 
compared to wild type neurons. Likewise, the neurons derived from the lumbar 
sympathetic chain and the nodose ganglion which have a null mutation in their bcl-2 
gene do not show sustained survival in vitro in the presence of NGF whereas those 
neurons derived from wild type embryos do. However, at later developmental 
stages, the difference in the survival response between wild type and bcl-2 deficient 
neurons is less pronounced, and by E18, bcl-2 does not appear to be required for 
neurotrophin promoted survival since wild type and bcl-2-deficient trigeminal and 
nodose neurons survive equally well with NGF and BDNF, respectively. It has 
previously been shown that the number of neurons in the trigeminal ganglion peaks 
between E13 and E14 and falls by half to reach a stable number by birth as a result 
of naturally occurring neuronal death (Davies & Lumsden, 1984). Accordingly, the 
number of apoptotic neurons in the trigeminal ganglion peaks at El 4 and declines to 
negligible levels by birth (Pinon et ai., 1996). The in vitro findings therefore suggest 
that bcl-2 expression is required for the sustained survival response of a subset of 
trigeminal, nodose and sympathetic neurons to neurotrophins during the early phase 
of naturally occurring neuronal death.
The finding that the survival of bcl-2-deficient cranial sensory neurons to 
neurotrophins is short lived during the early stages of naturally occurring neuronal 
death accords, with the previous demonstration that microinjection of antisense bci 
2 expression constructs into E10 chicken trigeminal mesencephalic nucleus (TMN) 
neurons cause a substantial and specific reduction in the number of these neurons 
surviving with BDNF (Allsopp et ai., 1995). Naturally occurring neuronal death takes
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place in the chicken TMN between E9 and El 4 (Rogers & Cowen, 1974), thus 
reduced Bcl-2 expression appears to compromise the neurotrophin survival response 
during the early stages of naturally occurring neuronal death. Interestingly, earlier in 
development, shortly after differentiating from progenitor cells, sensory neurons 
from bch2'^~ embryos and wild type embryos survive equally well in culture.
Although not required for the sustained neurotrophin survival response of mouse 
cranial sensory neurons at the end of the period of naturally occurring neuronal 
death, injection of a Bcl-2 expression vector into the trigeminal neurons of El 8 and 
newborn wild type mice is still able to prevent their death following NGF deprivation 
(J. Adu and A. M. Davies, unpublished observations). Likewise, DRG neurons isolated 
from transgenic mice expressing Bcl-2 under the control of the neuron-specific 
enolase promoter showed enhanced survival in the absence of NGF (Farlie et al., 
1995).
To ascertain the physiological significance of the in vitro observations, a comparison 
was made of the numbers of surviving and dying neurons in the trigeminal ganglia of 
wild type and bcl-2 mutant embryos during the period of naturally occurring 
neuronal death. In contrast to initial reports that the nervous system of bci-Z"^' 
animals is grossly normal (Nakayama et al., 1994,1994; Veis et al., 1993), there is 
a significant increase in the number of dying neurons in the trigeminal ganglia of bcl- 
2 -/-  embryos at El 4 and this is reflected in a 25% reduction in the total number of 
neurons in the trigeminal ganglia of Bcl-2-deficient embryos at El 6 and El 8. These 
findings suggest that Bcl-2 expression is necessary for sustaining the survival of a 
proportion of trigeminal ganglion neurons during the early stages of naturally 
occurring neuronal death in the trigeminal ganglion. Thus, the existence of specific 
neuronal deficiencies in bc/-2“/ “ mice are consistent with the impaired survival 
response of Bcl-2-deficient neurons to neurotrophins in vitro providing evidence for 
a physiological role for Bcl-2 in sustaining the survival of neurons during embryonic 
development.
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Although bcl-2 expression is only required for the survival of a subset of trigeminal 
neurons during development, the related protein bcl-x (Boise et al., 1993), has been 
shown to play a prominent role in regulating the survival of embryonic sensory 
neurons, bci-x"/" mice die in utero at E13 with extensive neuronal apoptosis in the 
central nervous system and dorsal root ganglia (Motoyama et al., 1995), suggesting 
that the survival of many neurons is dependent on bcl-x expression during the 
earliest stages of their development. Because bcl-x expression is retained in dorsal 
root and cranial sensory ganglia in postnatal and adult mice (Krajewski et ai., 1994; 
Gillardon et al., 1996), it is possible that bcl-x is also required for the survival of 
many sensory neurons at later stages of embryonic development and In the adult.
bcl-2 expression is also retained in sensory, sympathetic and motor neurons 
throughout life (Merry et al., 1994), and a recent study of bcl-2 null mice has 
revealed the appearance of statistically significant deficiencies in these populations 
of neurons during the postnatal period (Michaelidis et al., 1996). Between P3 and 
P9 the number of motorneurons in the facial nucleus of bcl-2"/" falls to 71 % of that 
in wild type mice and between P3 and PI 0 the number of sympathetic neurons in 
the superior cervical sympathetic ganglion falls to 60% of normal. There is also a 
significant reduction in the number of DRG neurons, but this does not become 
apparent until P44. Although further decreases in the neuronal complement of 
cranial sensory ganglia that may take place postnatally in bci-2"/" mice have not 
been investigated here, it has been shown that bcl-2 expression is required for 
maintaining the correct number of neurons in cranial sensory ganglia during the 
period of naturally occurring neuronal death.
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V. BCL-2 TRANSGENIC MICE: 
NEURONAL MATURATION AND NEURITE OUTGROWTH
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CHAPTER FIVE 
BCL-2 TRANSGENIC MICE: 
NEURONAL MATURATION AND NEURITE OUTGROWTH
INTRODUCTION
Extensive evidence has established that bcl-2 plays a key role in the prevention of 
apoptosis, both during development and normal tissue homeostasis, as well as in 
certain diseases (Thompson, 1996). However, evidence for bci-2 having further 
functions has recently been reported.
For example, bcl-2 overexpression in a neural crest-derived cell line enhances the 
outgrowth of neurite-like processes and increases the expression of neuron-specific 
enolase (Zhang et al., 1996). bci-2 also enhances the differentiation of the PC12 
neural cell line into sympathetic-like neurons in serum-free, but not serum- 
containing, media (Batistatou et al., 1993). In addition, midbrain-derived 
dopaminergic cell lines stabily expressing bcl-2 extend longer n eu rites than control 
transfected cells but do not show increased expression of many neuron-specific 
proteins (Oh et al., 1996). The above data raises the possibility that bcl-2 may play 
a role in regulating differentiation and/or axonal growth in the developing nervous 
system. However, the physiological and developmental significance of 
overexpressing bcl-2 in tumour cell lines is difficult to interpret. For these reasons, a 
comparative in vitro study of newly differentiated sensory neurons of bcl-2'/'’ and 
wild type mouse embryos was undertaken to determine if the absence of bcl-2 
affects the early development of these neurons. This study focused on the 
morphological changes that occur in the mouse trigeminal ganglion, as this 
population has been extensively studied and is well understood (Davies & Lumsden, 
1984,1986; Davies, 1987b; Pinon et al., 1996; Wilkinson et al., 1996). The 
majority of neurons in the trigeminal ganglion differentiate from progenitor cells
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between E9.5 and El 3.5 with the first axons emerging from the trigeminal ganglion 
at E9.5. The total number of neurons in the ganglion peaks between El 2 and El 4 
and decreases by 50% to reach a stable number by birth as a result of naturally 
occurring cell death which peaks between El 2 and El 4. These studies focus on 
neurons derived from embryos aged between El 1 and El 4, a period when most 
neurons are differentiating from their progenitor cells and extending axons to their 
target fields.
Previous studies have established that shortly after differentiating from progenitor 
cells, sensory neurons undergo a distinct morphological change. Initially, they have 
small, spindle-shaped, phase-dark cell bodies which become large spherical and 
phase-bright as they mature (Wright et al., 1992). It is shown here that early 
sensory neurons cultured from the trigeminal ganglia of bcl-2'^~ embryos at E ll  
and El 2 undergo this change more slowly than trigeminal neurons from wild type 
embryos of the same ages. The delay is not due to any survival effects of Bcl-2. 
Accordingly, there was a significantly smaller number of mature-type neurons in the 
trigeminal ganglia of El 2 and El 3 bcl-2~^' embryos, yet the total cellular content of 
these ganglia was similar to that of ganglia derived from wild type embryos. 
Furthermore, the trigeminal ganglia of both bc/-2"/" and wild type embryos contain 
similar numbers of neurofilament positive cells. The absence of Bcl-2 did not cause a 
uniform delay in the developmental program of sensory neurons because the time 
course of NGF receptor expression (both trkA and p75) was unaffected in the 
trigeminal neurons of bcl-2 null embryos. These findings indicate that Bcl-2 
expression is required for the normal progression of a particular early maturational 
change in embryonic sensory neurons. Furthermore, Bcl-2 is shown to have a role in 
regulating axonal growth rate in embryonic neurons. Using neurons derived from the 
trigeminal ganglia of El 1 and El 2 mice, it is clear that in the absence of Bcl-2 there 
is a marked decrease in neurite growth rate, irrespective of whether the neurons are 
grown with NGF, BDNF, or NT-3. These results, taken in conjunction with the
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maturation studies Indicate a role, or several roles, for bcl-2 apart from its well 
documented role in preventing apoptosis.
RESULTS
Neuronal Maturation in vitro
Newly-differentiated sensory neurons undergo a distinct maturational change in 
vitro . Those which are defined here as immature have small, spindle-shaped phase 
dark cell bodies whereas those which are defined as mature have large spherical 
phase-bright celi bodies (Fig. 5.1). The proportion of the morphologically distinct 
immature neurons in dissociated cuitures from bcl-2-deficient embryos was 
consistently higher than that observed in cultures derived from wild type embryos 
of the same age (Fig. 5.2). Furthermore, the proportion of immature neurons in 
cultures derived from embryos heterozygous for a null mutation in the bcl-2 gene 
was intermediate between that observed for wild type embryos and that observed 
for bcl-2-deficient embryos, suggesting a gene dosage effect.
An elevated number of immature neurons in dissociated cultures of early sensory 
ganglia from bcl-2"/" embryos could be due to differences in progenitor ceil 
differentiation or neuronal survival in these cuitures. To address directly the 
question of whether bcl-2-deficient sensory neurons mature more slowly than wild 
type neurons, defined cohorts of immature neurons in cultures of El 1 and E l2 
trigeminal neurons were identified 18 hours after plating and the fate of each 
individual ceil followed for up to 3 days (Fig. 5.3 and 5.4). These data show that 
bcl-2-deficient neurons retain an immature morphology much longer than wild type 
neurons. The marked difference in the rate of neuronal maturation cannot be 
attributed to differences in the survival of bci-2-deficient and wild type neurons as 
very few neurons died in the cohorts over the period of the study (Fig. 5.3 and 
5.4). Because all data were obtained prior to genotyping, these observations were 
not influenced by observer bias.
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BFigure 5.1 : Photomicrographs of El 1 trigeminal ganglion cultures showing the 
typical morphology of immature (A.B) and mature (C) early sensory neurons. The 
paired immunofluorescence (A) and phase contrast (B) photomicrographs 
demonstrate that cells identified as immature neurons are stained with anti­
neurofilament antiserum (Wright et al., 1992). Scale bar represents 50jum.
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5.2a: E l l  Trigeminal Neurons + NGF (Sng/ml) 
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Figure 5.2a: Percentage of neurons that are immature in dissociated cultures of El 1 
trigeminal ganglia derived from embrvos of each of the three genotypes. Neurons 
were cultured in the presence of NGF (5ng/ml). The bar charts represent the results 
of cultures established from 13 bcl-2-/-, 26 bcl-2+/-, and 14 wild type embryos. 
The means and standard errors of the means are shown. Each point on the graph 
represents the mean of a number of embryos. For each embryo, triplicate cultures 
were established for all conditions studied.
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5.2b: E12 Trigeminal Neurons + NGF (5ng/ml)
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Figure 5.2b: Percentage of neurons that are immature in dissociated cultures of El 2 
trigeminal ganglia derived from embrvos of each of the three genotypes. Neurons 
were cultured in the presence of NGF (5ng/ml). The bar charts represent the results 
of cultures established from 17 bcl-2"/", 29 bcl-2+/", and 18 wild type embryos. 
The means and standard errors of the means are shown. Each point on the graph 
represents the mean of a number of embryos. For each embryo, triplicate cultures 
were established for all conditions studied.
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5.2c: E l l  Trigeminal Neurons + BDNF (5ng/ml) 
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Figure 5.2c: Percentage of neurons that are immature in dissociated cultures of E11 
trigeminal ganglia derived from embryos of each of the three genotypes. Neurons 
were cultured in the presence of BDNF (5ng/ml). The bar charts represent the 
results of cultures established from 13 bcl-2-/-, 26 bcl-2+/-, and 14 wild type 
embryos. The means and standard errors of the means are shown. Each point on the 
graph represents the mean of a number of embryos. For each embryo, triplicate 
cultures were established for all conditions studied.
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5.2d: E12 Trigeminal Neurons + BDNF (5ng/ml)
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Figure 5.2d: Percentage of neurons that are immature in dissociated cultures of E ll  
trigeminal ganglia derived from embryos of each of the three genotypes. Neurons 
were cultured in the presence of BDNF (5ng/mi). The bar charts represent the 
results of cultures established from 17 bel-2“/", 29 bcl-2’^ /" and 18 wild type 
embryos. The means and standard errors of the means are shown. Each point on the 
graph represents the mean of a number of embryos. For each embryo, triplicate 
cultures were established for all conditions studied.
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5.3a: E ll Trigeminal Neurons + BDNF (5ng/ml)
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Figure 5.3: Results of neuron cohort experiments to compare the maturation and 
survival of trigeminal neurons from wild type and bcl-2=^ embrvos at E l l .  The 
number of immature neurons remaining in the cohorts (a) is expressed as a 
percentage of the initial cohort size up to 72 hours after plating. Likewise, the total 
number of neurons in the cohort (b) is again expressed as a percentage. The means 
and standard errors of the means are shown. Each point on the graph represents 
the mean of a number of embryos. For each embryo, triplicate cultures were 
established for all conditions studied. In total, at E l l ,  24 Bcl-2-deficient embryos 
and 23 wild type embryos were studied. The initial cohort size in each culture 
ranged from 20 to 60 neurons.
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5.3b: E ll Trigeminal Neurons + BDNF (5ng/ml)
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5.4a: E12 Trigeminal Neurons + NGF (5ng/ml)
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Figure 5.4: Results of neuron cohort experiments to compare the maturation and 
survival of trigeminal neurons from wild type and bd-2=^  embn/os at El 2 . The 
number of immature neurons remaining in the cohorts (a) is expressed as a 
percentage of the initial cohort size up to 72 hours after plating. Likewise, the total 
number of neurons in the cohort (b) is again expressed as a percentage. The means 
and standard errors of the means are shown. Each point on the graph represents 
the mean of a number of embryos. For each embryo, triplicate cultures were 
established for all conditions studied. A total of 22 Bcl-2-deficient embryos and 17 
wild type embryos were studied. The initial cohort size in each culture ranged from 
20 to 60 neurons.
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5.4b: E12 Trigeminal Neurons + NGF (5ng/ml)
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Development of Earlv Trigeminal neurons in vivo
To determine if neuronal maturation is delayed in the trigeminal ganglia of Bcl-2- 
deficlent embryos in vivo, the number of morphologically recognisable cresyl fast 
violet stained mature neurons were counted in the trigeminal ganglia of Bcl-2- 
deficient and wild type embryos at several embryonic ages. The criteria used for 
determining what was a neuron were the presence of cresyl-stained NissI substance 
in the cytoplasm and the presence of a densely-stained nucleolus in the nucleus 
whilst the nucleoplasm remains unstained. Neurogenesis in the mouse trigeminal 
ganglion and the recruitment of axons to the trigeminal nerve occurs between E9.5 
and El 3.5 (Davies & Lumsden, 1984; Wilkinson et al., 1996). The earliest age at 
which large numbers of neurons become distinguishable by morphological criteria 
from other cell types is El 2 (Davies & Lumsden, 1984) and for this reason this is 
the youngest age studied here. Because of their small size, immature neurons 
cannot be distinguished from their progenitor cells and glial cells and are therefore 
not included in these counts. There are significantly greater numbers of 
morphologically distinct neurons in the trigeminal ganglia of wild type embryos at 
both El 2 (p=0.0008, n=17, t-test) and El 3 (p,0.006, n=18, t-test)(Fig. 5.5). By 
El 4, however, the number of neurons of the trigeminal ganglia of Bcl-2-deficient 
embryos and wild type embryos was not significantly different (p>0.1, n=22, t- 
test). Because all data was obtained before the genotype were determined, the 
data is not influenced by observer bias.
To ascertain if the reduced number of morphologically identifiable neurons in the 
early trigeminal ganglia of Bcl-2-deficient embryos was due to a reduction in the 
total number of neurons in the ganglion, all neurons (both immature and mature) 
were positively identified using neurofilament staining at El 2 (Fig. 5.6). Estimates 
of the total number of neurofilament-positive cells in the ganglia of wild type and 
Bcl-2-deficient embryos showed no significant difference at this stage (Fig. 5.5), 
these observations suggest that the reduction in the numbers of morphologically
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recognisable neurons in the trigeminal ganglia of Bcl-2-deficient embryos during the 
early stages of ganglion formation is not due to a reduction in the total number of 
neurons in the ganglion. These in vivo observations are consistent with the results 
of the in vitro studies which suggest that Bcl-2-deficient neurons retain an immature 
morphology longer in vivo than wild type neurons.
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5.5a: Number of Morphologically Mature Trigeminal Neurons
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Figure 5.5a: Number of morphologically recognisable neurons in cresvl fast violet 
stained sections of the trigeminal ganglia of wild type and Bcl-2-deficient embryos 
at El 2. El 3 and El 4. The number of Bcl-2-deficient embryos studied at each age 
were as follows: El 2 n=4, at El 3 n=6, at El 4 n=5. For the wild type embryos, at 
El 2 n=6, at El 3 n=6, and at El 4 n=4. The means and standard errors of the means 
are shown.
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5.5b: Number of Neurofilament Positive Cells
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Figure 5.5b: Number of neurofilament positive neurons in anti-neurofilament stained 
sections of the trigeminal ganglia of wild type and Bcl-2-deficient embrvos at El 2. 
The number of Bcl-2-deficient embryos studied was 6 and for the wild type embryos 
n=5. The means and standard errors of the means are shown.
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Figure 5.6: Photomicrograph of a section of the trigeminal ganglia of an El 2 
embryo stained for cresvl fast violet (A) and neurofilament (B 1 Scale bar represents 
1 OOAvm.
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Quantification of trkA and p75 mRNAs
This work was done by Dr. S. Wyatt using competitive RT-PCR to quantify the level 
of the mRNAs encoding the NGF receptors, p75 and trkA. The aim of this study was 
to determine if the delayed morphological maturation of early sensory neurons in 
Bcl-2-deficient embryos was a feature of a more generalised delay in the 
development of these neurons. The levels of the mRNAs for both wild type and Bcl- 
2-deficient embryos increased to the same extent between E12 and El 4 (Fig. 5.7) 
as neurons within the trigeminal ganglia acquire NGF dependence.
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5.7a: Levels of trkA mRNA
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Figure 5.7a: Level of trkA mRNA in the trigeminal ganglia of wild type and Bcl-2- 
deficient embrvos at El 2. El 3. and El 4. For Bcl-2-deficient embryos at El 2 n=4, 
at El 3 n=6, and at El 4 n=6. For wild type embryos at El 2 n=5, at El 3 n=5 and at 
El 4 n=7. Each data point represents the mean of a number of embryos. The means 
and standard errors of the means are shown.
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5.7b: Levels of p75 mRNA
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Figure 5.7b: Level of p75 mRNA in the trigeminal aanaiia of wild type and Bcl-2- 
deficient embrvos at El 2. El 3. and El 4. For Bcl-2-deficient embryos at El 2 n=4, 
at El 3 n=6, and at El 4 n -6 . For wild type embryos at El 2 n=5, at El 3 n=5 and at 
El 4 n=7. Each data point represents the mean of a number of embryos. The means 
and standard errors of the means are shown.
183
Analysis of Neurite Growth Rate
A detailed comparative study of neurite growth rate in low-density dissociated 
cultures of trigeminal ganglion neurons, established form Bcl-2-deficient and wild 
type mouse embryos, was performed in collaboration with Mark Hilton. The ages 
studied, El 1 and El 2, reflect a time in development when many trigeminal axons 
are growing towards their peripheral and central targets in vivo. Figure 5.8 shows 
that at both ages and in the presence of NGF (a), BDNF (b) or NT-3 (c), Bcl-2- 
deficient neurons extended neurites at a slower rate than either heterozygous or 
wild type neurons. After 48 hours of incubation, neurites from Bcl-2-deficient 
neurons were between 44 and 60% shorter than those of wild type neurons in El 1 
cultures and 35% shorter in El 2 cultures. The differences between the wild type 
and Bcl-2-deficient neurons were statistically significant at 12, 24, and 48 hours 
incubation in all cases (p<0.0001 in all cases, t-tests). Because only neurons that 
survived the 48 hour duration of the study were considered, the differences in 
neurite outgrowth do not reflect differences in survival. Furthermore, these results 
were not influenced by observer bias because the genotypes were ascertained after 
all the measurements were made. These results appear to indicate a role for Bcl-2 in 
promoting neurite outgrowth in early trigeminal neurons. However, the possibility 
that this is another maturation effect cannot be discounted as no distinction was 
made between mature and immature neurons although this currently being studied. 
One point which may argue that the differences in neurite outgrowth are not simply 
a reflection of the level of maturation is the observation that the differences in 
neurite length are not Bcl-2 dose dependent, unlike maturation. This suggests that 
neurite growth rate differences are a distinguishable effect from maturation.
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5.8a: E ll Trigeminal Neurons + NGF (5ng/ml)
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Figure 5.8a: Results of neuron cohort experiments to compare axonal growth rates 
of trigeminal neurons from Bcl-2-deficient. heterozygous and wild type mice, at El 1 
in the presence of NGF f5ng/mn. The means and standard errors of the means are 
shown. Each point on the graph represents the mean of a number of embryos. For 
each embryo, triplicate cultures were established for all conditions studied. For Bcl- 
2-deficient embryos n=5 and for wild type embryos n=5.
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5.8b: E12 Trigeminal Neurons + NGF (5ng/ml)
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Figure 5.8b: Results of neuron cohort experiments to compare axonal growth rates 
of trigeminal neurons from Bcl-2-deficient. heterozygous and wild type mice, at El 2 
in the presence of NGF (5ng/ml). The means and standard errors of the means are 
shown. Each point on the graph represents the mean of a number of embryos. For 
each embryo, triplicate cultures were established for all conditions studied. For Bcl- 
2-deficient embryos n=7 and for wild type embryos n=6.
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5.8c: E li  Trigeminal Neurons + BDNF (5ng/ml)
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Figure 5.8c: Results of neuron cohort experiments to compare axonal growth rates 
of trigeminal neurons from Bcl-2-deficient. heterozygous and wild type mice, at El 1 
in the presence of BDNF (5ng/mO. The means and standard errors of the means are 
shown. Each point on the graph represents the mean of a number of embryos. For 
each embryo, triplicate cultures were established for all conditions studied. For Bcl- 
2-deficient embryos n=5 and for wild type embryos n=5.
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5.8d: E12 Trigeminal Neurons + BDNF (5ng/ml)
7i
6 12 24 48
time in culture (hours)
Figure 5.8d: Results of neuron cohort experiments to compare axonal growth rates 
of trigeminal neurons from Bcl-2-deficient. heterozygous and wild type mice, at El 2 
in the presence of BDNF (5ng/ml). The means and standard errors of the means are 
shown. Each point on the graph represents the mean of a number of embryos. For 
each embryo, triplicate cultures were established for all conditions studied. For Bcl- 
2-deficient embryos n=7 and for wild type embryos n=6.
188
5.8e: E ll Trigeminal Neurons + NT-3 (5ng/ml)
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Figure 5.8e: Results of neuron cohort experiments to compare axonal growth rates 
of trigeminal neurons from Bcl-2-deficient. heterozygous and wild type mice, at El 1 
in the presence of NT-3 (Sng/mO. The means and standard errors of the means are 
shown. Each point on the graph represents the mean of a number of embryos. For 
each embryo, triplicate cultures were established for all conditions studied. For Bcl- 
2-deficient embryos n=5 and for wild type embryos n=5.
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5.8f: E12 Trigeminal neurons + NT-3 (5ng/ml)
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Figure 5.8f: Results of neuron cohort experiments to compare axonal growth rates 
of trigeminal neurons from Bcl-2-deficient. heterozygous and wild type mice, at El 1 
in the presence of NGF (5ng/mh. The means and standard errors of the means are 
shown. Each point on the graph represents the mean of a number of embryos. For 
each embryo, triplicate cultures were established for all conditions studied. For Bcl- 
2-deficient embryos n=7 and for wild type embryos n=6.
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DISCUSSION
The data presented in this chapter provide compelling evidence for at least one 
novel role for bcl-2 during the early stages of neuronal development that is distinct 
from its well-recognised anti-apoptotic function. Newly differentiated sensory 
neurons initially have small, spindle-shaped phase dark cell bodies which 
subsequently enlarge becoming spherical and phase bright. By tracking the 
morphology of individual neurons at intervals in cultures established from the early 
trigeminal ganglia of bcl-2-deficient and wild type embryos, it has been 
demonstrated that this clearly recognisable morphological change is markedly 
delayed in bci-2-deficient neurons. This delay is not due to a decrease in the viability 
of bcl-2-deficient neurons because the early trigeminal neurons of bcl-2-deficient 
and wild type embryos survive equally well in vitro. Thus, the absence of bcl-2 has a 
marked effect on the in vitro development of early sensory neurons that is 
unrelated to its role in regulating ceil survival. Interestingly, later in development, 
during the peak period of naturally occurring neuronal death, bcl-2-deficient 
trigeminal neurons do die more rapidly than wild type neurons in NGF-supplemented 
medium. This decrease in the in vitro viability of older embryonic bcl-2-deficient 
trigeminal neurons is correlated with an increase in the number of dying neurons in 
the trigeminal ganglion at this stage in vivo, and a reduction in the total number of 
neurons in the ganglion before birth (Pinon et al., 1997). Reductions in the number 
of neurons in dorsal root and sympathetic ganglia and in motoneuron populations 
have also been reported in bcl-2-deficient mice postnataliy (Michaelldis et al.,
1996).
The in vitro observations of the delayed morphological maturation of early bcl-2- 
deficient sensory neurons were supported by an in vivo analysis of the trigeminal 
ganglia of bcl-2-deficient and wild type embryos. There are fewer morphologically 
recognisable neurons in the trigeminal ganglia of bcl-2-deficient embryos as 
compared with wild type embryos at both E l2 and E l3 as analysed in cresyl fast
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violet stained sections. This is the stage when many neurons are differentiating 
from progenitor cells and starting to extend axons to their targets (Davies, 1987b; 
Davies & Lumsden, 1984). Because of their small size, immature neurons are not 
distinguishable from progenitor cells and other non-neuronal cells in this histological 
analysis. The total neuronal complement of the trigeminal ganglion of Bcl-2-deficient 
embryos was, however, normal during this period of development as revealed by 
counting the number of neurofilament-positive cells in the trigeminal ganglia of Bcl- 
2-deficient and wild type embryos. The most likely explanation for these findings is 
that, as in vitro, the morphological maturation of early sensory neurons is delayed in 
vivo in the absence of Bcl-2.
Of particular interest is the demonstration that the delay in the morphological 
maturation of early Bcl-2-deficient neurons is not a consequence of a general 
retardation of the development of Bcl-2-deficient embryos or of the sensory 
neurons within these embryos. There was no apparent difference in the stage- 
specific external features (Theiler, 1972) of Bcl-2-deficient and wild type embryos 
in each litter and the time course and level of expression of both p75 and trkA 
mRNAs were virtually identical in embryos of both genotypes. Because these mRNAs 
are expressed predominantly, if not exclusively, in the neurons of the embryonic 
trigeminal ganglion and their levels increase markedly with the acquisition of NGF 
survival response in these neurons (Wyatt & Davies, 1993; Wyatt et al., 1990), 
these findings also reinforce the evidence based on the GAPDH measurements that 
the neuronal complement of the early trigeminal ganglion is similar in both Bcl-2- 
deficient and wild type embryos.
In addition to, or perhaps as a consequence of, the effects on neuronal maturation, 
Bcl-2 has been shown to influence the rate or neurite outgrowth in vitro. Neurons 
from Bcl-2-deficient embryos extend shorter neurites than neurons from wild type 
or heterozygous embryos at El 1 and El 2, in the presence of NGF (5ng/ml), BDNF 
(5ng/ml) or NT-3 (5ng/ml). Although this finding may be a consequence of the
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delay in the maturation of Bcl-2-deficient neurons, the fact that this is not a gene 
dose dependent effect, unlike maturation, argues for a role for Bcl-2 in neurite 
outgrowth that is distinct from its role in neuronal maturation.
Several studies of the consequences of manipulating the expression of Bcl-2 in 
various cell lines and neurons have raised the possibility that Bcl-2 may have 
functions in addition to its anti-apoptotic role. The differentiation of the PCI 2 
pheochromacytoma cell line into neurons is enhanced by overexpression of Bcl-2. 
However, this effect is only observed when the cells are grown in serum-free 
medium (Batistatou et al., 1993). Midbrain-derived dopaminergic cell lines stabily 
expressing Bcl-2 extend longer neurites than control transfected cells but do not 
have increased expression of many neuron-specific proteins (Oh et al., 1996). Bcl-2 
overexpression in a neural crest-derived cell line enhances the outgrowth of neurite- 
like processes and also increases the expression of neuron-specific enolase (Zhang 
et al., 1996). Several observations indicate that the level of Bcl-2 expression in 
mouse retinal ganglion cells (RGCs) influences the ability of their axons to 
regenerate into co-cultured tectal explants (Chen et al., 1997). In the early fetal 
stages, RGCs normally express high levels of Bcl-2 and are able to extend axons into 
co-cultured tectal tissue of the same age, whereas late fetal RGCs express low 
levels of Bcl-2 and are not able to grow axons into tectal tissue. The ability of early 
fetal RGCs to regenerate into tectal tissue is substantially reduced in retinal explants 
obtained from Bcl-2-deficient embryos, whereas late fetal and adult RGCs from 
transgenic mice overexpressing Bcl-2 in neurons are able to regenerate into tectal 
tissue.
In summary, the data presented in this chapter demonstrates at least one novel role 
for Bcl-2 in promoting the maturation of early sensory neurons of the trigeminal 
ganglion. A second role in neurite outgrowth is also suggested by the data although 
further work will be necessary to fully elucidate this. In particular it will be important 
to determine whether the reduced rate of neurite outgrowth in El 1 and El 2 Bcl-2-
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deficient neurons is a consequence of slowed maturation or whether Bcl-2 plays a 
role in neurite outgrowth in mature sensory neurons. It will also be necessary to 
determine whether axonal growth rates are reduced in vivo in Bcl-2-deficient 
embryos.
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VI. BAX TRANSGENIC MICE 
SURVIVAL STUDIES
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CHAPTER SIX 
BAX TRANSGENIC MICE 
NEURONAL SURVIVAL STUDIES
INTRODUCTION
To date, the role of Bax in regulating neuronal survival has been poorly elucidated. 
Data presented in Chapter Three suggests that supraphysiological expression of 
human Bax can promote survival of embryonic chicken neurons in the absence of 
trophic support. This finding was unexpected, since Bax has previously been shown 
to promote cell death in IL-3-dependent cell lines and inhibit the death repressor 
action of Bcl-2 (Oltvai et al., 1993). However, the interpretation of the data in 
Chapter Three is complicated by the species difference between the Bax cDNA that 
was available for injection and the host neurons, and also by the high, non- 
physiological levels of Bax ectopically expressed in the host neurons. It is possible 
that the survival-promoting effect of Bax is an artefact of the experimental system 
used in Chapter Three. Indeed, Bax overexpression has recently been shown to 
promote cell death in rat sympathetic neurons both in the presence and absence of 
NGF (Vekrellis et al., 1997).
In this chapter, Bax null mutant mice have been used to try and clarify the role Bax 
plays in regulating the survival of developing sensory neurons. These mice survive 
postnataliy and show cellular hyperplasia in various cells of the immune system and 
cellular hypoplasia in the cells of the testis, rendering the males infertile (Knudson et 
al., 1995). Here, bax null mutant mice were used to make a detailed study of the 
cells of the nodose and trigeminal ganglia and to examine the role of Bax in these 
cells.
196
Cell culture experiments were carried out over a range of embryonic ages to assess 
the role of Bax in both factor-dependent and factor-independent survival of the 
neurons in vitro. To determine if these in vitro studies had any relevance to the 
situation in vivo, the number of neurons in the trigeminal ganglia of both bax~^" and 
bax+^+ embryos was studied using the histological techniques described previously.
RESULTS
Response of Bax-deficient Sensory Neurons to Neurotrophins in vitro 
Trigeminal Ganglion
At El 4, there was a marginally increased level of long term survival of Bax-deficient 
trigeminal neurons in the presence of NGF (5ng/ml). This difference was statistically 
significant by 120 hours after plating (t-test, P<0.05). At this time, there were no 
surviving neurons from wild type embryos or bax'^^~ embryos, whereas 
approximately 7% of Bax-deficient trigeminal neurons were still surviving (Fig. 6.1a). 
In cultures that were not supplemented with NGF, there was no difference between 
the Bax-deficient neurons and the neurons of the other two genotypes with all 
neurons dying rapidly within the first 48 hours (Fig.6.1 b).
By El 6, Bax-deficient trigeminal neurons showed increased survival as compared to 
those neurons from bax+^~ or bax*^/+ embryos in the presence of NGF (5ng/ml), 
but the difference was relatively small (Fig. 6.2a). 144 hours after plating, all except 
the Bax-deficient neurons had died, and only about 12% of these neurons were still 
surviving. In the absence of NGF, neurons from Bax-deficient embryos survived 
markedly better than those derived from heterozygous or wild type embryos (Fig. 
6.2b). All of the neurons from the wild type embryos and those heterozygous for a 
null mutation in the bax gene were dead by 48 hours after plating. At this time, 
nearly 60% of trigeminal neurons from Bax-deficient embryos were still alive. This 
figure decreased with time, plateauing at around 7% 120 hours after plating.
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At El 8, the Bax-deficient trigeminal neurons showed substantially better survival in 
the presence of NGF (1 Ong/ml) than their wild type or bax+^~ counterparts (Fig. 
6.3a). Likewise, in the absence of NGF, bax-deficient trigeminal neurons show 
enhanced survival (Fig. 6.3b). After 48 hours in culture under these conditions all 
the wild type and bax+^~ neurons were dead, whereas approximately 40% of the 
Bax-deficient neurons were still surviving. There was little further reduction in this 
number for the duration of the experiment.
By P I, there was again substantially better survival of Bax-deficient trigeminal 
neurons in the presence of NGF (1 Ong/ml) (Fig. 6.4a). However, the difference in 
survival between these neurons and the wild type and bax'^^" neurons was not as 
marked as at El 8. When cultured without NGF (Fig. 6.4b), Bax-deficient trigeminal 
neurons survive markedly better than neurons derived from neonates of the other 
two genotypes. 48 hours after plating, all the neurons from the wild type neonates 
and those from neonates heterozygous for the bax null mutation were dead. At this 
time, approximately 60% of the Bax-deficient neurons were still surviving and this 
figure did not decrease markedly during the remainder of the experiment.
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6.1a: E14 Trigeminal Neurons + NGF (5ng/ml)
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Figure 6.1a: Percent survival of El 4 trigeminal neurons from bax-A ( n=41 bax+A 
fn=8) and bax +/+  (n=4) embrvos grown for 168 hours in culture with NGF 
(Snq/mn. The means and standard errors of the means are shown. Each point in the 
graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied.
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6.1b: E14 Trigeminal neurons, without factors
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Figure 6.1 b: Percent survival of El 4 trigeminal neurons from bax-/- ( n = 4 \ bax+/- 
(n=81 and bax +/+  (n=4) embryos grown for 1 68 hours in culture without NGF. The 
means and standard errors of the means are shown. Each point in the graph 
represents the mean of a number of embryos. For each embryo triplicate cultures 
were established for all conditions studied.
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6.2a: E16 Trigeminal Neurons + NGF (5ng/ml)
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Figure 6.2a: Percent survival of El 6 trigeminal neurons from baxV- Tn-S). bax+A 
(n=13). and bax + /+  (n=6) embryos grown for 168 hours in culture with NGF 
(5ng/ml). The means and standard errors of the means are shown. Each point in the 
graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied.
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6.2b: E16 Trigeminal Neurons, without factors
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Figure 6.2b: Percent survival of El 6 trigeminal neurons from bax-/- (n=51 bax+A  
(n=13). and bax + /+  fn=G) embryos grown for 168 hours in culture without NGF. 
The means and standard errors of the means are shown. Each point in the graph 
represents the mean of a number of embryos. For each embryo triplicate cultures 
were established for all conditions studied.
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6.3a: E18 Trigeminal Neurons + NGF (lOng/ml)
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Figure 6.3a: Percent survival of El 8 trigeminal neurons from bax-/- (n=S). bax+/~ 
(n=12)* and bax + /+  (n=6) embrvos grown for 312 hours in culture with NGF 
(1 Ong/ml). The means and standard errors of the means are shown. Each point in 
the graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied.
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6.3b: E18 Trigeminal Neurons, without factors
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Figure 6.3b: Percent survival of El 8 trigeminal neurons from bax-A (n=5). bax+/- 
( n = 1 a n d  bax + /+ (n -6 )  embryos grown for 312 hours in culture without NGF. 
The means and standard errors of the means are shown. Each point in the graph 
represents the mean of a number of embryos. For each embryo triplicate cultures 
were established for all conditions studied.
204
6.4a: P I Trigeminal Neurons + NGF (lOng/ml)
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Figure 6.4a: Percent survival of PI trigeminal neurons from bax-/- (n=81 bax+/- 
(n=14). and bax + /+  (n=5) neonates grown for 312 hours in culture with NGF 
(lOng/mO. The means and standard errors of the means are shown. Each point in 
the graph represents the mean of a number of neonates. For each neonate triplicate 
cultures were established for all conditions studied.
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6.4b: P I Trigeminal Neurons, without factors
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Figure 6.4b: Percent survival of PI trigeminal neurons from bax-/- (n=81. bax+/~ 
(n=14). and hax + /+  (n -5 ) neonates grown for 312 hours in culture without NGF. 
The means and standard errors of the means are shown. Each point in the graph 
represents the mean of a number of neonates. For each neonate triplicate cultures 
were established for all conditions studied.
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Nodose Neurons
At El 4, Bax-deficient nodose neurons survived better in the presence of BDNF 
(5ng/ml) than neurons derived from bax+/“or wild type embryos (Fig. 6.5a). By 
120 hours after plating, there were no neurons surviving from embryos of these 
genotypes whilst 20% of Bax-deficient neurons were still surviving. In the absence 
of BDNF, there was no difference between the three genotypes (Fig. 6.5b). In all 
cases, all neurons were dead by 24 hours after plating.
At El 6, Bax-deficient nodose neurons showed a marked increase in survival in the 
presence of BDNF (5ng/mi) (Fig. 6.6a) as compared to wild type neurons and those 
derived from embryos which were heterozygous for the Bax null mutation. When 
cultured without BDNF, Bax-deficient neurons showed increased survival in vitro. 48  
hours after plating, there were no nodose neurons derived from wild type or 
embryos surviving (Fig. 6.6b) whilst approximately 40% of Bax-deficient neurons 
were still alive. This number declined with time in culture and reached a plateau at 
120 hours after plating with just under 10% of the Bax-deficient neurons still alive.
At El 8, Bax-deficient neurons again survived better with BDNF (1 Ong/ml) than 
neurons from wild type of heterozygous animals (Fig. 6.7a). This same pattern was 
seen in cultures without BDNF (Fig. 6.7b). In the absence of BDNF, all neurons 
derived from bax+^"' and baxi'^’^  embryos were dead 48 hours after plating. 
Approximately 55% of the Bax-deficient neurons were still alive. This declined 
slightly over the next few days, plateauing at around 40% survival.
A very similar pattern was seen for PI nodose neurons where there was once again 
enhanced survival of neurons derived from Bax-deficient neonates both in the 
presence of BDNF (10ng/ml)(Fig. 6.8a) and in the absence of neurotrophic factors 
(Fig. 6.8b).
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6.5a: E14 Nodose Neurons + BDNF (5ng/ml)
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Figure 6.5a: Percent survival of El 4 nodose neurons from baxV- (n=4). bax+/- 
(n=8). and bax + /+  (n -4 ) embrvos grown for 1 68 hours in culture with BDNF 
(5ng/ml). The means and standard errors of the means are shown. Each point in the 
graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied.
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6.5b: E14 Nodose Neurons, without factors
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Figure 6.5b: Percent survival of El 4 nodose neurons from bax-A (n = 4 \ bax+A 
(n=8). and bax + /+  (n=4) embryos grown for 168 hours in culture without BDNF. 
The means and standard errors of the means are shown. Each point in the graph 
represents the mean of a number of embryos. For each embryo triplicate cultures 
were established for all conditions studied.
209
6.6a: E16 Nodose Neurons + BDNF (5ng/ml)
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Figure 6.6a: Percent survival of El 6 nodose neurons from bax-/- (n=S). bax+A 
(n=13), and bax + /+  (n -6 ) embrvos grown for 168 hours in cuiture with BDNF 
(5ng/ml). The means and standard errors of the means are shown. Each point in the 
graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied.
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6.6b: E16 Nodose Neurons, without factors
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Figure 6.6b: Percent survival of El 6 nodose neurons from bax-/- (n=51. bax+/- 
(n=13). and bax + /+  (n=6) embryos grown for 168 hours in culture without BDNF. 
The means and standard errors of the means are shown. Each point in the graph 
represents the mean of a number of embryos. For each embryo triplicate cultures 
were established for all conditions studied.
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6.7a: E18 Nodose Neurons + BDNF (lOng/ml)
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Figure 6.7a: Percent survival of El 8 nodose neurons from bax-/- rn=5). bax+/- 
(n=1 21 and bax + /+  (n=6) embrvos grown for 312 hours in culture with BDNF 
nOng/m n. The means and standard errors of the means are shown. Each point in 
the graph represents the mean of a number of embryos. For each embryo triplicate 
cultures were established for all conditions studied.
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6.7b: E18 Nodose Neurons, without factors
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Figure 6.7b: Percent survival of El 8 nodose neurons from bax-/- fn=51 bax+A
and bax + /+  (n=6) embryos grown for 31 2 hours in culture without BDNF. 
The means and standard errors of the means are shown. Each point in the graph 
represents the mean of a number of embryos. For each embryo triplicate cultures 
were established for all conditions studied.
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6.8a: P I Nodose Neurons + BDNF (lOng/ml)
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Figure 6.8a: Percent survival of PI nodose neurons from bax-/- (n=71. bax+/~ 
fn=141. and bax + /+  (n=51 neonates grown for 312 hours in cuiture with BDNF 
nOng/mO. The means and standard errors of the means are shown. Each point in 
the graph represents the mean of a number of neonates. For each neonate triplicate 
cultures were established for all conditions studied.
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6.8b: P I Nodose Neurons, without factors
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Figure 6.8b: Percent survival of PI nodose neurons from baxV- (r\=7). bax+/- 
(n=141. and bax + /+  (n -3 )  neonates grown for 312 hours in culture without BDNF. 
The means and standard errors of the means are shown. Each point in the graph 
represents the mean of a number of neonates. For each neonate triplicate cultures 
were established for all conditions studied.
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Decreased Survival of Bax-deficient Neurons in Response to 
Neurotrophins
An interesting survival pattern was seen in both the nodose and trigeminal cranial 
sensory neurons derived from Bax-deficient embryos at El 8 and neonates at P I . 
Over 312 hours in culture, the neurons that were grown without neurotrophic 
support survived better than those that were grown in the presence of their 
appropriate neurotrophic factor. This pattern was more marked in nodose neurons 
but was present in both cell types. Furthermore, the distinction was clearer at PI 
than at El 8, and again this is particularly true of the nodose neurons.
At El 8, Bax-deficient trigeminal neurons (Fig. 6.9a) survived better in the absence 
of neurotrophins at time points after 192 hours in culture. Furthermore, when NGF 
(1 Ong/ml) was added to cultures that had been grown without factors, 48 hours 
after plating, the neurons in these cultures died more rapidly than those in cultures 
that lacked NGF. A similar pattern was seen in cultures of PI Bax-deficient 
trigeminal neurons (Fig. 6.9b). Here after 168 hours in culture there was a clear 
difference between cells that were grown for the duration of the experiment in the 
absence of neurotrophins and those which were grown with NGF (1 Ong/ml) either 
from the outset or after 48 hours.
The same pattern was observed for nodose neurons. Here, at El 8, the Bax-deficient 
neurons cultured without factors survived better at time points after 144 hours 
after plating compared to those in cultures containing BDNF (Fig. 6.10a). The same 
pattern was repeated in the data obtained from Bax-deficient PI nodose neurons 
(Fig. 6.10b). After only 96 hours in culture there was a clear difference between the 
survival of Bax-deficient nodose neurons grown in the presence of BDNF and those 
that were not. At the end of the experiment, 312 hours after plating, there were 
virtually no cells surviving in the dishes supplemented with BDNF whilst 50% of the 
neurons were still alive in the cultures that lacked neurotrophins.
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Figure 6.9a: Survival of Trigeminal Neurons derived from Bax-deficient embrvos at 
El 8 fn = 5 \ grown for 312 hours in culture without factors, with NGF (10na/m n  
from the outset or added to the cultures after 48 hours. The means and standard 
errors of the means are shown. Each point in the graph represents the mean of a 
number of embryos. For each embryo triplicate cultures were established for all 
conditions studied.
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6.9b: P I Trigeminal Neurons
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Figure 6.9b: Survival of Trigeminal Neurons derived from Bax-deficient neonates at 
PI (n=7). grown for 312 hours in culture without factors, with NGF (1 Ong/ml^ from 
the outset or added to the cultures after 48 hours. The means and standard errors 
of the means are shown. Each point in the graph represents the mean of a number 
of neonates. For each neonate triplicate cultures were established for all conditions 
studied.
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6.10a: E18 Nodose Neurons
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Figure 6.10a: Survival of Nodose Neurons derived from Bax-deficient embrvos at 
El 8 (n -5 ), grown for 312 hours in culture without factors, with BDNF (1 Ong/mH 
from the outset or added to the cultures after 48 hours. The means and standard 
errors of the means are shown. Each point in the graph represents the mean of a 
number of embryos. For each embryo triplicate cultures were established for all 
conditions studied.
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6.10b: P I Nodose Neurons
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Figure 6.10b: Survival of Nodose Neurons derived from Bax-deficient neonates at PI 
f^n=71. grown for 312 hours in culture without factors, with BDNF (1Qna/mn from 
the outset or added to the cultures after 48 hours. The means and standard errors 
of the means are shown. Each point in the graph represents the mean of a number 
of neonates. For each neonate triplicate cultures were established for all conditions 
studied.
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Effects of Neurotrophic Factors on Neurite Outgrowth of Bax-deficient 
Neurons
Whilst studying the cultures of Bax-deficient trigeminal and nodose neurons grown 
in medium not supplemented with neurotrophic factors, it was apparent that many 
of the neurons in these cultures did not extend long neurites compared with those 
cultured in the presence of neurotrophic factors. To determine whether the 
reduction in neurite length was a direct result of neurotrophin deficiency, the 
number of trigeminal and nodose neurons projecting neurites of greater than two 
soma diameters were counted 48, 72, and 96 hours after plating in cultures lacking 
neurotrophins. These data were compared to the number of trigeminal and nodose 
neurons projecting neurites longer than two soma diameters in cultures that lacked 
neurotrophic factors for the first 48 hours, but to which neurotrophins were added 
after this time. These data are summarised in Figures 6.11 and 6.12.
At El 8, around 50% of trigeminal neurons grown without NGF for 48 hours had 
neurites of greater than 2 soma diameters (Fig. 6.1 la ). After another 48 hours in 
culture, this figure had increased to 60%. In cultures that were supplemented with 
NGF(1 Ong/ml) after 48 hours, over 90% of the surviving neurons had processes 
longer than two soma diameters by 96 hours after plating. Very similar observations 
were made on PI trigeminal neurons where after 96 hours in culture without NGF 
less than 70% of the neurons had processes that were greater then two soma 
diameters (Fig. 6.11 b). In cultures that were supplemented with NGF after 48 hours, 
100% of the neurons had processes fulfilling this criterion by 96 hours after plating.
At El 8, around 50% of nodose neurons grown without BDNF for 48 hours in vitro 
had neurites greater than two soma diameters. By 96 hours, this figure had risen to 
almost 70% (Fig. 6.12a). In cultures that were supplemented with BDNF (1 Ong/ml) 
after 48 hours, 100% of the neurons had processes of greater than 2 soma 
diameters after 96 hours incubation. PI nodose neurons showed virtually identical
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results (Fig. 6.12b).
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Figure 6.1 la: Bar graphs of the proportion of E l8 Bax-deficient trigeminal neurons 
bearing neurites of greater than 2 soma diameters. The means and standard errors 
of the means are shown. Each point in the graph represents the mean of 5 embryos. 
For each embryo triplicate cultures were established for all conditions studied.
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6.11b: P I Trigeminal Neurons
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Figure 6.11 b: Bar graphs of the proportion of PI Bax-deficient trigeminal neurons 
bearing neurites of greater than 2 soma diameters. The means and standard errors 
of the means are shown. Each point in the graph represents the mean of 7 
neonates. For each neonate triplicate cultures were established for all conditions 
studied.
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Figure 6 .12a: Bar graphs of the proportion of El 8 Bax-deficient nodose neurons 
bearing neurites of greater than 2 soma diameters. Each point in the graph 
represents the mean of 5 embryos. For each embryo triplicate cultures were 
established for all conditions studied.
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6.12b: P I Nodose Neurons
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Figure 6 .12b: Bar graphs of the proportion of PI Bax-deficient nodose neurons 
bearing neurites of greater than 2 soma diameters. The means and standard errors 
of the means are shown. Each point in the graph represents the mean of 7 
neonates. For each embryo triplicate cultures were established for all conditions 
studied.
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Survival of Bax-deficient Neurons in vivo
Histological analysis of the number of neurons in the trigeminal ganglia of Bax- 
deficient embryos was carried out at El 4, El 6, and El 8. At all ages there were 
significantly more neurons in the ganglia of Bax-deficient embryos (Fig. 6 .13a). 
Furthermore, there was a marked decrease in the number of pyknotic neurons 
observed in Bax-deficient specimens (Fig. 6 .13b). At El 4, there was a 67%  
decrease in the number of pyknotic neurons observed in the trigeminal ganglia of 
Bax-deficient embryos. By El 6, this difference had fallen to 48% and by El 8 there 
was no difference observed.
This very marked decrease in pyknosis observed at El 4, which is the peak of 
naturally occurring neuronal death in the trigeminal ganglion in vivo, is reflected by 
the fact that the greatest difference between neuronal number in the wild type and 
Bax-deficient trigeminal ganglia is at El 6. It is perhaps worth noting that the 
neuronal and pyknotic counts observed were higher than those previously reported 
even in the wild type embryos. This does not necessarily mean that there is a 
problem with the quantification as this may be due to the different background 
strains of the mice studied.
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Figure 6 .13a: Bar graphs showing the estimated number of neurons in the trigeminal 
ganglia of Bax-deficient and wild type embrvos. The means and the standard errors 
of the means are shown. For Bax-deficient embryos, n=14 at El 4, n=10 at El 6, and 
n=17 at El 8. For wild type embryos, n=18 at El 4, n=10 at El 6, and n=16 at El 8.
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6.13b: Estimated Number of Pyknotic Trigeminal Neurons
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Figure 6 .13b: Bar graphs showing the estimated number of pyknotic neurons in the 
trigeminal ganglia of Bax-deficient and wild type embrvos. The means and the 
standard errors of the means are shown. For Bax-deficient embryos, n=14 at El 4, 
n=10 at El 6, and n=17 at El 8. For wild type embryos, n=18 at El 4, n=10 at El 6, 
and n=16 at El 8.
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DISCUSSION
The data obtained from both in vitro and in vivo experiments using Bax null mutant 
mice have indicated that Bax does play a role in executing the cell death programme 
in at least some sensory neurons during development. However, the in vitro and in 
vivo data conflict with regard to the developmental period during which Bax is most 
important in regulating neuronal cell death. In culture, El 4 Bax-deficient sensory 
neurons do not show significantly enhanced survival over wild type neurons, either 
with or without neurotrophins. However, at older ages, significantly more bax 
sensory neurons survive in both neurotrophin supplemented and neurotrophin 
deficient cultures compared to wild type neurons. The importance of Bax's role in 
the cell death programme appears to become more pronounced with increasing age. 
Thus, the difference in survival between and neurons is greatest at
P I , the oldest age studied. From the in vitro studies it seems likely that Bax does 
not play a significant part in regulating developmental neuronal cell death in the 
mouse trigeminal ganglion, where developmental cell death peaks at El 4 and is 
largely over by birth (Davies & Lumsden, 1984; Pinon et al, 1996).
In contrast, it seems from the study of the developing trigeminal ganglia of bax 
and wild type mice in vivo that Bax does play a significant role in the execution of 
developmental neuronal cell death. Large differences between the number of 
neurons in bax and wild type trigeminal ganglia are apparent at El 4 (the earliest 
age studied) and El 6. Accordingly, the greatest reduction in the number of 
pyknotic nuclei in bax**/” trigeminal ganglia as compared to wild type ganglia occurs 
at El 4, and by El 8 the number of pyknotic nuclei in the ganglia of both genotypes 
is the same.
A number of possibilities could explain the discrepancy between the in vitro and in 
vivo data. For example, it is possible that the greater number of neurons in bax 
trigeminal ganglia compared to wild type ganglia does not reflect a role for Bax in 
neuronal killing but rather in the programmed death of cells within the target field
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that synthesise neurotrophins. Thus, in the absence of Bax, a greater number of 
neurotrophin synthesising cells would survive which would increase target field 
neurotrophin expression and this in turn, according to the neurotrophin hypothesis, 
would increase the number of neurons surviving the period of developmental cell 
death. The validity of this hypothesis could be tested by using quantitative RT-PCR 
to measure the relative levels of neurotrophin mRNAs in the target fields of bax 
and wild type embryos.
A number of different stimuli apart from growth factor deficiency can induce 
apoptosis. Cell death induced by different stimuli may not be executed in the same 
way using the same death promoting molecules. It is possible that in the case of 
sensory neurons the process of dissection, trypsinisation, trituration and plating in 
defined medium activates a cell death programme that involves other pro-apoptotic 
members of the Bcl-2 family, such as Bcl-xs and/or Bad, or alternatively a 
mechanism not involving members of the Bcl-2 family. This may explain why cell 
death of El 4, and to a certain extent El 6, trigeminal neurons appears to be Bax- 
independent in vitro, but Bax dependent in vivo.
The presence of non-neuronal cells in culture may provide one possible explanation 
to account for the increased survival of older sensory neurons in vitro at a 
time when there is little difference in the survival of bax”/ ” and bax + neurons in 
vivo. It is possible that the absence of a functional bax gene not only increases the 
numbers of neurons within sensory ganglia but also increase numbers of certain 
types of non-neuronal cells within the ganglia. Because of technical difficulties it was 
not possible to separate neurons from non-neuronal cells in cultures established 
from individual embryos. As a result, there may have been higher numbers of non­
neuronal cells in the cultures from Bax-deficient animals, particularly at older 
embryonic ages. Thus, the number and identity of non-neuronal cells in cultures 
from older bax ”/ ” sensory ganglia may be markedly different to that in cultures 
from wild type ganglia of the same age. Ganglionic non-neuronal cells in culture
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synthesise a number of growth promoting molecules including trophic factors and 
extracellular matrix proteins. It is therefore possible that the extended survival of a 
subpopulation of bax"/" neurons in the absence of added trophic factor may, in part, 
be due to the production of trophic molecules by a population of non-neuronal cells 
that are particularly augmented in bax"/" cultures.
Another curiosity of the tissue culture data presented in this chapter is that survival 
of bax "/" neurons is greater in the absence of neurotrophic factor than in the 
presence of neurotrophic factors. Most surprisingly, the addition of neurotrophic 
factor to cultures of bax"/" neurons that had previously been cultured without 
neurotrophins accelerates cell death. One possible explanation for this latter 
phenomenon is that during culture in the presence of neurotrophins trk receptors 
are down-regulated and/or p75 neurotrophin receptors are up-regulated. Much 
evidence now exists to suggest that binding of neurotrophins to p75 in the absence 
of the appropriate high affinity trk receptor can induce apoptosis in at least some 
cell types (Rabizeh et al., 1993; Barrett & Bartlett, 1994; Casaccia-Bonnefil et al.,
1996; Farde et al., 1996). Further work, in particular to determine what happens to 
the expression of trk and p75 receptors in prolonged culture, both in the presence 
and absence of neurotrophins, will be needed to determine whether this is indeed 
the case.
Previously published data have suggested that the levels of Bcl-2 and Bax expressed 
by neurons are important in determining whether neurons live or die (Allsopp et al.,
1993, 1995; Martinou et al, 1993, Garcia et al, 1992; Vekrellis et al., 1997). 
However, the data presented in this chapter clearly show that the Bax;Bcl-2 
rheostat model (Oltvai et al., 1993) cannot entirely account for the regulation of 
neuronal survival in all sensory neurons at all stages of development. For example, 
the in vitro data clearly shows that older sensory ganglia contain two populations of 
neurons. One population shows greatly enhanced survival in the absence of Bax, as 
would be expected according to the Bax: Bcl-2 rheostat model. However, a second
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population of neurons also exists that dies rapidly irrespective of whether Bax is 
expressed or not. Moreover, although bax trigeminal ganglia show reduced 
numbers of pyknotic nuclei at El 4 and El 6 compared to wild type ganglia, a 
considerable number of pyknotic nuclei are still present, indicating that the absence 
of Bax does not entirely prevent developmental neuronal death. The existence of 
Bcl-2/Bax independent mechanisms that regulate neuronal survival is also suggested 
from the data presented in Chapter 4 of this thesis. Although Bcl-2 null mutant 
embryos contain fewer trigeminal neurons than wild type embryos at El 6 and El 8, 
the majority of neurons still survive the period of neuronal cell death. It would be 
interesting to determine whether the phenotype of the sensory neuronal sub­
population lost in the Bcl-2 knockout is the same as that of the neuronal population 
whose numbers are increased in the Bax knockout. The survival of those neurons 
whose fate does not appear to depend upon Bcl-2 and Bax expression may be 
regulated by other pro- and anti-apoptotic members of the Bcl-2 family, or by 
another unrelated mechanism. Analysis of transgenic animals containing single and 
double null mutations of other Bcl-2 family members could resolve this question.
One should be cautious in interpreting the results of experiments involving 
transgenic animals. It is not known to what extent, if any, the expression of Bcl-2 
family members in any one cell type are linked and to what extent there is overlap 
and redundancy amongst members of the Bcl-2 family. For example, if Bax 
expression is down-regulated or abolished in neurons, does the expression of other 
pro-apoptotic members of the Bcl-2 family increase to compensate, or does the 
level of Bcl-2 in neurons decrease to try and maintain the correct Bax: Bcl-2 ratio? If 
this were the case then it could obscure the true function and/or importance of the 
gene under investigation. The number of neurons that normally die by a Bax- 
dependent mechanism may be much greater than that suggested by the neuronal 
counts in trigeminal ganglia of El 4 and El 6 Bax knockout embryos. Perhaps in the 
absence of Bax other pro-apoptotic members of the Bcl-2 family take over its
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function in many neurons, possibly after compensatory up-regulation of their 
expression, so that the density of target field innervation is maintained near normal. 
Further studies at the molecular level will be required to determine whether the of 
expression of bcl-2 family members are co-ordinately regulated.
Finally, another interesting observation to emerge from the study of sensory 
neurons from bax null mutant embryos is that bax-deficlent neurons cultured In the 
absence of neurotrophic factors show reduced neurite length compared to those 
grown with neurotrophins. Some of the earliest studies on the prototypical 
neurotrophin, NGF, showed that it could enhance neurite outgrowth from 
sympathetic neurons. However, since sympathetic neurons are critically dependent 
on NGF for survival it was not entirely clear whether enhancement of neurite 
outgrowth is a result of general increased vitality or whether NGF specifically 
regulates process outgrowth. To date, little data have emerged on ability of other 
neurotrophins to regulate process outgrowth. Since a proportion of bax-deficient 
sensory neurons survive in the absence of neurotrophins, they could provide a good 
model system to Investigate the role that neurotrophins play in regulating neurite 
outgrowth in this neuronal type.
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